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ABSTRACT 
Obstructive sleep apnea (OSA) is a major public health problem. Severe OSA 
classified in terms of apnea-hypopnea index (AHI) is associated with increased 
morbidity and mortality. Milder forms of OSA and prolonged partial upper airway 
obstruction are not equally high-risk conditions, although affected individuals can be 
as symptomatic as those with severe OSA. Treatment regime for these patients vary 
from country to country.  
While measurement of the arterial oxyhemoglobin saturation (SaO2, SpO2 with 
pulse oximetry) is mandatory in the evaluation of sleep-disordered breathing (SDB 
= all breathing abnormalities from normal breathing to apnea), CO2 is rarely 
measured. CO2 measurements have been mainly done in populations where 
hypercapnia (High arterial CO2, (PaCO2)) is suspected. There has not been a great 
need for CO2 measurement in sleep research as the effects of severe SDB are readily 
seen with SpO2. SpO2 measurement is robust and the signal is simple to interpret 
and feasible for automatic analyses. At the moment, obtaining a good quality CO2 
signal requires more effort. The signals are affected by several factors and are prone 
to artifacts. On the other hand, the importance of CO2 in the control of breathing 
and the wealth of information the CO2 signal may contain, could improve the SDB 
diagnostics. 
The aim of this study was to determine the patterns of transcutaneous CO2 
(PtcCO2) during different forms of SDB, also including prolonged partial upper 
airway obstruction. 
PtcCO2 dynamics were studied retrospectively from cardiorespiratory 
polygraphic recordings performed at the Tampere University Hospital sleep clinic. 
These patients were referred to hospital due to a suspicion of SDB. A set of scoring 
rules was developed to characterize progressive flow limitation events. These events 
were then screened from 425 patient recordings performed between March 2004 and 
April 2007. Apneas, hypopneas and steady flow limitation were screened as 
sequences from 555 patient recordings from between June 2005 and May 2007. 
Physiology and anatomy change during pregnancy and sleep problems including 
SDB are commonly reported. In a prospective study, standard polysomnography 
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(PSG) with PtcCO2 were performed in 18 healthy women during their third trimester 
and in 12 healthy non-pregnant controls for a more exact characterization of SDB. 
Progressive flow-limitation was systematically associated with increasing PtcCO2, 
whether or not, the episode was associated with increased respiratory effort. 
Respiratory efforts started to increase when PtcCO2 exceeded the PtcCO2 plateau 
level. PtcCO2 plateau was the highest level of PtcCO2 which was associated with 
stable breathing. Progressive flow limitation was associated with small SpO2 drop, 
but not systematically. 
Different sleep apnea types associated with different PtcCO2 levels. PtcCO2 
during central and mixed sleep apnea did not differ from PtcCO2 in wakefulness. 
PtcCO2 during obstructive sleep apnea and hypopnea did not differ from PtcCO2 
levels observed during normal stable breathing in sleep (PtcCO2 plateau). Steady 
flow-limitation sequences associated with PtcCO2 levels that were higher than those 
observed during the PtcCO2 plateau. There was no difference in SpO2 between flow-
limitation and stable breathing.  
Pregnant women did not differ from controls in terms of SDB; flow-limitation, 
snoring, AHI and oxyhemoglobin desaturation index of 3% (ODI3) were similarly 
low in both groups. However, pregnant women more frequently presented PtcCO2 
“peaks”, which were scarce in non-pregnant controls (n = 78 vs. 5). These peaks 
associated with flow-limitation and altered ventilatory control. PtcCO2 levels were 
not different during wakefulness or sleep, but the variance of PtcCO2 during non-
rapid eye movement (NREM) sleep in pregnant women was smaller than in non-
pregnant controls.  
In conclusion, PtcCO2 measurement is sensitive to ventilatory changes during 
sleep. Sleep-related increase in PaCO2 can be identified with PtcCO2. Progressive 
flow limitation associates with PtcCO2 increase and PtcCO2 levels associate to sleep 
depth as well as sleep apnea types. Ventilatory changes in pregnancy may lead to 
PtcCO2 “peaks”, which have not been described before. 
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TIIVISTELMÄ 
Obstruktiivinen uniapnea on huomattava kansanterveydellinen ongelma. Erityisesti 
vaikeaan uniapneaan liittyy lisääntynyttä sairastuvuutta ja kuolleisuutta. 
Obstruktiivisen uniapnean lievempiin muotoihin tai osittaiseen 
ylähengitystieahtaumaan ei liity vastaavaa riskiä, mutta näistä tautimuodoista kärsivät 
eivät oireiden perusteella välttämättä eroa vaikeasta uniapneasta. Viimeksimainittujen 
hoitokäytännöt eroavat alueittain ja maittain. 
Valtimoveren happikyllästeisyyden (SaO2, SpO2 jos pulssioksimetri) mittaaminen 
on pakollista unenaikaisten hengityshäiriöiden (kaikki normaalista hengityksestä 
apneaan) arvioinnissa. Hiilidioksidia (CO2) sen sijaan mitataan harvemmin. CO2- 
mittauksia on tehty pääosin potilasryhmissä, joissa hypercapnia (korkea valtimoveren 
hiilidioksidipitoisuus) on todennäköistä. CO2:n mittaamiselle unen aikana ei ole ollut 
suurta tarvetta, koska vaikeiden unenaikaisten hengityshäiriöiden seuraukset ovat 
nähtävissä SpO2-mittauksella. SpO2-mittaus on vakaa ja signaali on helppo tulkita, 
joten automaattiset analyysit ovat yleisesti käytössä. Tällä hetkellä hyvälaatuisen CO2-
signaalin saaminen on hankalampaa, koska mittaus on alttiimpi virheille. Toisaalta, 
CO2 on tärkeä hengityksen säätelijä ja CO2-signaalin sisältämä informaatio voi 
parantaa unenaikaisten hengityshäiriöiden diagnostiikkaa. 
Tämän tutkimuksen tarkoituksena oli määrittää transkutaanisen eli iholta 
mitattavan hiilidioksidin (PtcCO2) toimintaa unenaikaisten hengityshäiriöiden 
aikana, sisältäen myös osittaisen ylähengitystieahtauman. 
PtcCO2:n dynamiikkaa tutkittiin takautuvasti Tampereen yliopistollisen sairaalan 
unilaboratoriossa tehdyistä yöpolygrafioista. Nämä tutkimukset on tehty mahdollisen 
uniapneaepäilyn vuoksi. Progressiiviselle virtausrajoitukselle kehitettiin kriteeristö ja 
kyseisiä hengitysjaksoja seulottiin 425 potilaan aineistosta, joka oli kerätty aikavälillä 
3/2004 – 4/2007. Apneaa, hypopneaa ja tasaista virtausrajoitusta puolestaan 
tutkittiin jaksoina 555 potilaan aineistosta, joka oli kerätty välillä 6/2005 – 5/2007. 
Raskauden aikana fysiologia ja anatomia muuttuvat ja uniongelmat sekä unenaikaiset 
hengitykseen liittyvät ongelmat ovat tavallisia. Etenevässä tutkimuksessa tehtiin 18 
terveelle, viimeisellä raskauskolmanneksella olevalle ja 12 terveelle verrokille 
unipolygrafia ja PtcCO2-mittaus. Tutkimuksen tarkoituksena oli määrittää 
unenaikaiset hengityshäiriöt aikaisempaa tarkemmin. 
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Progressiiviseen virtausrajoitukseen liittyi systemaattisesti PtcCO2:n nousu, 
huolimatta siitä liittyikö kyseiseen jaksoon lisääntyneitä hengitysyrityksiä vai ei. 
Hengitysyritykset lisääntyivät kun PtcCO2-arvo ylitti PtcCO2-tasanteen. PtcCO2 
tasanne oli korkein PtcCO2-taso, johon liittyi tasaista hengitystä. Progressiiviseen 
virtausrajoitukseen liittyi yleensä pieni SpO2-lasku, mutta näin ei tapahtunut 
systemaattisesti. 
Tietyt PtcCO2-tasot liittyivät tiettyihin uniapneatyyppeihin. Sentraalisen ja 
sekatyyppisen uniapnean aikana PtcCO2 oli samalla tasolla kuin valveen aikana. 
Obstruktiivisen uniapnea ja hypopnean aikana PtcCO2-taso puolestaan ei eronnut 
tasaisen yöllisen hengityksen PtcCO2-tasosta. Tasaisen virtausrajoituksen aikainen 
PtcCO2 puolestaan oli korkeammalla kuin tasaisen hengityksen PtcCO2-taso, mutta 
SpO2 eroa ei havaittu näiden kahden jakson välillä. 
Raskaana olevat eivät eronneet verrokeista unenaikaisten hengityshäiriöiden 
suhteen. Virtausrajoitus, kuorsaus, apnea-hypopnea indeksi (AHI) sekä 3%: n SpO2 
lasku (ODI3) olivat yhtä alhaisia molemmissa ryhmissä. Raskaana olevilla esiintyi 
verrokkeja useammin PtcCO2-käyrässä “piikkejä” (n = 78 vs 5). Näihin piikkeihin 
liittyi virtausrajoitusta ja hengityksen säätelyn muuttumista. Eri univaiheiden aikana 
PtcCO2-tasoissa ei havaittu eroja ryhmien välillä, mutta PtcCO2:n varianssi oli 
pienempi NREM-unen aikana raskaana olevilla. 
PtcCO2-mittaus on herkkä hengityksen muutoksille unen aikana. Uneen liittyvä 
hiilidioksidin nousu voidaan havaita PtcCO2-mittauksella. Progressiiviseen 
virtausrajoitukseen liittyy PtcCO2:n nousu ja PtcCO2-tasot ovat yhteydessä sekä 
unen syvyyteen että uniapneatyyppeihin. Raskaudenaikaiset hengitysmuutokset 
voivat johtaa “PtcCO2 -piikkeihin” joita ei ole aikaisemmin kuvattu.  
 
 ix 
CONTENTS 
1 Introduction .......................................................................................................................... 15 
2 Review of the literature ....................................................................................................... 16 
2.1 Sleep and breathing ................................................................................................. 16 
2.1.1 Sleep ........................................................................................................ 16 
2.1.2 Respiratory neurons and control of breathing ................................. 17 
2.1.2.1 Chemoreceptors .................................................................. 17 
2.1.3 Upper airway .......................................................................................... 18 
2.1.3.1 Upper airway anatomy and physiology ........................... 19 
2.1.4 Effects of sleep on breathing .............................................................. 20 
2.2 Sleep-disordered breathing ..................................................................................... 22 
2.2.1 Definitions and scoring ........................................................................ 22 
2.2.2 Prolonged partial upper airway obstruction, inspiratory 
flow-limitation and snoring ................................................................. 23 
2.2.3 Sleep-disordered breathing during pregnancy .................................. 25 
2.2.4 Pathophysiology and mechanics of sleep-disordered 
breathing ................................................................................................. 25 
2.2.4.1 Anatomy ............................................................................... 26 
2.2.4.2 Airway control ..................................................................... 26 
2.2.4.3 Control of breathing, loop gain and the role of CO2 
during sleep-disordered breathing ................................... 27 
2.2.4.4 Role of arousal in sleep-disordered breathing ............... 32 
2.2.5 Consequences of sleep-disordered breathing ................................... 33 
2.3 Clinical methods ....................................................................................................... 34 
2.3.1 Transcutaneous carbon dioxide .......................................................... 34 
2.3.2 Arterial oxyhemoglobin saturation ..................................................... 38 
2.3.3 Airflow detection ................................................................................... 38 
3 Aims of the study ................................................................................................................. 40 
4 Subjects and methods .......................................................................................................... 41 
4.1 Subjects ...................................................................................................................... 41 
4.1.1 Characteristics of the patients in retrospective studies (I 
and II) ...................................................................................................... 41 
4.1.2 Characteristics of the subjects in the prospective study 
(III) .......................................................................................................... 41 
4.2 Methods ..................................................................................................................... 42 
4.2.1 Demographic measurements and obstetrical examination ............ 42 
 x 
4.2.2 Sleep studies ........................................................................................... 42 
4.2.2.1 Cardio-respiratory sleep studies........................................ 42 
4.2.2.2 Polysomnography ............................................................... 43 
4.2.3 Scoring of the respiratory events, leg movements and 
PtcCO2 plateau....................................................................................... 44 
4.2.4 Data analyses .......................................................................................... 47 
4.2.5 Statistical analyses .................................................................................. 48 
5 Results .................................................................................................................................... 49 
5.1 Patients and subjects ................................................................................................ 49 
5.2 Sleep-disordered breathing and non-invasive blood gas 
measurements ........................................................................................................... 50 
5.2.1 Progressive flow limitation (study I) .................................................. 50 
5.2.2 Sleep apnea and steady flow limitation (study II) ............................ 52 
5.2.3 Pregnancy and sleep-disordered breathing (study III) .................... 58 
5.3 Pregnancy and sleep ................................................................................................. 60 
6 Discussion .............................................................................................................................. 62 
6.1 Progressive inspiratory flow limitation and PtcCO2 plateau (Study I) ............ 63 
6.2 Sleep apnea, flow limitation and PtcCO2 (Study II) ........................................... 65 
6.3 Pregnancy, sleep-disordered breathing and PtcCO2 (Study III) ....................... 67 
6.4 Strengths and Limitations ....................................................................................... 69 
6.5 Clinical significance of the findings ...................................................................... 71 
6.6 Future directions ...................................................................................................... 71 
7 Summary and conclusions ................................................................................................... 73 
8 Acknowledgements .............................................................................................................. 75 
9 references ............................................................................................................................... 77 
 
 xi 
ABBREVIATIONS 
AASM American Academy of Sleep Medicine 
AHI Apnea-hypopnea index 
AI Apnea index 
BMI Body mass index 
CAI Central apnea index 
CPAP Continuous positive airway pressure 
EEG Electroencephalography 
EMG Electromyography  
EOG Electrooculography 
EtCO2 End-tidal carbon dioxide 
FRC Functional residual capacity 
GABA Gamma-aminobutyric acid 
GG Genioglossus muscle 
HD High-drive  
HI Hypopnea index 
LM Leg movements 
MAI Mixed apnea index 
NonHD Non-high-drive 
NREM Non-rapid eye movement sleep 
OAI Obstructive apnea index 
OSA Obstructive sleep apnea 
PaCO2 Partial pressure of carbon dioxide in arteries 
PaO2 Partial pressure of oxygen in arteries 
Pcrit Critical closing pressure of the upper airway 
PLM Periodic leg movements 
PtcCO2 Partial pressure of transcutaneous carbon dioxide 
RDI Respiratory disturbance index 
REM Rapid eye movement sleep 
RERA Respiratory effort-related arousal 
RTN Retrotrapezoid nucleus  
 xii 
SaO2 Arterial oxyhemoglobin saturation 
SCSB Static-charge-sensitive bed 
SpO2 Arterial oxyhemoglobin saturation measured with pulse 
oximetry 
SDB Sleep-disordered breathing  
Ti  Inspiratory time  
TP Tensor palatini muscle 
TST Total sleep time 
UARS Upper airway resistance syndrome 
VE  Minute ventilation 
VLPO Ventrolateral preoptic nucleus 
VRG Ventral respiratory group 
VT Tidal volume 
WASM World Association of Sleep Medicine 
 
 xiii 
ORIGINAL PUBLICATIONS 
Publication I Rimpilä V, Saaresranta T, Huhtala H, Virkki A, Salminen AV, Polo 
O. Transcutaneous CO2 plateau as set-point for respiratory drive 
during upper airway flow-limitation. Respir Physiol Neurobiol. 2014 
Jan 15; 191:44-51. doi: 10.1016/j.resp.2013.10.014. Available online: 
2013 Nov 4. 
Publication II Rimpilä V, Hosokawa K, Huhtala H, Saaresranta T, Salminen AV, 
Polo O. Transcutaneous carbon dioxide during sleep-disordered 
breathing. Respir Physiol Neurobiol. 2015 Dec; 219:95-102. doi: 
10.1016/j.resp.2015.10.002. Available online: 2015 Oct 22. 
Publication III Rimpilä V, Jernman R, Lassila K, Uotila J, Huhtala H, Mäenpää J, 
Polo O. Upper airway flow limitation and transcutaneous carbon 
dioxide during sleep in normal pregnancy. Sleep Med. 2017 
Aug;36:67-74. doi: 10.1016/j.sleep.2017.05.005. Available online: 
2017 May 29. 
 
 
  
 xiv 
 
 
 
 15 
1 INTRODUCTION 
Sleep-disordered breathing (SDB) is a major health problem (Peppard, et al. 2013). 
It is commonly assessed with apnea-hypopnea index (AHI), which describes how 
many repetitive complete or partial upper airway closure events occur on average 
within an hour of sleep. This index forms the basis for obstructive sleep apnea (OSA) 
diagnosis. OSA is associated with reduced quality of life, numerous comorbidities as 
well as increased mortality. (Punjabi, et al. 2009) 
However, even with low AHI, some patients are highly symptomatic and benefit 
from SDB treatment and adhere to it (Anttalainen, et al. 2007). This implies that 
AHI cannot be used to describe the full spectrum of SDB. In fact, events with 
sustained partial upper airway obstruction without arousals or desaturations are not 
considered to be important. Clinical significance and definitions for partial upper 
airway obstruction are not well established. While an apnea is defined as complete 
absence of breathing, it is difficult to establish a solid definition for non-apneic 
abnormal breathing (Pamidi, et al. 2017).  
In addition, measurement of oxyhemoglobin saturation (SaO2 and SpO2 when 
measured with pulse oximetry) is a standard procedure in the assessment of SDB but 
the measurement of CO2, which has the major role is respiratory control, is seldomly 
performed. In this regard, it becomes difficult to understand why SDB has a certain 
phenotype if major controller and outcome of ventilation is not monitored. An 
estimate of arterial CO2 (PaCO2) can be acquired by using transcutaneous carbon 
dioxide measurement (PtcCO2) (Storre, et al. 2011). PtcCO2 can be used 
continuously and nocturnal PtcCO2 profile becomes available. 
Our aim was to understand how PtcCO2 is affected by SDB. Specifically, we 
investigated whether respiratory effort during inspiratory flow-limitation was 
associated with specific PtcCO2 threshold. In addition, association between PtcCO2 
and different subtypes of SDB was investigated. SDB can have detrimental effects 
during pregnancy and the effects of partial upper airway obstruction on PtcCO2 were 
studied during final trimester in healthy pregnant women and controls. 
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2 REVIEW OF THE LITERATURE 
2.1 Sleep and breathing 
2.1.1 Sleep 
Some form of rest is vital to most if not all organisms, which speaks for a very early 
origin in evolution. The main function of sleep/rest could therefore be linked to 
most primitive functions of an organism such as energy metabolism. (Porkka-
Heiskanen, et al. 2002) In humans, the two-process model of Borbely has been 
proposed to explain the timing, depth, and duration of the sleep (Borbely. 1982). 
Circadian control, which is called process C, incorporates the time of day to the 
model, i.e. falling asleep is more likely to occur at night. This process is strongly 
influenced by the light exposure. Homeostatic control, process S, includes the 
duration of wakefulness prior to sleep, i.e. the longer an individual stay awake, the 
more the propensity to fall asleep increases. (Borbely. 1982) The circadian rhythm 
(process C) is generated by the suprachiasmatic nucleus (Saper. 2013). 
Sleep is traditionally divided into different stages. Main types are rapid eye 
movement (REM) sleep and non-rapid eye movement sleep (NREM). NREM is also 
subdivided into different stages according to frequency and phenomena observed in 
electroencephalogram (EEG) during polysomnography (PSG) (Rechtschaffen, 
Kales. 1968, Iber, et al. 2007). Sleep structure is commonly assessed with 30 second 
epochs, which are used to build sleep stage profile (hypnogram) for the night. 
Normally the deepest sleep is observed in the beginning of the night and periods of 
NREM and REM sleep form cycles that repeat three to five times during the night 
(Dogas, et al. 2014).  
Physiologically wakefulness is maintained by neural pathways that originate from 
the brainstem. Two major pathways have been identified. The first branch originates 
from the upper brainstem and projects to the thalamus. These neurons are active 
during wakefulness and REM, which are characterized by cortical activity and 
become much less active during NREM sleep. The second branch originates from 
the upper brainstem and the caudal hypothalamus. These neurons project to the 
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lateral hypothalamus and basal forebrain, activating the neurons throughout the 
cerebral cortex. Lesions in these areas can cause narcolepsy or profound sleepiness 
and coma. (Saper, et al. 2005) 
Sleep is promoted by the ventrolateral preoptic nucleus (VLPO), which is located 
in the anterior hypothalamus and is active during sleep. Neurons in VLPO project 
to the hypothalamus and nuclei in the brainstem, which are involved in arousal and 
wakefulness. VLPO neurons contain inhibitory neurotransmitters gamma-
aminobutyric acid (GABA) and galanin. Lesions in this area reduce the amount of 
sleep more than 50%. VLPO is innervated by the nuclei in brainstem, and both 
noradrenaline and serotonin inhibit the activity of VLPO neurons. (Gallopin, et al. 
2000) 
2.1.2 Respiratory neurons and control of breathing 
Although seemingly simple, breathing is a complex activity of dedicated neurons and 
adjacent muscles. In humans and mammals in general, the main respiratory centers 
are located in the medulla (Lahiri, Forster. 2003). The most important group of these 
is the ventral respiratory group (VRG). The rostral VRG contains the Bötzinger 
complex, which is active during expiration as well as the pre-Bötzinger complex, 
which acts as a pacemaker. A group of inspiratory neurons is located caudally in the 
pre-Bötzinger complex, and this group innervates the spinal motoneurons, which 
control the activity of the diaphragm and external intercostal muscles. Nucleus 
ambiguus contains the laryngeal motoneuron cell bodies, and it is located next to 
this part of the VRG. Moving further caudally is the expiratory region, which 
projects axons to spinal motoneurons that control the abdominal and internal 
intercostal muscles. The VRG extends to spinal cord, and groups of inspiratory 
neurons are found (group C2 and C3). Yet another group of cells called dorsal 
respiratory group is found in the medulla, which contains inspiratory neurons and 
receives input from laryngeal and pulmonary receptors. Peripheral and central 
respiratory inputs are integrated in the pons (pontine respiratory group), which 
projects to respiratory neurons in the medulla. (Lahiri, Forster. 2003)  
2.1.2.1 Chemoreceptors 
The carotid body is considered to be the most important peripheral chemoreceptor 
although other sites are also found in the aorta (Kumar, Prabhakar. 2012, Nurse. 
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2014). Only the carotid body will be discussed here. Carotid bodies are located 
bilaterally in the common carotid arteries at the bifurcation to internal and external 
carotid arteries. Carotid bodies are very small (2 to 3 mm in man), but have probably 
the greatest blood flow per unit mass in the body (Kumar, Prabhakar. 2012). The 
carotid body is considered to be primarily an oxygen sensor, but the afferent activity 
of the organ is modulated by a prevailing pH/CO2 level (Nurse. 2014). 
Afferent activity of the carotid body is not linear. Hypoxia causes hyperbolic 
response curve with decreasing partial pressure of oxygen (PaO2). In addition, 
afferent activity is not completely inhibited with hyperoxia. Contrary to O2, CO2 has 
a threshold value around 20 mmHg below which the afferent discharge disappears 
during normoxia. If PaO2 is reduced, the CO2 threshold value is also decreased. In 
the physiological range, the afferent discharge for CO2 is linear and a plateau is 
reached around 70 to 80 mmHg. However, if PaO2 is decreased from normoxia, the 
discharge is increased. (Kumar, Prabhakar. 2012) 
Chemoreception that occurs within the brain is commonly referred as central 
chemoreception. The main functions are the regulation of PaCO2 and regulation of 
pH. It is generally thought that pH is the main signal for chemoreception. (Nattie, 
Li. 2012) A Number of different sites within the brain are sensitive to CO2/pH 
changes, but retrotrapezoid nucleus (RTN) is the most important since the 
elimination of two proton receptors (TASK-2 and GPR4) within these cells leads to 
profound reduction in central chemoreflex. RTN has multiple projections to 
respiratory neurons, namely to VRG, Kölliker-Fuse, lateral parabrachial nucleus, and 
nucleus tractus solitarius, which are responsible for expiratory and inspiratory 
motoneuron activity as well as respiratory rhythm generation. (Guyenet, Bayliss. 
2015) 
2.1.3 Upper airway 
The primary event causing the SDB is the narrowing or full closure of the upper 
airway (Remmers, et al. 1978). Anatomically, this structure spans from the nares 
down to the level of epiglottis. In humans, this anatomical structure contains a 
relatively high amount of soft tissue, which is supported by a limited number of rigid 
structures. For these reasons, the upper airway is actively kept open by the upper 
airway dilator muscles. (Wilkinson, et al. 2008) Especially during wakefulness, the 
upper airway control needs to adapt various activities such as speaking, sneezing and 
coughing in addition to breathing, but during sleep, airway becomes more 
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susceptible to collapse as these behavioral influences are no longer active and the 
activity of the respiratory motoneurons declines (Kubin. 2016).  
2.1.3.1 Upper airway anatomy and physiology 
During inspiration, the diaphragm generates negative pressure which decreases the 
airway lumen if not overcome by force generated by the upper airway dilators 
(Henke, et al. 1990). The most studied airway dilators are the genioglossus (GG) 
muscle and the tensor palatini (TP) muscle (Pillar, et al. 2000, McSharry, et al. 2013). 
The GG is an inspiratory active muscle with tonic and phasic activity, and it has been 
shown that single motor units in the GG start to fire before the single motor units 
of the diaphragm (Butler, Gandevia. 2008), providing airway support during 
inspiration. The GG also responds to negative airway pressure (Horner, et al. 1994). 
Negative pressure in the airway activates the mechanoreceptors in the larynx (de 
Carlos, et al. 2013), which reflexively increases GG activity (Mathew, et al. 1982, 
Horner, et al. 1991, Fogel, et al. 2003, Carberry, et al. 2015). Upper airway patency is 
not solely determined by the activity of upper airway dilators, but it is also dependent 
on the anatomy of the upper airway (Chen, et al. 2016). An increased neck 
circumference correlates with the presence of snoring and sleep apnea (Stradling, 
Crosby. 1991), indicating that an excessive amount of soft tissue reduces the airway 
size. In a magnetic resonance imaging study, tongue volume was significantly larger 
in OSA patients (Lam, et al. 2005). Also, bone structures such as a posterior position 
of the mandible may limit the airway size and predispose to airway collapse 
(Jamieson, et al. 1986). A concept of critical closing pressure (Pcrit) has been 
developed in order to characterize the patency of the upper airway to keep open 
(Schwartz, et al. 1988). In a healthy individual, the critical closing pressure during 
passive condition is around -5 cmH2O (Isono, et al. 1997). This means that when 
the airway muscles are not responding, a negative pressure is needed to close the 
airway, and therefore at a normal atmosphere (zero pressure difference) the airway 
stays open. 
Pregnancy proposes an added challenge for upper airway. Reduced lung volume 
increases the upper airway collapsibility (Owens, et al. 2010). The upper airway is 
affected by increased adipose tissue related to weight gain. Mucosal edema may also 
be present, which could be the result of estrogen (Hegewald, Crapo. 2011) or 
increased blood volume (Sanghavi, Rutherford. 2014). In addition, progesterone 
stimulates breathing, which could be destabilizing, but it also increases the GG 
activity under inspiratory resistive load, which on the other hand is stabilizing 
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(Popovic, White. 1998). However, despite pregnancy-related weight gain, a normal 
singleton or multiple pregnancy does not predispose to SDB (Brownell, et al. 1986, 
Nikkola, et al. 1996, Maasilta, et al. 2001). 
2.1.4 Effects of sleep on breathing 
Sleep is associated with reduced ventilation (hypoventilation) and therefore imposes 
a challenge to ventilatory control stability and homeostatic regulation of O2 and CO2 
transport (Dempsey, et al. 2004). Areas within the brain that are responsible for 
wakefulness and sleep are anatomically linked to those responsible for control of 
breathing (Nattie, Li. 2010, Nattie, Li. 2012). Therefore, state changes are linked to 
changes in ventilation and vice versa. During sleep, the activity of “wakefulness”-
neurons is greatly reduced as reviewed by Saper (Saper, et al. 2010), which leads to 
reduced ventilatory output as well as reduced sensitivity for blood gases (Nattie, Li. 
2010). These normal physiological processes predispose to SDB. 
During NREM sleep the activity of the respiratory neurons decrease. This is 
presumably caused by the reduced activity of noradrenergic and serotonergic 
neurons in the pons and medulla as well as histamine and orexins in addition to 
increased activity of GABA-ergic neurons (Kubin. 2016). One study showed that 
87% of studied respiratory neurons were less active during NREM. In addition, 
populations of “strong” and “weak” respiratory neurons were found, and it was 
discovered that weak cells reduced their activity more than strong cells during 
NREM (Orem, et al. 1985). 
On average, the respiratory neurons located in the brainstem are more active 
during REM than during NREM. Cholinergic, GABA-ergic, and glutamate 
containing neurons are active during REM. A large breath variability during REM 
occurs in parallel with other REM specific phasic phenomena, such as muscle 
twitches and rapid changes in heart rate and blood pressure (Kubin. 2016). 
In addition, during wakefulness, the orexinergic neurons in the lateral 
hypothalamus stimulate neurons in the RTN and rostral medullary raphe, which 
probably contributes to the wakefulness drive for breathing. During sleep, the 
activity of orexinergic neurons is inhibited, which leads to decreased activity of the 
connected areas and reduced chemosensitivity and ventilatory output (Nattie, Li. 
2010, Nattie, Li. 2012). 
During sleep onset, the minute ventilation (VE) decreases and the onset of this 
change occurs before stage 2 sleep. Most of the reduction results from the decrease 
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in tidal volume (VT) (Colrain, et al. 1987). Furthermore, ventilation during sleep is 
characterized by instability if changes between sleep stages occur frequently. EEG 
frequency change from alpha (8-12 Hz) to theta (3-7 Hz) is characterized by 
reduction in ventilation and vice versa. The number of breaths during state changes 
has an effect on ventilatory response, i.e. the longer time spent in theta, the bigger 
the ventilatory response when switching to alpha, possibly due to a PaCO2 increase. 
Similarly, going from alpha to theta, the ventilation change decreases parallel to alpha 
duration, possibly reflecting the ventilatory overshoot in the alpha state which 
attenuates with time. (Trinder, et al. 1992) 
The transition from wakefulness to NREM-sleep has varying effects on the upper 
airway dilators. Studies that looked at the finite transitions from alpha to theta 
demonstrate that there is a sudden drop in total inspiratory electromyography 
(EMG) activity in the GG and the TP of which the GG recovers within a couple of 
breaths and exceeds the baseline EMG, while the TP EMG decreases further. 
(Worsnop, et al. 1998) It was later shown that it is the inspiratory motor units that 
cease to fire at sleep onset (Wilkinson, et al. 2008). Altogether, upper airway 
resistance increases during sleep (Henke, et al. 1990). The resistance is increased both 
in non-snorers and snorers during sleep, whereas inspiratory flow rates are reduced 
and maximal resistance is increased along with deepening sleep only in snorers 
(Skatrud, Dempsey. 1985). When sleep stages are considered, a recent study shows 
that the GG activity (peak and tonic EMG) is the highest during wakefulness, 
followed by slow wave sleep (SWS) and stage N2 sleep, and lowest during REM 
sleep. The TP EMG is decreased during sleep with no difference between sleep 
stages (N2, SWS and REM) (Carberry, et al. 2016). Increased GG activity during 
SWS (McSharry, et al. 2013) has been attributed to increased reflex activity (Hicks, 
et al. 2017). When external negative pressure is applied with an iron lung, the GG 
activity is increased during wakefulness but diminished in NREM sleep (Fogel, et al. 
2003), indicating that the negative pressure-reflex (a reflex that activates the muscles 
of the airway to prevent collapse) in general is diminished during sleep. Specifically, 
the reflex diminishes at sleep onset as a function of sleep depth when transitions 
from alpha to theta EEG frequency occur (Gora, et al. 1998). During REM, the 
negative pressure-reflex is reduced even more (White. 2005).  
Also, lung volume contributes to upper airway collapsibility. During sleep, the 
functional residual capacity (FRC) is reduced (Hudgel, Devadatta. 1984), and it has 
been shown that peak and tonic GG EMG activities were increased with a lower 
lung volume. However, despite this activation of the GG muscle the pharyngeal 
collapsibility increased (Stanchina, et al. 2003).  
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Altogether, reduced neuronal activity of the respiratory centers as well as 
chemoreceptors along with the upper airway dilators makes the airway more 
susceptible to collapse. Airway patency becomes more dependent on the anatomical 
properties, as part of the dilator muscle activity is lost during sleep. As a result, 
ventilation is reduced and slight CO2 retention occurs.  
2.2 Sleep-disordered breathing 
2.2.1 Definitions and scoring 
Sleep-disordered breathing is an umbrella term for various forms of respiratory 
disturbance that are encountered only during sleep (Mohammadieh, et al. 2017). A 
spectrum of these disturbances varies from minor inspiratory flow-limitation, which 
reduces the maximum flow during one breath, to a severe obstructive sleep apnea 
characterized with upper airway closure for extended periods of time in parallel with 
a severe hypoxia and hypercapnia (Berger, et al. 2000), frequent arousals and blood 
pressure changes throughout the night (Peppard, et al. 2013, Randerath, et al. 2018).  
In clinical practice, common criteria to address SDB is that provided by the 
American Academy of Sleep Medicine (AASM) (Iber, et al. 2007, Berry, et al. 2012). 
These scoring criteria are different for adults and children and only criteria that apply 
for adults are presented here. For an apnea event the criteria states that there should 
be an at least 90% drop in the flow sensor from the pre-event baseline and the 
duration of the event must be 10 seconds or more. In addition, apnea is classified as 
obstructive, mixed or central according to the presence or absence of respiratory 
effort. If respiratory efforts are present throughout, the event is labeled 
“obstructive”. If there are no respiratory efforts during the apnea, the event is labeled 
as “central”. An apnea is scored “mixed” if there is no respiratory effort in the 
beginning, but efforts emerge before the end of the apnea. For hypopnea (reduction, 
rather than absence of airflow) rules exist, but there is a continuing debate as to how 
these events should be defined. Currently, it is stated that in order to score hypopnea, 
there should be an at least 30% reduction in flow amplitude from the pre-event 
baseline, the event duration is 10 seconds or more, and the event is associated with 
a 3% oxygen desaturation from baseline or is associated with arousal. (Berry, et al. 
2012) Different criteria yield different AHI values, which in some cases determine 
whether a patient receives reimbursement for treatment or not. The AHI is 
 23 
determined by counting the number of apnea and hypopnea events together and 
dividing it by the hours of sleep. It is usually thought that the AHI should be more 
than 5 in order to be considered abnormal. AHI ≥ 5 and < 15 is considered mild 
sleep apnea, AHI ≥15 but < 30, moderate sleep apnea and severe sleep apnea when 
index is ≥ 30.  
A Class of events that does not fulfill the criteria for apnea or hypopnea may be 
called respiratory effort-related arousals (RERAs). RERAs are defined as respiratory 
events with increasing respiratory effort or flattening of the inspiratory signal 
denoting flow-limitation, which leads to arousal. Event duration is at least 10 
seconds. (Iber, et al. 2007) Previously (Iber, et al. 2007), the use of esophageal 
manometry was the preferred method to determine respiratory effort, which greatly 
reduced the number of centers which would analyze this type of event, although 
inductance plethysmography could be used also. Snoring is part of the SDB 
continuum and three methods are recommended by the recent AASM manual: 
acoustic sensor, piezoelectric sensor or nasal pressure transducer (nasal cannula). 
(Berry, et al. 2017) Nasal cannula however had limited sensitivity compared to two 
other methods (Arnardottir, et al. 2016). Scoring RERA and snoring remains to be 
optional in clinical practice as their clinical significance is not completely resolved. 
The approach of counting the AHI seems straightforward, but the problem is that it 
does not recognize individuals who are affected by partial upper airway obstruction 
which does not fit into hypopnea or RERA criteria. The respiratory disturbance 
index (RDI) may be counted as the sum of AHI + RERA. However, this metric is 
not commonly used, and a number of different definitions for the RDI has been 
used, which has been confusing. (Berry, et al. 2012) 
2.2.2 Prolonged partial upper airway obstruction, inspiratory flow-limitation 
and snoring 
The evolution of pulse oximeters in the 1970s made sleep apnea a visible and 
potentially serious disease with repetitive episodes of desaturation. The innovation 
of nasal continuous positive airway pressure (CPAP) made sleep apnea a treatable 
condition. These innovations resulted in great interest in diagnosing and treating 
patients with increased AHI.  
The innovation of the static-charge-sensitive bed (SCSB) in Finland in the 1980s 
(Alihanka, et al. 1981) aroused interest in another form of sleep-disordered 
breathing, which was called partial upper airway obstruction. These events associate 
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with increased respiratory effort and have a characteristic high frequency movement 
signal (spiking) (Polo, et al. 1991, Himanen, et al. 2018). Since these episodes could 
not be counted as any index such as the AHI and were not associated with arterial 
oxyhemoglobin desaturation, they were not considered severe and symptomatic 
enough to be treated. These episodes were medically neglected as “simple 
snoring”.  However, research interest in non-apneic form of sleep-disordered 
breathing has continued alongside conventional sleep apnea for at least 30 years 
(Polo, et al. 1989, Pamidi, et al. 2017). Research has demonstrated that prolonged 
partial upper airway obstruction alone, even in the absence of sleep apnea, may cause 
symptoms and respond and adhere to CPAP therapy (Anttalainen, et al. 2007). In 
fact, in women the excessive daytime sleepiness and daytime fatigue have been found 
related to snoring (but not to the AHI) independent of the AHI, age, obesity, 
smoking or sleep parameters (Svensson, et al. 2008). Self-reported snorers are also 
three times more likely to report excessive daytime sleepiness when compared to 
non-snorers (Zielinski, et al. 1999). A Recent study by Schöbel suggests that snoring 
was associated with lower baroreceptor sensitivity and reduced baroreceptor gain 
indicating reduced parasympathetic tone during the daytime (Schöbel, et al. 2014).  
Partial obstruction is a common finding and similar concepts have evolved in 
other countries, including the upper airway resistance syndrome (UARS) and upper 
airway flow limitation, which are not completely overlapping with prolonged partial 
upper airway obstruction. UARS was initially described as repetitive respiratory 
arousals with increased respiratory efforts (Guilleminault, et al. 1993). As a term, 
flow limitation encompasses different conditions irrespective of the concomitant 
respiratory drive. Whether a mild OSA should be treated is still an open question 
(McNicholas, et al. 2016), with a notion that at least those who are symptomatic 
should be treated (Engleman. 2002). The distinction in concepts is crucial because 
mild OSA means a low AHI (usually 5 – 15/h), which by itself does not tell anything 
about the amount of partial obstruction during the night. 
Contrary to sleep apnea, prolonged partial obstruction is harder to quantify. 
Apneic or cyclic episodes in general are easily counted, whereas in partial 
obstruction, a measure of inspiratory flow amplitude, VT, VE or effort measurement 
is needed. Unfortunately, reliable measurement of these parameters makes the 
recording technically more challenging. Prolonged partial obstruction is not 
commonly reported and remains to be largely undiagnosed (Anttalainen, et al. 2016). 
In sleep studies, pulse oximetry is used to assess adequate ventilation, whereas CO2 
is usually not measured. This is problematic because during partial obstruction, 
ventilation is sufficient to maintain relatively normal oxygen levels, but PaCO2 levels 
 25 
may increase and lead to increased ventilatory efforts (Rauhala, et al. 2007). It has 
also been shown that sleepiness is associated with snoring, rather than with oxygen 
dips (Stradling. 1995). When CPAP was titrated so that also flow limitation was 
eliminated in addition to apneas, hypopneas and snoring; smaller scatter in vigilance 
parameters was observed (Meurice, et al. 1998). A population study from Brazil 
showed that only 5% of asymptomatic individuals will have more than 30% total 
sleep time with inspiratory flow limitation (Palombini, et al. 2013). Finally, even a 
low AHI is associated with an increased risk for hypertension (Peppard, et al. 2000). 
Whether these findings could be explained with the presence of partial obstruction 
and related increased work of breathing remains to be studied. Perhaps by combining 
the AHI with an index for flow-limited breaths with increased effort, it could be 
better addressed whether the symptoms of the patient are a result of SDB or not. 
Existing problems for disease definitions and practices were recently reviewed 
(Randerath, et al. 2018). 
2.2.3 Sleep-disordered breathing during pregnancy 
The prevalence for habitual self-reported snoring varies from 12% to 23% in 
pregnant women vs. 4% in non-pregnant premenopausal women (Loube, et al. 1996, 
Franklin, et al. 2000, Guilleminault, et al. 2000). The SDB risk during pregnancy is 
increased in obese pregnant women (Maasilta, et al. 2001, Pien, et al. 2014). In a large 
cohort study, SDB was associated with preeclampsia and hypertensive disorders after 
the effect of weight was controlled, suggesting a direct link between these conditions 
(Facco, et al. 2017). Prolonged flow limitation and partial upper airway obstruction 
are common during pre-eclampsia (Edwards, et al. 2001, Connolly, et al. 2001). It is 
associated with nocturnal blood pressure increase, but it is reversible with CPAP 
(Edwards, et al. 2000). SDB during pregnancy may lead to the delivery of infants that 
are small for gestational age (Pamidi, et al. 2016). Nasal CPAP treatment is safe and 
effective during pregnancy (Polo, Ekholm. 1995, Edwards, et al. 2000), but in order 
to evaluate the effect of SDB treatment on fetal and maternal outcomes, randomized 
controlled trials are needed (Pamidi, Kimoff. 2018). 
2.2.4 Pathophysiology and mechanics of sleep-disordered breathing  
A number of different factors determine whether an individual will have episodes of 
sleep apnea during different times at night. These factors include: 1) the anatomical 
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properties of the upper airway, 2) ventilatory control system, often modelled with 
loop gain, 3) neuromuscular responses to respiratory stimulation, and 4) the arousal 
threshold. (Wellman, et al. 2011, Owens, et al. 2015) It is now thought that 
determining the relative contribution of these factors in affected individuals will help 
to determine which kind of treatment modality would be most effective. For 
example, patients with a relatively non-collapsible upper airway (Pcrit, -5 to -2 
cmH2O) had higher loop gain than patients with a clearly collapsible airway (Pcrit > 
-2 cmH2O) (Eckert, et al. 2013). However, determining these factors is generally not 
part of current clinical practice.  
2.2.4.1 Anatomy 
OSA patients as well as snorers have a smaller airway size compared to normal (Polo, 
et al. 1991), with the reduction occurring mostly in the lateral diameter of the airway. 
This reduction is best explained by an increased lateral pharyngeal wall width 
(Schwab, et al. 1995). In addition, the tongue area was also enlarged in apneic patients 
but not in snorers or those with a milder disease. Furthermore, the soft palate area 
was larger in the apneic patients but similar between snorers and controls. This effect 
was related to a longer length of the soft palate. The amount of subcutaneous fat 
was also higher in OSA patients as demonstrated with increased fat width both 
laterally and posteriorly, resulting in an increased neck size. (Schwab, et al. 1995) 
These anatomical differences render the airway of OSA patients more susceptible to 
collapse.  
Obesity and SDB are tightly connected: increasing weight increased the amount 
of SDB events. The effects of obesity on SaO2 desaturation was modeled, and it has 
been shown that the body mass index (BMI) is an independent predictor of 
desaturation severity, after controlling the effects of age, gender, sleeping position, 
event duration, and baseline SaO2. It was also shown that the effects on desaturation 
are greater during REM compared to NREM. Also, the effect of VT reduction 
increases with the BMI. (Peppard, et al. 2009) 
2.2.4.2 Airway control 
During sleep, the upper airway becomes vulnerable to collapse as outlined in section 
2.1.4. Normally, this leads initially to decreases in VT and VE, but the effect of this 
mechanical load is fully compensated, and VE as well as VT are reserved. (Badr, et al. 
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1990) With inspiratory flow-limitation during sleep, the maximal flow is limited, and 
increases in effort only decrease the intra-thoracic pressure (Schneider, et al. 2009). 
Once an obstructive event has begun, the only way to increase the flow is to increase 
the activity of pharyngeal dilators, which is diminished during sleep (Younes. 2008). 
In order to compensate, inspiratory time (Ti) and breathing frequency are increased, 
and it has been shown that the inspiratory duty cycle (proportion of Ti of total 
ventilatory cycle duration) increases linearly as the upper airway obstruction worsens 
(Schneider, et al. 2009). Increases in frequency lead to increased dead space 
ventilation, which decreases the alveolar ventilation. However, in women, the 
frequency response is more pronounced than in men, but its effect is diminished due 
to a smaller dead space, resulting in comparable alveolar ventilation. The duty cycle 
and frequency responses vary between subjects, and they might help to determine 
the quantitative trait of the individual. (Schneider, et al. 2009) Upper airway 
obstruction increases the respiratory drive (Badr, et al. 1990). 
During inspiration, negative intraluminal pressure is generated, which activates 
the genioglossus. Patients with OSA are able to recruit the GG muscle, but the 
recruitment is not adequate to keep the airway open (Fogel, et al. 2005). It was shown 
that in OSA patients the peak phasic and tonic EMG is higher during wakefulness, 
suggesting that the airway patency is compromised. Despite the increased activity, 
the supraglottic resistance was still higher in the OSA patients. Applying CPAP 
reduced the GG activity considerably in the patients while no effect was observable 
in controls. (Mezzanotte, et al. 1992) It is noteworthy that OSA patients do not 
necessarily have apnea events throughout the night, and spontaneous stable flow-
limited breathing and snoring occurs. These periods are characterized by increased 
GG muscle tone, whereas TP activity or end-expiratory lung volume do not seem to 
play a role. GG activity is reduced during REM, which could explain the common 
notion that apnea episodes are more severe (in terms of SaO2 drop) during REM. 
(Jordan, et al. 2009)  
2.2.4.3 Control of breathing, loop gain and the role of CO2 during sleep-disordered 
breathing 
The respiratory system like many other systems in the body is controlled by feedback 
loops. Feedback systems have an inherent property to become unstable under certain 
conditions, and engineering concept of loop gain has been used to model the 
instability relating to sleep apnea. (Khoo, et al. 1982, Younes, et al. 2001) Effectively, 
loop gain describes the magnitude of the system’s response. High loop gain leads to 
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a fast and effective response, whereas low loop gain gives a slower and more 
dampened response. (Khoo, et al. 1982) Loop gain has three important parts: 
controller gain, plant gain, and communication. In the respiratory system, the central 
and peripheral chemoreceptors constitute the controller gain, which determines the 
optimal ventilation in the given environment. Plant gain describes how the system 
performs these actions. In practice, plant gain describes the ratio between CO2 
change and ventilatory change, i.e. effectiveness of ventilation. Communication 
between these two occurs via circulation. It is important to note that the anatomy 
produces an inevitable delay to the system as it takes a few seconds from blood to 
travel from the lungs to the carotid body. In general, loop gain is low in healthy 
volunteers, and breathing is very stable during sleep. (Wellman, et al. 2003) Increased 
gains are present in OSA patients (Salloum, et al. 2010).  
In order for ventilation to become unstable, there has to be a phase shift between 
the controller gain and plant gain (White. 2005). As stated above, this is a property 
of the respiratory system. In addition, it is required that the response to a stimulus 
such as hypercapnia or hypoxia is larger than the initial stimulus itself (ratio > 1). 
Under these conditions, the system produces an amplified response in the wrong 
time, and instead of dampening, the disturbance is also amplified, and the system 
cycles between extreme states such as episodes of apnea and hyperpnea.  
There are a number of factors that have an effect on controller gain and plant 
gain. Plant gain is the ratio ΔCO2/ΔVE. Plotted ventilation (VE) and PaCO2 form a 
hyperbola at stable CO2 production (Dempsey. 2005). If the chemoresponse remains 
unchanged, it holds that a change in ventilation that is needed to produce central 
apnea changes according to a prevailing CO2 level. (Figure 1, panel A) This means 
that during hypercapnia (going right on the hyperbola), the ventilatory change 
needed to produce central apnea is reduced because the slope of the hyperbola is 
reduced. Consequently, the plant gain increases, reducing the system stability. The 
opposite is true during hypocapnia (going left), as the slope of hyperbola increases 
and a higher ventilatory change is required in order to reach an apneic threshold (a 
situation when central ventilatory output is zero and ventilation ceases). Some of the 
conditions that cause high plant are: high PaCO2 as explained above, low cardiac 
output, low metabolic rate, low dead space, and low FRC (White. 2005).  
Controller gain is the ratio ΔVE/ΔCO2, and it essentially describes the 
chemosensitivity. Plotted chemosensitivity forms a line in the VE/CO2 plot. 
Conditions such as hypoxia increase the controller gain, which means that the slope 
of the chemoresponse becomes steeper (Figure 1, panel B) (Dempsey. 2005). When 
the isometabolic hyperbola is used as a model, it can be seen that with a steeper 
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slope, a smaller change in ventilation is needed in order to reach the apneic threshold, 
and the system instability increases. Therefore, high loop gain conditions reduce 
PaCO2 from the eupneic level more easily, which destabilizes the respiratory control 
and emphasizes the importance of the correct CO2 level. A classic example of this is 
the Cheyne-Stokes breathing during heart failure, where the circulation time is 
increased (Tkacova, et al. 2001) and overt sympathetic activity increases the 
chemoreceptor activity, and a characteristic ventilatory pattern is seen where apnea 
and hyperpnea follow each other.  
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Figure 1.  Visualization of loop gain. A) Plant gain, Changes in ventilation lead to movement on the 
metabolic hyperbola, which decrease (hyperventilation) or increase (hypoventilation) the 
plant gain. B) Controller gain, Changes in slope correspond to ventilatory change needed 
to cross the apneic threshold, thus linking the ventilatory sensitivity with stability of the 
ventilatory control. Image created according to data and concepts presented in Dempsey 
et al, Exp Physiol 2005, 90(1) 13-24.  
The control of breathing plays an important role in maintaining the vicious cycle 
during sleep apnea. This applies both to obstructive apnea as well as central apnea. 
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During an apneic event, CO2 accumulates and O2 is consumed as usual, leading to 
increased respiratory drive. At the end of an apnea, airway is opened and 
hyperventilation occurs (Berger, et al. 2000). For ventilation, there are two important 
CO2 levels; first is the eupneic CO2 level which is the target level and synonymous 
to stable homeostasis. The other level is usually called an apneic threshold as it 
represents the CO2 level below which ventilation ceases. The distance between these 
two is the CO2 reserve. It follows that any condition which reduces the CO2 reserve 
also increases the ventilatory instability. If loop gain is high, the hyperventilation 
drives PaCO2 too low which leads to ventilatory inhibition, increasing the probability 
of having another apnea. (Salloum, et al. 2010) In addition, during sleep, hypocapnia 
associates with increased upper airway expiratory resistance. As a result, inspiratory 
flow-limitation is demonstrated with hypocapnia (Sankri-Tarbichi, et al. 2011). 
In patients with severe sleep apnea, the CO2 accumulation that occurs during an 
event may not be compensated with the resulting ventilatory overshoot even in the 
absence of overall hypoventilation that commonly occurs in sleep (Salepci, et al. 
2015). The duration of the inter event interval may limit the effect of compensatory 
hyperventilation, which leads to CO2 accumulation (Gislason, et al. 1989, Berger, et 
al. 2000). Also, patients with severe OSA are more prone to develop periodic 
breathing compared to patients with mild to moderate OSA when assessed with 
proportional assist ventilation, which increases the controller gain (Younes, et al. 
2001). Tracheotomy can convert obstructive apneas to central ones as the 
obstruction is removed but the loop gain is still high. Obstructive apneas can 
transform into central ones if hypoxia is present. And conversely, increased oxygen 
levels can convert central apneas to obstructive ones (Longobardo, et al. 2008). 
Increased controller gains predispose both obstructive and central apneas (Salloum, 
et al. 2010). There was no difference in loop gain between N2 and N3 sleep in OSA 
patients, but loop gain during N2 sleep increased during the night (Landry, et al. 
2018) 
It is clear that CO2 is an important respiratory controller if not the most 
important, and studies where inhaled gas levels are manipulated give insight to 
respiratory control. For example, CO2 inhalation abolishes central apneas in 
congestive heart failure patients, while O2 only has a modest effect. An increase in 
SaO2 to a similar level as during administration of CO2 did not increase PtcCO2 or 
reduce apneic events. (Lorenzi-Filho, et al. 1999) Similarly, adding CO2 to inhaled 
air almost completely abolishes central apneas in idiopathic central sleep apnea; the 
PtcCO2 increase was 1.3 mmHg (39.3 to 40.6 mmHg) (Xie, et al. 1997). Isocapnic 
and hypercapnic treatment regimens reduce the AHI by approximately 30%, while 
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the hyperoxia response cannot be predicted from the controller or plant gain, CO2 
reserve or Pcrit. It can even lengthen individual apnea episodes. Non-responders 
(CO2) had a narrower CO2 reserve and smaller gains in addition to disadvantaged 
craniofacial anatomy. (Xie, et al. 2013) Minor hypercapnic exposure can be 
effectively used to treat refractory SDB as an adjunct to CPAP therapy (Thomas, et 
al. 2005). However, increasing CO2 in the inspired air increases plasma noradrenaline 
compared to air (Andreas, et al. 1998). Also, high CO2 levels (7.0%) increase muscle 
sympathetic nerve activity (Somers, et al. 1991). It was shown as early as in 1988 that 
CO2 inhalation decreases the duration and frequency of obstructive apneas when 3 
to 6% CO2 is used. An increase in chin/chest wall EMG was observed, and it was 
postulated that CO2 stabilizes the upper airway. Also, 50% oxygen causes 
lengthening of apneas, and there was a small decrease in phasic and tonic chin EMG. 
(Hudgel, et al. 1988) These studies show the critical role of CO2 in the ventilatory 
control, although O2 has a profound effect when hypoxia is severe enough. During 
obstructive event, an increase in the pump muscle activity cannot increase the flow, 
and pharyngeal dilator activity is needed. Therefore, metabolically the outcome of 
obstruction is determined by the ventilatory response of the pharyngeal dilators to 
changes in PaCO2 and PaO2. (Younes. 2008)  
2.2.4.4 Role of arousal in sleep-disordered breathing 
Arousals are an integral part of SDB, especially in obstructive conditions where 
upper airway patency is compromised and cannot be restored by simply increasing 
the respiratory effort. A review by Berry (Berry, Gleeson. 1997) showed that arousal 
occurs at a certain level of respiratory effort regardless of the stimulus (hypoxia, 
hypercapnia or added resistive load). Another study showed that not all obstructive 
apneas are resolved with arousal, but are followed by arousal (meaning that upper 
airway opening is provoking the arousal) or there may not be an arousal at all, which 
led to conclusion that arousals are not needed for upper airway opening and that the 
association is incidental. (Younes. 2004) These studies show that the threshold for 
recruiting the upper airway dilators is different from that of arousal. If the airway 
dilators are recruited, the arousal is not needed, but it may still occur since the 
information about blood gases is delayed and arousal may be triggered by the blood 
gas levels even though the airway is already open. In this situation, the arousal acts 
more as a destabilizing factor because the ventilatory response is more vigorous with 
arousal than without it, leading to an excessive CO2 reduction, diminished 
respiratory drive, and reduced upper airway tone all of which predispose to 
 33 
obstruction and may worsen the condition. (Eckert, Younes. 2014) Arousal 
threshold is not a fixed value, and a number of factors can increase it, such as: deeper 
sleep, prior sleep fragmentation, depressants (such as ethanol) and the presence of 
OSA. (Berry, Gleeson. 1997) 
2.2.5 Consequences of sleep-disordered breathing 
SDB has many negative effects on an individual level, and because the condition is 
fairly common, these effects are also seen on a population level. OSA increases the 
risk of stroke and death from any cause independent of known risk factors with a 
hazard ratio of 1.97. (Yaggi, et al. 2005) SDB is an independent risk factor for 
mortality, especially in men between 40-70 years. Nocturnal hypoxemia was an 
independent factor for mortality, whereas arousal frequency or central apneas were 
not. Men were also at risk of dying from coronary artery disease. (Punjabi, et al. 2009) 
Untreated severe (AHI > 30) SDB is associated with an increased risk of all-cause 
mortality with a hazard ratio of 3.0, and the results did not change after daytime 
sleepiness was taken in to account (Young, et al. 2008). A Busselton health study 
showed similar results; mild OSA (RDI 5 to 15/h) was not an independent risk factor 
for mortality, whereas moderate to severe (RDI > 15) was with an adjusted hazard 
ratio of 6.24 (Marshall, et al. 2008). A controlled observational study showed that in 
men with AHI > 30/h, the risk of a fatal or non-fatal cardiovascular event is 
increased. Simple snoring (AHI < 5) was not associated with increased risk. (Marin, 
et al. 2005) Incident cardiovascular disease is associated with worsening SDB during 
five years of follow-up if SDB is already present (Chami, et al. 2011). It is likely that 
OSA contributes to the development and progression of cardiovascular diseases 
such as hypertension through its physiological consequences which include: 
increased sympathetic activation, blood pressure fluctuation, decreased heart rate 
variability, increased intra-thoracic pressure, hypoxia-reoxygenation cycles, and 
hypercapnia. (Shamsuzzaman, et al. 2003) 
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2.3 Clinical methods 
2.3.1 Transcutaneous carbon dioxide 
The respiratory status of the patient is commonly measured with arterial blood gases. 
This measurement can be painful and it only provides a single value. Blood gases 
can, however, change rapidly in clinical situations and therefore continuous non-
invasive measurements are of great interest. (Storre, et al. 2011) One of the 
methodologies is PtcCO2. Commercially available PtcCO2 sensors were introduced 
in the 80’s and were mainly used in neonatology together with transcutaneous oxygen 
(PtcO2) (Midgren, et al. 1984, Midgren, Hansson. 1987). Nowadays, PtcCO2 
measurement is used to accompany many clinical settings such as mechanical 
ventilation, bronchoscopy, and sleep studies (Eberhard. 2007). PtcCO2 
measurement is used to measure the partial pressure of carbon dioxide that diffuses 
through the skin (Clark, et al. 1992). Measured PtcCO2 reflects the CO2 tension at 
the level of epidermis and does not equal to PaCO2. CO2 penetrates the thin 
membrane on the sensor and changes the pH of the liquid used on the sensor. This 
pH change is measured and a partial pressure of CO2 can be determined. PtcCO2 
measurement has an inherent time lag which is influenced by capillary volume and 
blood flow and tissue diffusivity. (Clark, et al. 1992) Measurement is also hindered 
when there is a strong peripheral vasoconstriction. Increasing the temperature 
shortens the response time, but may cause skin burns. 43°C seems to be a good 
compromise. (Nishiyama, et al. 2006)  
PtcCO2 measurement can give useful information regarding the control of 
breathing. PtcCO2 levels from wakefulness to sleep according to sleep depth, being 
the lowest in stage 1 and the highest in REM sleep. (Andreas, et al. 1998, Holmedahl, 
et al. 2014) Accordingly, younger subjects are more sensitive to CO2 than older ones 
since they present lower PtcCO2 levels during wakefulness, SWS and REM sleep but 
the absolute changes between stages are similar between groups (Naifeh, et al. 1989). 
Postmenopausal women have a higher PtcCO2 during sleep, compared to 
premenopausal women, which supports this finding (Aittokallio, J., et al. 2006). 
However, postmenopausal estrogen users have also higher PtcCO2 levels during 
sleep compared to non-users, an unexpected effect which could be a result from 
peripheral vasodilation caused by estrogen since ventilatory and sleep parameters 
between groups are very similar (Aittokallio, J., et al. 2009). An increase in PtcCO2 
during sleep is characterized by flow-limitation and prolonged spiking on the Emfit 
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sensor, which is a marker of increased respiratory effort (Rauhala, et al. 2007). 
PtcCO2 during OSA is higher than during central sleep apnea in patients with a heart 
failure (Tkacova, et al. 2001). In addition, patients with idiopathic central sleep apnea 
hyperventilate during wakefulness (Xie, et al. 1995). The treatment of hypercapnic 
OSA patients with non-invasive positive pressure ventilation (volume-cycled 
ventilator) reduces the sleep related PtcCO2 increase (Piper, Sullivan. 1994). 
Nocturnal PtcCO2 patterns can be used to predict vascular parameters such as flow-
mediated dilatation and nitroglycerin-mediated dilatation as well as metabolic status 
(Aittokallio, J., et al. 2008, Virkki, et al. 2008, Aittokallio, J., Saaresranta, et al. 2009). 
Results obtained from PtcCO2 measurement are sometimes (Janssens, et al. 
2001), but not always, concordant with PaCO2. The limits of agreement can be too 
wide, and therefore the PtcCO2 should not be used as a surrogate of PaCO2 (Rauch, 
et al. 1999, Weaver. 2007). A study by Chin showed that PaCO2 correlates with 
PtcCO2 during hypercapnia, but not during normocapnia (Chin, et al. 1997). The 
correlation with capillary CO2 appears to be good (Randerath, et al. 2010, Pinnola, 
Bastos. 2014). In patients with a respiratory failure undergoing non-invasive 
ventilation, PtcCO2 has unacceptable wide limits of agreement; PtcCO2 
underestimates high PaCO2 values (Kelly, Klim. 2011). Newer devices show a better 
correlation and limits of agreement to arterial PaCO2 values than the TCM4 device 
(Storre, et al. 2011). This implies that the data from the new devices can be used as 
a surrogate of PaCO2. Continuous nighttime monitoring allows detecting 
fluctuations in PtcCO2, which are not detected with a single morning measurement 
of arterial blood gases (Storre, et al. 2011). Regardless of the correlation, the 
transcutaneous monitor measures PCO2 in the heated skin and not the PaCO2, and 
the measurement should be interpreted in that light (Stock. 1988). It could be feasible 
to use PtcCO2 as a measure of tissue CO2 level. Studies using PtcCO2 in primarily 
OSA patients and healthy controls are shown in Table 1. 
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2.3.2 Arterial oxyhemoglobin saturation 
Oximeters have been standard equipment for PSG for decades, and they provide an 
easy, affordable and accurate way to monitor the relative amount of oxygen in the 
blood. The method is based on the difference in the absorbance of oxyhemoglobin 
and deoxyhemoglobin at a certain visible light and near-infrared wavelengths 
(Mendelson. 1992). Desaturation events that associate with apnea or hypopnea 
episodes are easily detected with oximeter. 
Like all measurements, oximetry has its own caveats. Measurement works best 
when SaO2 is above 90%. In these conditions, the measurement bias is below 2% 
and precision is above 97%. Below 90% the bias and precision worsen, which is of 
interest in patients with long apneas, where SpO2 is reduced well below 90%. Low 
perfusion caused by vasoconstriction, or low cardiac output may also result in 
inaccurate SpO2 values. Nail polish can interfere with the measurement, as well as 
movement of the measurement site, as reviewed by Jubran. (Jubran. 2015) 
2.3.3 Airflow detection 
The detection of an apnea is a relatively straightforward procedure both visually and 
with automated methods, if clear cut-offs are easily determined for absent flow. If 
the breathing is monitored with nasal cannula only, mouth breathing may still be 
present and breathing events may be mislabeled as apneas when they are actually 
hypopneas. The detection and characterization of inspiratory flow-limitation is even 
harder because it is a quantitative variable by nature. Factors that determine the 
presence of flow-limitation are the negative pressure generated by the lungs and the 
resistance in the upper airway (Henke, et al. 1990). Patients with SDB usually have 
an anatomically compromised upper airway (Schwab, et al. 1995) which increases the 
resistance leading to inspiratory flow-limitation. Nasal pressure is nowadays 
commonly measured with nasal cannula/prongs and transformed to nasal flow 
(Farre, et al. 2001). The determination of resistance would require the measurement 
of pressure from the upper airway, but these measurements are invasive and 
therefore not commonly used in clinical practice (Mansour, et al. 2004). Inspiratory 
flow-limitation can be detected visually from the nasal flow signal (Ayappa, et al. 
2000), but it remains subjective and prone to errors. Various computational methods 
have been developed to detect flow-limitation and increase the accuracy (Aittokallio, 
T., et al. 2001, Mansour, et al. 2004, Morgenstern, et al. 2008). Developments of 
these methods are needed in order to determine the clinical correlates to inspiratory 
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flow-limitation. A nasal cannula and the pressure transducer system can be used to 
detect all types of SDB, and it is sensitive enough to detect the same events as 
esophageal manometry, having the advantage of being non-invasive (Ayappa, et al. 
2000). Even though nasal cannula can provide good flow signal, it is still not 
quantitative. Amplitude of the signal may also be affected if the position of the 
cannula changes. Nasal secretions may interfere with the cannula and affect the 
signal. Low sampling frequency makes the assessment of snoring difficult and prone 
to errors, as reviewed by Arnardottir. (Arnardottir, Gislason. 2016)  
 
Table 1.  Tähän mukamas table 1 
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3 AIMS OF THE STUDY 
The aim of these studies was to determine how different types of sleep-disordered 
breathing affect the transcutaneous carbon dioxide measurement. Primary focus of 
CO2 measurements has previously been the detection of hypercapnia caused by 
hypoventilation (Iber, et al. 2007, Berry, et al. 2012). It was already known that 
PtcCO2 is sensitive for respiratory phenomena but more information was needed 
because the PtcCO2 signal can be difficult to interpret. Ventilation is primarily 
controlled by CO2 and the implementation of this information to SDB analysis is of 
interest. Anatomical and physiological changes occur during pregnancy, which 
predispose to SDB. We wanted to know if these changes are reflected in PtcCO2 
already during normal pregnancy. Our aim was also to develop a working model for 
SDB, which could helpful in research as well as clinical work. The following 
hypotheses were presented: 
I It was hypothesized that there is an optimal level for PtcCO2 during sleep. 
If that is the case then respiratory effort during flow-limitation should be different 
on different sides of this level.  
II It was hypothesized that different types of SDB present at different levels 
of PtcCO2. Aim of this study was to determine the association between PtcCO2 and 
subtypes sleep apnea (central, mixed, obstructive), hypopnea, steady flow-limitation, 
wakefulness and normal breathing during sleep. 
III It was hypothesized that pregnant women have more flow-limitation and 
snoring and that these would be associated with higher PtcCO2 levels compared to 
non-pregnant controls. It was also hypothesized that sleep stage specific PtcCO2 
differences should be present between pregnant and controls given the altered 
physiology (anatomic changes, hormonal changes) during pregnancy. 
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4 SUBJECTS AND METHODS 
Studies I and II were performed with retrospective data and therefore the approval 
of the ethics committee was not required for these studies. The protocol for Study 
III was approved by the ethics committee of the Tampere University Hospital 
district, and all participants provided an informed consent. 
4.1 Subjects 
4.1.1 Characteristics of the patients in retrospective studies (I and II) 
The patients in these two studies come from a population with suspected SDB who 
were referred to the Tampere University Hospital to verify the suspicion. A cardio-
respiratory sleep study was performed in order to find SDB. The patients’ medical 
history was not used in these studies and only the information derived from the 
recording file was used.  
For the first study (I), 425 cardiorespiratory sleep recordings from the time period 
between 3/2004 – 4/2007 were initially screened for the presence of inspiratory 
flow-limitation. 137 were selected for a detailed analysis, and data from 36 subjects 
was studied in detail. For the second study (II), data from 6/2005 to 5/2007 
consisting of 555 patients was screened for the presence of normal breathing and 
sequences of apnea, hypopnea and flow-limitation. After screening, 44 patients with 
88 sequences were studied in detail. These study populations overlap, but the scoring 
and data analysis was performed independently for each study. 
4.1.2 Characteristics of the subjects in the prospective study (III) 
A group of 18 healthy pregnant women was recruited from maternity clinics in 
Tampere region as well as from the antenatal outpatient clinic and the antenatal ward 
of Tampere university hospital. Inclusion criteria for the study were, age between 18 
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and 45, gestational age 33 ± 1, and a singleton pregnancy without fetal demise. Pre-
eclampsia or other complications requiring monitoring were used as exclusion 
criteria. Twelve non-pregnant healthy women were recruited as controls from the 
Department of Obstetrics and Gynecology of the Tampere University Hospital, the 
medical school of University of Tampere and the Tampere University of Applied 
Sciences. Controls were included in the study if they were generally healthy and had 
a normal BMI.  
4.2 Methods 
4.2.1 Demographic measurements and obstetrical examination 
For studies I and II, gender, age, and BMI were available from the sleep recording 
files. In the third study, initial weight, height, BMI, and blood pressure were collected 
from the maternity cards of pregnant subjects. In addition, ultrasound was 
performed to assess fetal movements, weight estimate, amniotic fluid index, and 
umbilical artery blood flow. Supine blood pressure and a urine test for protein and 
glucose were also analyzed.  
4.2.2 Sleep studies 
4.2.2.1 Cardio-respiratory sleep studies 
Cardio-respiratory sleep studies included the measurements of SpO2 (1 Hz, no filter), 
nasal flow (200 Hz, no filter) from the nasal cannula connected to pressure 
transducer, anterior tibial EMG(200 Hz, low frequency filter (LF) 10 Hz, high 
frequency filter (HF) 70 Hz), body position (1 Hz, no filter), respiratory movements 
from the uncalibrated thoracic and abdominal inductance plethysmography (10 Hz, 
no filter), snoring from piezoelectric sensor (200 Hz, no filter), and 
electrocardiogram (200 Hz, no filter). An Embletta recorder using the Somnologica 
software from Medcare Flaga hf (Reykjavik, Iceland) was used to record the signals. 
A TCM4 device (Figure 2) from Radiometer (Copenhagen, Denmark) was used to 
record PtcCO2 (1 Hz, no filter) and PtcO2 (1 Hz, no filter). A Custom written 
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software by PhD Jussi Virkkala (TCM4ebm) was used to import the data from the 
TCM4 device to Somnologica online. 
 
Figure 2.  A TCM4 device from Radiometer that was used in the studies to record the 
transcutaneous carbon dioxide and oxygen levels. 
4.2.2.2 Polysomnography 
PSG was performed in study III. EEG was recorded with eight channels (A1, A2, 
O1, O2, F3, F4, C3, and C4 referenced to Fz (200 Hz, LF 0.3 Hz, HF 35 Hz)), 
electrooculography (EOG) with 2 channels (200 Hz, LF 0.3 Hz, HF 35 Hz), 
submental EMG with 3 and tibialis anterior EMG with 2 channels (200 Hz, LF 10 
Hz, HF 70 Hz). Nasal pressure was measured with a cannula (200 Hz, no filter) and 
respiratory effort with inductance plethysmography belts placed around the 
abdomen and chest (10 Hz, no filter). Body position was recorded with an 
accelerometer within the patient unit placed on the abdomen of the subject (1 Hz, 
no filter). An Embla recorder using the Somnologica software from Medcare Flaga 
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hf (Reykjavik, Iceland) was used to perform the PSG, and a TCM4 device was used 
to record PtcCO2 and PtcO2 (1 Hz, no filter). TCM4ebm was used for data import. 
4.2.3 Scoring of the respiratory events, leg movements and PtcCO2 plateau 
Conventional scoring criteria for SDB (Iber, et al. 2007) with slight modifications 
were used in conjunction with the development of new scoring criteria for the 
purpose of the study. In the first study, hypopnea was scored when a 50% reduction 
of nasal flow was observed for 10 seconds and accompanied with a 3% desaturation 
from the pre-event baseline. In the second and third study, a 30% reduction of flow 
for 10 seconds was used to score hypopnea. No desaturation criterion was used, but 
desaturation for 3% or more was tabulated. Apneas were scored according to the 
AASM manual (Iber, et al. 2007). 
Since there are no commonly accepted criteria how to score inspiratory flow-
limitation (Pamidi, et al. 2017), such set of rules was developed for the first study. In 
the first retrospective study (study I), episodes of flow-limitation were included if 
progressive pattern of inspiratory flow-limitation was observed for at least 2 minutes. 
Two minutes was an arbitrary value, but it is considerably longer than an average 
hypopnea or flow limitation part of obstructive hypopnea usually. Progressive 
deterioration of flow contour was used as it was postulated that diminished flow 
would lead to decreased VE and increase in PtcCO2. The differentiation between 
episodes was based on respiratory effort measured with thoraco-abdominal bands 
(both signals viewed independently, combined signal of the two was not used); 
episodes with an increasing amplitude were marked as high-drive (HD) and episodes 
with a steady or decreasing amplitude were marked as non-high-drive (NonHD). 
Rounded flow contour was preferred at the beginning of episode, but not required 
as long as the flow-limitation was progressively increasing. The presence of snoring 
was used as a supportive criterion for increased respiratory effort for HD episodes 
(Figure 3). NonHD and HD scoring was done blind to PtcCO2 signal. Sudden 
termination of the episode was required in order to have clear end for the episode.  
 45 
 
Figure 3.  Characteristics of flow and effort patterns for flow limitation episodes determined in study I. 
Nasal cannula was used to determine the flow. Thoraco-abdominal inductance 
plethysmography was used to determine the respiratory effort. Plateau represents a 
breathing sequence during which the PtcCO2 level remains stable and the breathing is 
minimally obstructed. Characteristic of Non-High-Drive (NonHD) event is shown on the left 
where the flow deteriorates but increased effort is not seen. Notice the change in 
abdominal pattern during High-Drive (HD) event on the right indicating increased effort. 
Mean PtcCO2 values during NonHD, plateau and HD were 5.74 kPa, 5.75 kPa and 5.92 
kPa, respectively. Reproduced with permission from Respir Physiol Neurobiol. 
2014;191:44-51. 
In the second study (study II), sequences of apnea and hypopnea were investigated. 
In order to include sequences that are sufficiently long to represent given SDB type, 
it was required that the sequence length is at least 5 minutes or contains ten or more 
individual respiratory events. Also, consecutive events within the sequence had to 
resemble each other in terms of ventilatory pattern and length so that 50% of the 
events had the same classification (central apnea, mixed apnea, obstructive apnea or 
hypopnea). Sequences were labeled according to the most frequent event type. In 
order to be included, the patient was required to have at least one of the mentioned 
apnea/hypopnea sequences, and also sequence of wake and steady breathing for 
reference. Sequences were scored blind to simultaneous PtcCO2 signal. 
In the third study (III), a proprietary scoring utility of Somnologica was used to 
score inspiratory flow-limitation. A default flattening index of 0.13 was used. Flow-
limited and non-flow-limited breaths were determined for each sleep stage. 
In the third study (study III), it was also noticed that pregnant subjects had 
distinctive PtcCO2 peaks during sleep which are not seen in control subjects (or 
previous patient files). These peaks were considered worth reporting, and a set of 
rules to characterize the events and to perform a post hoc-analysis was established. 
The peaks seemed to have an amplitude of more than 0.1 kPa, and that was chosen 
as a cutoff point. In order to avoid scoring the effects of single episodes of apnea 
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and hypopnea, the event duration was given a minimum length of 90 seconds with 
no upper limit. In these populations long apneas or hypopneas are rare and flow-
limitation is more common. Presence of flow limitation was determined manually 
for peak episodes. If episodes of apnea or hypopnea were detected, they were 
tabulated. The requirement for sleep was not strict, and an epoch of wakefulness was 
allowed, but two consecutive wake epochs led, however to exclusion from the 
analysis. REM sleep was excluded as it is common for PtcCO2 to fluctuate during 
this state due to ventilatory instability. Arousals and respiratory arousals associated 
with the events were also scored. The start and end points of the events were visually 
determined to time points where the PtcCO2 slope started to progressively increase 
and when the start value was reached again after the peak or slope returned to zero. 
Leg movements (LM) and periodic leg movements (PLM) were scored according 
to the criteria of the World Association for Sleep Medicine (WASM) (Zucconi, et al. 
2006) with the exception that the EEG criterion had to be omitted in cardio-
respiratory studies. In the second study, LMs within 10 seconds on both sides of the 
apnea/hypopnea termination were excluded from the PLM index, as it was observed 
that leg movements synchronized with apneas beyond the limits described by 
Zucconi et al. (Zucconi, et al. 2006) and including these events to PLM index was 
thought to distort the index. 
It was postulated that increased CO2 during sleep combined with steady 
unobstructed breathing is a desired condition. The term “tcCO2 plateau” was used 
to reflect this idea and it was based on the observation that in an overnight PtcCO2 
profile the PtcCO2 is sometimes almost horizontal. In the first study, the plateau was 
defined as a stable breathing sequence for at least 2 minutes with a normal or near 
normal inspiratory flow contour with the highest PtcCO2. Minor snoring was 
allowed. Plateau candidates were initially scored from overnight PtcCO2 profile. The 
sequence closest to flow-limitation episodes was used in the analysis in the first study 
in case there were multiple stable sequences available. In the second study, a 
sequence of stable breathing with an at least 5-minute duration with the greatest 
stability was chosen, and the PtcCO2 values during this period were assigned as 
“PtcCO2 plateau”. Unobstructed breathing was preferred, and only minimal flow 
limitation was allowed. 
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4.2.4 Data analyses 
PtcCO2 signals were analyzed with an R-based (Transient Pattern Analyzer, TPA) 
software developed by PhD Arho Virkki. The software version of the TCM4 device 
contained an error and caused the PtcCO2 signal to oscillate.  
In the first study, the PtcCO2 signal was advanced 30 seconds in order to 
compensate the circulatory delay between the observed ventilatory event and blood 
gas change in the peripheral tissue. A linear regression line was fitted to the signal 
with the least squares method, and the start/end point was used in the analysis. The 
PtcCO2 plateau was assigned 100% and relative values from the episodes were used 
in the analysis.   
In the second study the PtcCO2 signal was not adjusted because the analyzed 
sequences where longer and stable, and it was thought that an adjustment would only 
have a negligible effect. Since there are considerable inter-individual differences in 
PtcCO2 values, wakefulness was set as 0 kPa and absolute differences (ΔkPa) 
between sequences were used in the analysis. The analysis was also performed with 
relative values by setting the wakefulness as 100%. In addition, the effect of using 
wakefulness or steady breathing as reference level was explored by setting the steady 
breathing (PtcCO2 plateau) as 100%. 
In the third study, PtcCO2 was determined for each sleep stage. With sampling 
rate of 1 Hz, each sleep epoch produced 30 PtcCO2 data points, which were then 
pooled to determine the median values for each sleep stage. For the flow limitation 
analysis, the PtcCO2 signal was advanced 30 seconds because individual breaths were 
studied. Normal breathing and flow limitation were analyzed separately. All data 
points recorded during inspirations (1 to 3 per inspiration) received a PtcCO2 value 
and sleep stage label. If less than 75 data points (seconds) were available for given 
condition, that sleep stage was excluded from the respiratory analysis. This was done 
in order to limit the effect of very short episodes of flow-limitation on overall results 
if a subject had only few detected flow limitations within a sleep stage.  
In the first study, nocturnal mean, median and minimum values were determined 
for SpO2. SpO2 values in the beginning and in the end of each flow-limitation 
episode were collected. In the second study, median values were determined from 
stable breathing sequences (wakefulness, plateau/steady breathing and flow-
limitation). For cyclic sequences, pre-event peak values of SpO2 were determined 
and the nadir values and mean values of these per sequence were used in the analysis. 
Overnight SpO2 mean and minimum values were determined as well. In the third 
study ODI3 and the overnight SpO2 mean and minimum values were determined. 
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4.2.5 Statistical analyses 
In the first study, three groups of patients were formed based on the presence of 
event types ( 1) only HD events, 2) only NonHD events and 3) both HD and 
NonHD present), and demographics were analyzed with the Kruskal-Wallis test and 
episode duration with the Mann-Whitney U-test. Body position, snoring, LM and 
PLM were treated as qualitative measures, and the Chi-Square test was used to assess 
the differences between NonHD and HD episodes. The presence of PtcCO2 slope 
was analyzed with the one sample t-test, and the comparison between episodes slope 
with the Mann-Whitney U-test. PtcCO2 comparison against the plateau was assessed 
with a pairwise t-test, and a linear mixed model was used to test whether the starting 
or ending levels of episodes differed from each other. Spearman’s correlation was 
used to assess the connection between PtcCO2 increase and SpO2 decrease during 
episodes. SpO2 change during the episodes was assessed with the Wilcoxon signed 
rank test, the Mann-Whitney U-test was used to compare the SpO2 change between 
episodes, and a linear mixed model was used to test whether the starting or ending 
levels of episodes differed from each other. A paired samples T-test and Pearson 
correlation were used to compare nocturnal mean SpO2 and plateau mean SpO2.  
In the second study, the effect of gender on PtcCO2 was tested with the Mann-
Whitney U-test and the effect of age with a univariate analysis of variance. The 
Kruskal-Wallis test with the Bonferroni correction was used to assess the PtcCO2 
and SpO2 differences between sequences. Levene’s test for equality of variances was 
used to test the effect of using wakefulness or steady breathing as a baseline for 
breathing sequences.  
In the third study, the Mann-Whitney U-test was used to determine differences 
in age, BMI and PSG measures. The prevalence of PtcCO2 peaks between groups 
was tested with Pearson´s Chi-Square test. The variance of PtcCO2 during different 
sleep stages was tested with non-parametric Levene´s test. 
SPSS (IBM SPSS statistics for Windows. Armonk, NY; IBM Corp.) versions 19, 
20, and 24 were used to analyze the statistics. P-value of less than 0.05 was 
considered significant. 
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5 RESULTS 
5.1 Patients and subjects 
After screening, the final study population was 36 patients for the first study. Half 
of the patients had AHI less than 5/h. The mean age of this population was 48 years 
with a mean BMI of 27.7 kg/m2. There were no significant differences in 
demographic variables between the three patient groups. 
In the second study, data from 44 patients was analyzed after screening. The mean 
age was 53 with a mean BMI of 30.5 kg/m2. The mean AHI was 21.8/h of which 
13.4/h consisted of hypopnea. Study populations differ between studies I and II 
because in the first study the inclusion was based on presence of flow limitation 
events whereas in the second study the selection was based on the presence of 
apnea/hypopnea sequence. 
The third study differed from the two other studies in that the subjects were all 
healthy. Altogether, eighteen pregnant women and twelve controls were studied. The 
controls were younger than the pregnant ones (26 vs. 30, p < 0.001), but had a similar 
BMI to pregnant women in the beginning of pregnancy (22.0 kg/m2 vs. 21.7 kg/m2, 
p = 0.245). Pregnant women were normotensive and had no proteinuria. Ultrasound 
examinations showed normal bioprofiles. 
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Table 2.  Characteristics of patients and subjects from the three studies 
 Study I Study II Study III 
   Pregnant Controls 
 Median (Min – Max) Mean/Median (SD/IQR) Median (Q1-Q3) Median (Q1-Q3) 
N (M:F) 36 (23:13) 44 (34:10) 18 12 (0:12) 
Age 48 (26 - 74) 52.8 (11.0) 30 (26-36) 26 (24-31) 
BMI (kg/m2) 26.8 (20.5 – 41.4) 30.5 (5.9) 22.0 (19.0 – 29.4) 21.7 (18.8 – 25.4) 
AHI (#/h) 4.9 (0 – 42.3) 21.8 (13.2) 1.6 (0.7 – 3.3) 0.8 (0.2 – 0.5) 
AI (#/h) 0.8 (0 – 22.2) 8.4 (8.4)   
CAI (#/h)  1.7 (2.9)   
OAI (#/h)  5.5 (6.2)   
MAI (#/h)  1.2 (2.9)   
HI (#/h) 3.4 (0 - 40.7) 13.4 (10.0)   
ODI3 (#/h)   0.4 (0 – 2.1) 0.2 (0 – 0.4) 
SaO2 mean (%) 95.0 (88.3 – 97.6) 93.8 (2.0) 95.9 (91.5 – 96.3) 97.5 (96.1 – 97.9) 
SaO2 min (%) 84 (67 – 91) 82.4 (6.4) 93.0 (91.5 – 94.0) 94.5 (93.3 – 95.8) 
PtcCO2 wake (kPa)  5.18 (0.45)   
PtcCO2 set-point/ 
plateau (kPa) 
5.72 (4.84 – 6.73) 5.47 (0.61)   
PLM index (#/h) 4.9 (0 – 88) 10.9 (28.7) 2.4 (0 – 5.2) 0.5 (0 – 1.4) 
LM index (#/h) 11.7 (1.6 – 94)    
FL index   11.3 (6.1 – 23.6) 10.10 (6.3 – 18.4) 
Snore time   0 (0 – 0.33) 0 (0 – 0.08) 
Mean values in study II are shown with italics. AHI: apnea-hypopnea index; Abbreviations: AI: apnea index; CAI: central apnea 
index; OAI: obstructive apnea index; MAI: mixed apnea index; HI: hypopnea index; ODI3: 3% oxyhemoglobin desaturation; 
SaO2: oxyhemoglobin saturation; PtcCO2: transcutaneous carbon dioxide; PLM: periodic leg movement: LM: leg movement; FL: 
flow-limitation.  
5.2 Sleep-disordered breathing and non-invasive blood gas 
measurements  
5.2.1 Progressive flow limitation (study I) 
In the first study, seven patients had only NonHD episodes, 25 patients had only 
HD episodes, and four patients had both types. Episode characteristics are shown 
in Table 3. A supine position during an episode was equally common in NonHD 
and HD. LM and PLM were more frequent during HD episodes, but the differences 
were not significant. Both flow-limitation types were associated with a PtcCO2 
increase that differed from zero. The average slope was 4.04 kPa/h (5.11 kPa/h for 
NonHD and 3.61 kPa/h for HD, p < 0.001). A PtcCO2 increase was also observed 
during the plateau, but the slope was considerably smaller (0.33 kPa/h, p = 0.045 
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for slope and p < 0.001 between plateau and NonHD/HD episodes). On average, 
NonHD episodes started below the plateau and terminated near PtcCO2 plateau, 
whereas HD episodes started from the plateau level and terminated above it. 
However, neither starting levels nor termination levels of PtcCO2 differed from each 
other. Altogether, a trend towards higher PtcCO2 levels during HD episodes was 
observed but not significant difference between episodes. Sometimes flow limitation 
evolves over several minutes, and the transition in effort is clearly seen (Figure 4). 
Flow limitation episodes were commonly associated with decrease in SpO2. The 
median decrease was 2.0 % (p < 0.001) in both episodes. There was no statistical 
difference in the starting levels of SpO2 in NonHD and HD episodes, but HD 
episodes terminated at lower SpO2 level. A Flow limitation episode was not always 
associated with a SpO2 decrease; 77.3 % NonHD and 75.9 % of HD episodes had a 
SpO2 decrease. A small but significant correlation was observed between a SpO2 
decrease and a PtcCO2 increase. (NonHD: ρ = -0.382, p = 0.004 and HD: ρ = -
0.460, p = 0.031). The mean nocturnal SpO2 correlated highly with the plateau SpO2 
(r = 0.939).  
Table 3.  Progressive flow-limitation episodes 
 NonHD HD p 
N 22 55  
Episode duration (s) 177 (131 – 221) 397 (242 – 594) <0.001 
PtcCO2 (% of plateau)    
    Episode start (%) 95.8 (0.036)a 99.3 (0.029) 0.071 
    Episode end (%) 100.1 (0.029) 105.2 (0.044)a 0.055 
    Slope (kPa/h) 5.11 (4.88) 3.61 (3.28) 0.182 
SaO2 (%)    
    Episode start (%) 96.50 (95.75 – 98) 95 (93 – 96) 0.212 
    Episode end (%) 94 (93-95.25) 93 (90.75 – 94) 0.03 
    ΔSaO2 (end – start) -2.00 (-4.0 to -0.75) -2.00 (-3.25 to -0.75) 0.871 
Supine position, n (%) 10 (45.5) 26 (50) 0.80 
Snore, n (%) 0 (0) 28 (50.9) <0.001 
LM, n (%) 3 (13.6) 14 (25.5) 0.37 
PLM, n (%) 1 (4.6) 11 (20) 0.10 
Abbreviations: PtcCO2: transcutaneous carbon dioxide; SaO2: oxyhemoglobin saturation; LM: leg 
movement; PLM: periodic leg movement. a, p < 0.001 compared to plateau (100%) 
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Figure 4.  An overnight view of PtcCO2 and a detailed view of a flow limitation event containing both 
low and high-drive elements. A) Evening wakefulness level of PtcCO2 is seen in the 
beginning. The plateau level for PtcCO2 is determined from stable breathing in the 
morning just before awakening. Dashed box shows the flow-limitation event. B) 
Progression of flow-limitation is seen on the flow channel. Transition in effort and 
increased snoring is seen between 1:59 – 2:00, which corresponds to PtcCO2 crossing the 
determined plateau level. PtcCO2 signal was advanced 30 seconds to compensate the 
measurement delay. Reproduced with permission from Respir Physiol Neurobiol. 
2014;191:44-51. 
5.2.2 Sleep apnea and steady flow limitation (study II) 
Eighty-eight SDB sequences were detected in the second study. Episode 
characteristics are shown in Table 4. Flow-limitation and hypopnea sequences were 
most common; 32 sequences of both were found. Only three sequences of mixed 
apnea were found and these were pooled together with seven central apnea 
sequences for the analysis. One-third of flow-limitation and steady breathing 
sequences occurred in a supine position, whereas at least 70% of the cyclic SDB 
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sequences occurred while supine. 608 individual SDB events from apnea (central, 
mixed and obstructive) and hypopnea sequences were included. Of these events, 
87.8 % were associated with oxyhemoglobin desaturation of 3 % or more. There was 
only a small variation in the events within sequences; 41 SDB events (6.7 %) did not 
match with their sequence classification. The range of observed mean values of 
PtcCO2 for the sequences was from 3.85 kPa to 6.54 kPa. When wakefulness PtcCO2 
(5.18 kPa, 100%) was used as a reference value, central and mixed apnea sequences 
showed no difference in the PtcCO2 levels, whereas all other sequences assumed a 
higher level of PtcCO2. Obstructive apnea and hypopnea sequences had the same 
level of PtcCO2 (0.29 kPa, 5.8 % and 0.27 kPa, 5.4 % increase from wake) as PtcCO2 
level observed during steady breathing (0.41 kPa, 8.4 % increase from wake). Steady 
flow-limitation sequences had the highest PtcCO2 levels (0.60 kPa, 12.2 % increase 
from wake), other sequences being significantly below this level. Figure 5 shows 
overnight PtcCO2 and SpO2 profiles with insets from different levels of PtcCO2 
associated with wakefulness, steady breathing during, hypopnea and flow limitation 
(Figure 5). Figure 6 shows the PtcCO2 and SpO2 results from the second study with 
episodes arranged according to hypothesized CO2 increase (Figure 6). Figure 7 
shows individual PtcCO2 values for each episode (Figure 7). The variance of PtcCO2 
became smaller when steady breathing was used as a reference value instead of 
wakefulness (Figure 8). 
The median wakefulness SpO2 levels did not differ from that of steady breathing, 
but SpO2 was lower during flow limitation. Further, there was no difference between 
SpO2 values during steady breathing and flow-limitation. During cyclic SDB 
sequences, the peak SpO2 levels did not differ from each other. SpO2 nadirs during 
hypopnea sequences (91.6 %) were shallower than during central or obstructive 
sequences (Figure 6).  
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Table 4.  Sleep apnea and flow-limitation sequences 
  Cyclic breathing   
Sequence (n) Wake CA + MA OA Hypopnea Steady breathing Flow-limitation 
N 44 7 + 3 14 32 44 32 
PtcCO2 (kPa) 5.18 (0.45) 5.11 (1.00) 5.31 (0.37) 5.50 (0.75) 5.47 (0.61) 5.64 (0.66) 
PtcCO2 Δwake (kPa)  0.10 (0.43) 0.29 (0.25) 0.27 (0.47) 0.41 (0.43) 0.60 (0.32) 
PtcCO2 (%), (%-units) 100 (0) 102.0 (8.5) 105.8 (5.5) 105.4 (9.4) 108.4 (8.6) 112.2 (6.8) 
SaO2, event start (%) - 96.4 (1.4) 96.6 (1.9) 95.9 (1.8) - - 
SaO2, event desat (%) - 89.9 (5.6) 88.8 (7.0) 91.6 (3.6) - - 
 95.0 (2.0) - - - 94.0 (3.0) 94.0 (3.0) 
Sequence length (min) 4:41 7:48 8:46 7:00 5:56 7:06 
Supine (%) 69.8 70.0 92.9 74.2 31.0 32.3 
Values presented as medians with interquartile range in the parenthesis. Sequence lengths are shown as mean values. 
Abbreviations: CA: central apnea; MA: mixed apnea; OA obstructive apnea; PtcCO2; transcutaneous carbon dioxide; SaO2: 
arterial oxyhemoglobin saturation. 
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Figure 5.  An overnight PtcCO2 and SaO2 profile and expanded views from selected parts of the 
night showing the correspondence between PtcCO2 and respiratory phenomena. Evening 
and morning PtcCO2 levels are very similar suggesting minimal signal drift (1 and 5). 
Notice how hypopnea episode (3) is below flow-limitation (2) in terms of PtcCO2.Notice 
also that PtcCO2 level during steady breathing with minimal flow-limitation (4) is above 
hypopnea episode and below flow limitation episode in terms of PtcCO2. Reproduced with 
permission from Respir Physiol Neurobiol. 2015;219:95-102. 
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Figure 6.  PtcCO2 and SaO2 during wakefulness, steady breathing (plateau) and SDB episodes. A) 
Change in PtcCO2 compared to wakefulness. Lines indicate significant difference between 
episodes. Flow-limitation is higher than other episodes. Notice that obstructive sleep 
apnea and hypopnea sequences do not differ from steady breathing. X-axis is similar to B 
panel but omitted for better view. B) Similar to A), but shown with percentages using 
wakefulness as baseline. Lines removed as they are the same as in A panel. C) SaO2 
levels during flow limitation are lower than in wakefulness but not during steady breathing 
in sleep. Max. and min. values for SaO2 are shown for cyclic events. Multiple comparisons 
adjusted with Bonferroni correction (significant p-value = 0.0033) Reproduced with 
permission from Respir Physiol Neurobiol. 2015;219:95-102. 
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Figure 7.  Individual PtcCO2 values for each episode. Episode order is arranged according to 
hypothesized increasing PtcCO2 value. Open circles represent the PtcCO2 value and lines 
that connect the circles indicate that the episodes are from the same patient. If the patient 
does not have an episode, the lines point to next episode that is found. For example, the 
patient with lowest PtcCO2 values does not have an obstructive apnea episode, but has all 
the other types. Reproduced with permission from Respir Physiol Neurobiol. 2015;219:95-
102. 
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Figure 8.  PtcCO2 distributions shown with different baselines. If steady breathing during sleep is 
used as the reference value the variance of SDB events becomes smaller. W = 
wakefulness, C = central and mixed apnea, O = obstructive apnea, H = hypopnea, S = 
steady breathing, F = flow-limitation. Note that the y-axis on the right panel is moved 
upwards to allow better comparison between panels. Reproduced with permission from 
Respir Physiol Neurobiol. 2015;219:95-102. 
5.2.3 Pregnancy and sleep-disordered breathing (study III) 
Conventional SDB parameters AHI and ODI3 showed no difference between 
pregnant and controls. In addition, FL-index (percentage of flow-limited breaths 
during sleep) and snore time, showed no difference between groups (Table 3). Only 
three subjects (two pregnant, one control) from the whole population were identified 
as snorers. In addition, a systematic analysis (flow limitation determined by the 
algorithm) did not reveal a greater PtcCO2 increase during flow limitation in the 
pregnant women in any of the sleep stages. 
An unexpected feature of PtcCO2 peaks was more common in pregnant women 
(78 vs. 5, p = 0.028). The mean amplitude of peaks was 0.20 kPa with a mean 
duration of 241 s. The number of peaks per person ranged from 1 to 22. Inspiratory 
flow-limitation was associated with 52 peaks (62.7%). The peaks were also associated 
with arousals (N =51) of which 14 were respiratory arousals. Flow amplitude 
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reduction to hypopnea was associated with 24 peaks and one peak was associated 
with apnea. It was common that flow limitation pattern developed gradually and was 
equally resolved. A SpO2 drop of 3-4 % was associated with 8 PtcCO2 peaks (Figure 
9). Two of the pregnant women had oscillating PtcCO2 as seen in Figure 9B, but 
only in the other the peaks were above amplitude criterion. This cyclic PtcCO2 
pattern was not associated with flow limitation but minimally fluctuating ventilation 
over time.  
 
 
 
Figure 9.  Overnight profiles showing hypnogram and PtcCO2 from two pregnant women and one 
control. A) Pregnant woman with inspiratory flow limitation events associated with PtcCO2 
“peaks” (arrows). B) Pregnant woman with PtcCO2 peaks not associated with flow-
limitation. C) A control subject without PtcCO2 peaks. Notice the stable PtcCO2 levels 
during deep sleep as well as decreasing signal trend suggesting technical drift. 
Reproduced with permission from Sleep Med. 2017;36:67-74. 
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5.3 Pregnancy and sleep 
Clear changes in sleep were observed between pregnant and control populations 
(Table 5). In comparison, pregnant women had a reduced total sleep time, sleep 
efficiency, N3 sleep and REM sleep duration and increased N1 sleep duration as well 
as increased wake after sleep onset. Pregnant women also had a lower mean SpO2 
(95.9% vs. 97.5%, p < 0.001) and minimum SpO2 (93.0 vs. 94.5%, p = 0.008) 
compared to controls. Heart rate during the night was also increased in pregnant 
women.  
PtcCO2 measurement showed no difference between pregnant and controls in 
any of the sleep stages (Table 6). The use of absolute or relative values made no 
difference. It was observed, however, that the variance in PtcCO2 during NREM 
sleep was smaller in pregnant women than in controls. A PtcCO2 analysis for the 
sleep stages was possible only for 15 pregnant women and eight controls due to 
signal drift or otherwise bad quality data.  
Table 5.  Polysomnography data 
 Pregnant (N = 18) Controls (N = 12) p 
TST (min) 361.0 (330.5-418.9) 415.5 (391.5 – 429.4) 0.007 
Sleep onset (min) 17.5 (11.5 – 27.6) 21.5 (15.1 – 27.0) 0.518 
WASO (min) 110.5 (58.5 – 151.1) 39.7 (21.8 – 77.0) 0.003 
Sleep efficiency (%) 76.7 (68.3 – 88.6) 91 (85.0 – 95.0) 0.002 
N1 sleep (min) 30.3 (25.5 – 45.3) 21.0 (16.3 – 30.8) 0.004 
N2 sleep (min) 141.8 (96.0 – 168.0) 140.5 (109.9 – 174.0) 0.884 
N3 sleep (min) 118.5 (97.5 – 143.6) 156.5 (133.3 – 190.8) 0.009 
REM sleep (min) 53.0 (40.3 – 69.5) 91.5 (73.5 – 99.6) 0.001 
Average heart rate (bpm) 71.7 (64.3 – 79.0) 59.6 (55.7 – 66.9) 0.002 
Values presented as medians and interquartile range. Abbreviations: TST: total sleep time; WASO: 
wake after sleep onset; N1, N2, N3; non-rapid eye movement (NREM) sleep stages 1,2 and 3; REM: 
rapid eye movement.  
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Table 6.  Transcutanenous CO2 during sleep 
 Pregnant Controls p p (variance) 
N 15 8   
PtcCO2, absolute (kPa)     
    Wake 6.19 (5.41 – 6.65) 6.16 (5.96 – 6.51) 0.776  
    N1 sleep 6.28 (5.35 – 6.75) 6.49 (6.04 – 6.74) 0.428  
    N2 sleep 6.28 (5.43 – 6.75) 6.57 (5.97 – 6.89) 0.392  
    N3 sleep 6.32 (5.92 – 6.65) 6.52 (5.97 – 7.08) 0.506  
    REM sleep 6.41 (5.28 – 6.95) 6.39 (5.72 – 6.78) 0.825  
    NREM sleep 6.29 (5.48 – 6.67) 6.56 (5.98 – 7.01) 0.357  
ΔPtcCO2 (kPa)     
    Wake (reference) 0 0   
    N1 sleep 0.08 (- 0.03 – 0.18) 0.20 (0.03 – 0.61) 0.115 0.323 
    N2 sleep 0.12 (0.05 – 0.29) 0.24 (- 0.04 – 0.65) 0.506 0.213 
    N3 sleep 0.15 (0.08 – 0.38) 0.21 (0.04 – 0.53) 0.825 0.075 
    REM sleep 0.15 (0.08 – 0.43) 0.16 (- 0.15 – 0.49) 0.925 0.067 
    NREM sleep 0.11 (0.07 – 0.22) 0.24 (0.03 – 0.62) 0.506 0.038 
Values presented as medians and interquartile range. p (variance) denotes the Levene’s test. Abbreviations: 
PtcCO2; transcutaneous carbon dioxide; NREM: non-rapid eye movement; N1, N2, N3; NREM sleep stages 
1,2 and 3; REM: rapid eye movement. 
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6 DISCUSSION 
This study focused on associations between SDB, control of breathing, and PtcCO2 
measurement. Since carbon dioxide is one of the main controllers of ventilation 
during sleep, we wanted to know how sensitive the simple PtcCO2 measurement is 
for these phenomena. Essentially, the study can be divided into two parts. In the 
first, observational part of the study, cardio-respiratory sleep recordings were 
analyzed retrospectively in studies I and II to study the associations between PtcCO2 
and different classes of SDB, namely progressively developing and stable inspiratory 
flow-limitation, snoring, and sleep apnea in its various forms. In the third study (III), 
pregnant women on their third trimester were studied to see the effects of flow-
limitation on PtcCO2. The aim of these studies was to understand the 
phenomenology related to SDB in the context of PtcCO2. 
There are three main findings. First, in the context of progressively worsening 
flow-limitation (NonHD and HD episodes), which decreases VE and increases CO2, 
increased ventilatory effort (HD episode) is clear only after a certain threshold CO2 
level (PtcCO2 plateau) is exceeded. Ventilatory efforts are also evident below the 
threshold level because the CO2 level is above the apneic threshold but the efforts 
are not augmented (NonHD episode). Second, in sleep apnea patients capable of 
normal breathing, steady flow-limitation leads to significantly higher PtcCO2 levels 
during sleep than what is observed during normal breathing or during apnea or 
hypopnea sequences. The SpO2 level was not different between normal breathing 
and flow-limitation, which probably explains why these events have drawn less 
interest compared to apneic events because no change is observed with the routinely 
used methods. Third, healthy pregnant women have practically no SDB when 
assessed with conventional parameters AHI and ODI or even with snore time or 
percentage of flow-limited breaths. Yet it was discovered that distinctive PtcCO2 
peaks are more common in pregnant women and that these peaks are mostly 
characterized with inspiratory flow limitation. It could be speculated that anatomic 
and hormonal changes such as reduction of functional residual capacity of the lungs 
and mucosal edema increase the probability of upper airway obstruction and prohibit 
the effect of ventilatory response, leading to augmented PtcCO2 increases. No 
difference was observed between pregnant subjects and controls in PtcCO2 during 
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wakefulness and sleep. However, it was found that the variance of PtcCO2 during 
NREM sleep was smaller in pregnant women compared to non-pregnant women, 
suggesting a stricter ventilatory control or diminished CO2 increase due to lighter 
sleep.  
6.1 Progressive inspiratory flow limitation and PtcCO2 plateau 
(Study I)  
Number of patients that were analyzed was small compared to initial population that 
was screened. Only 8.5% of the initial population had predetermined events. Given 
the strict criteria for events this was no surprise. When the characteristics of the final 
population are compared to those in other studies, resemblance to UARS patients is 
seen (Gold, et al. 2002). Interesting, yet anecdotal finding in our study was that half 
of the patients had AHI below 5/h, even though we did not have any kind of cut-
off criteria for AHI. Patients with more severe obstruction may not be able to have 
flow limitation events of this length, but instead develop obstructive apnea, 
hypopnea or shorter flow limitation event.  
At the time of the study there was no commonly accepted criterion (such as 
AASM) how to score flow limitation per se. RERA could be scored if the event did 
not meet the criterion for hypopnea, but arousal was required and without EEG 
arousal could not be determined by definition. Therefore, these events could not be 
called RERAs. Flow limitation may present with different forms that associate with 
different upper airway dynamics (Aittokallio, T., et al. 2001). It has been shown that 
when CPAP pressure was decreased to suboptimal levels the progression of flow 
limitation was observed (Owens, et al. 2012). It was also shown that inspirations with 
rounded breaths were followed by breaths showing initial peak flow, which then 
deteriorated towards the end of the inspiration (Owens, et al. 2012). Progressive 
pattern for flow limitation was chosen in our study so that the increase in effort 
could be seen due to increasing PaCO2 that should stimulate the breathing (Johnson, 
et al. 2005). Progressive pattern was also evident during negative effort dependence 
as increased respiratory effort over consecutive breaths lead to deterioration of flow 
(Owens, et al. 2012). Two-minute minimum for sequence length was decided in 
order to limit the analysis to flow limitation as the majority of apnea/hypopnea 
events are considerably shorter and with this duration the PtcCO2 dynamics can be 
visualized (Gislason, et al. 1989). It was previously shown that prolonged flow 
limitation associates with increasing PtcCO2 (Rauhala, et al. 2007). It was also shown 
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that flow limitation may also occur without increased respiratory effort (Ayappa, et 
al. 2000). It was postulated that there is a target level for optimal PtcCO2 level, since 
long horizontal PtcCO2 levels (PtcCO2 plateaus) are observed during sleep 
recordings. Since the control of ventilation is mostly dependent on PaCO2 
(Dempsey. 2005), this level might be crucial in the determination of respiratory 
effort, which could explain the observed differences in respiratory effort during flow 
limitation. Esophageal pressure measurement is the gold standard for determining 
respiratory effort, but due to its invasiveness, inductance plethysmography is more 
commonly used. Both methods are accepted for effort measurement (Berry, et al. 
2017). Changes in inductance plethysmography correlate with esophageal 
measurement (Masa, et al. 2003) 
Number of events that were found was relatively low. This could be the effect of 
requiring rather long periods of flow limitation. Falling asleep associates decreased 
upper airway muscle support as shown with Pcrit (Carberry, et al. 2016), increased 
resistance (Skatrud, Dempsey. 1985) and diminished negative pressure-reflex (Gora, 
et al. 1998) leading to reduced ventilation. It is speculated that simultaneous 
reduction in PaCO2 sensitivity (Teran, et al. 2014) could enable situation where 
increasing PaCO2 due to flow limitation does not have stimulating effect because the 
PaCO2 threshold is increasing also. HD events were found more often and they were 
longer than NonHD events. Both events had increasing PtcCO2, which shows that 
progressive flow limitation had a clear effect on PtcCO2. We could not show that 
the events are at different levels of PtcCO2 because there was no difference between 
start or end levels, suggesting that there is an overlap between the events. However, 
interesting finding was that NonHD events started below the plateau level and ended 
at the plateau level whereas HD events started from the plateau level and ended 
above it. Without EEG it is only possible to speculate the sleep stage, but it seems 
probable that NonHD events occurred during lighter sleep because the events were 
terminated near the plateau level, indicating that increases in effort and arousal 
threshold might play a role. HD events on the other hand may have occurred during 
deeper sleep since increase in PtcCO2 occurred above the plateau level and despite 
increased respiratory efforts the HD events were significantly longer than NonHD 
events. With deepening sleep the sensitivity to PaCO2 changes is reduced as reviewed 
by Teran (Teran, et al. 2014), which could explain this finding. Position may not 
explain these findings as supine position was equally common. These findings 
suggest that the degree of flow limitation and PtcCO2 form a continuum. When the 
ventilation deteriorates, threshold levels for blood gases and respiratory effort are 
inevitably reached, leading to increased respiratory efforts (Figure 4). Only four 
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patients had both types of events. Whether this small overlap is a marker of different 
populations remains to be solved in future studies. We were unable to find any 
difference between these groups, but the sample was small, which limits the statistical 
power.  
Scoring of the plateau level for PtcCO2 is the most subjective feature of this study. 
The aim was to find a period of stable PtcCO2 as a marker of stable breathing, a 
desirable condition during sleep. Normal rounded inspiratory flow shape would have 
been optimal, but given the population it was not feasible requirement and minor 
flow limitation was allowed. Term eupnea is also used to describe this level of 
breathing and associated CO2 and O2 during sleep (Dempsey, et al. 2012). PtcCO2 
plateau events scored in this manner should represent the highest level that patient 
was able to have stable breathing. It is likely that these plateaus are from SWS since 
breathing is most stable during deep sleep, even in OSA patients (Ratnavadivel, et 
al. 2009). Positive PtcCO2 slope was also observed during plateau episodes, which 
indicates that breathing has not been in complete balance as some of plateaus had 
flow limitation. However, the PtcCO2 slopes observed during NonHD and HD 
events were more than 10-times steeper, indicating that CO2 accumulation during 
plateaus was considerably slower. In addition, when short sequences are used the 
effect is amplified if the slope is expressed as kPa/h. 
Oxyhemoglobin decrease during NonHD and HD events had similar magnitude 
(2%) although there was a difference between event termination levels, HD events 
being lower. This may be the result of longer episodes and possibly greater 
reductions in VT, which ultimately leads to reduced oxygen levels in the blood. 
Contrary to systematic PtcCO2 increase, SpO2 decrease was not observed during all 
of the events. This finding is in line with other studies and reviews showing that flow 
limitation may (Calero, et al. 2006) or may not (Rauhala, et al. 2007, Arora, et al. 
2015) associate with SpO2 decrease. SpO2 measurement bias is near 2 %, and 
therefore small changes in the value should be interpreted with caution (Jubran. 
2015).  
6.2 Sleep apnea, flow limitation and PtcCO2 (Study II) 
Selection of patients in this second study had important implications for 
interpretation of the results. It was required that the patient had stable breathing 
during the night. This requirement indirectly excludes most severe patients because 
they are not able to have normal breathing during the night. So, in parallel to first 
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study, this population did not represent average sleep apnea population and the 
results should be viewed in that light. Number of selected patients was rather low 
compared to initial population (7.9 %), but the inclusion criteria were again quite 
strict, so small numbers were expected. Number of SDB sequences remained low as 
well, so the conclusions should be drawn carefully as most of the sequences were 
hypopneas or flow limitation. However, the sequences were carefully selected and 
therefore represented their SDB subtype when the individual events are 
monotonous and repetitive. Known effects of supine position on upper airway 
collapsibility (Oksenberg, et al. 2000) were clearly seen in the results. Cyclic events 
occurred mostly in supine position whereas non-supine position predominates flow 
limitation and stable breathing sequences.  
Our results show that the type of SDB has an effect on observed PtcCO2 level. 
PtcCO2 during central apnea sequence did not differ from wakefulness PtcCO2 
levels, whereas the difference between central apnea and stable breathing could be 
demonstrated (Figure 6). These findings are in line with previous studies which show 
the connection between the presence of sleep apnea and CO2. Hypocapnia induced 
with mechanical ventilation resulted in central sleep apnea (Rowley, et al. 2006). 
Conversely, increasing the inhaled CO2 (1-2.3 %) diminishes central apneas (Xie, et 
al. 1997) and even higher levels of inhaled CO2 (3-6 %) will effectively remove 
episodes of obstructive sleep apnea (Hudgel, et al. 1988). We were unable to show 
the difference between central sleep apnea and obstructive sleep apnea. Tkacova had 
previously shown that in heart failure patients the proportion of obstructive apneas 
reduced and central apneas increased overnight in association to PtcCO2 decrease 
(Tkacova, et al. 2001). However, we did not use proportions but instead one 
sequence of events was used to describe the event type, which may explain the 
different findings. Highest PtcCO2 was observed during flow limitation, which may 
be a result of multiple factors. First, during a sequence of apnea events the PtcCO2 
oscillates between hypercapnia and hypocapnia. When median value was used, the 
result is PtcCO2 value between the two extremes. On the other hand, during the 
selected flow limitation sequences there was no hyperpnea that would lower PtcCO2. 
Second, it is likely that apnea sequences and flow limitation sequences occurred 
during different sleep stages as deepening sleep reduces PaCO2 sensitivity (Teran, et 
al. 2014) and associates with increasing PtcCO2 (Holmedahl, et al. 2014). However, 
recent study showed that differences in loop gain between N2 and N3 NREM sleep 
are not significant in OSA patients (Landry, et al. 2018). Our finding that PtcCO2 
was higher during flow limitation compared to stable breathing was not surprising 
given the results from the first study but also when compared to those of Calero et 
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al. They showed that suboptimal CPAP pressure resulted in flow limitation and 6 
mmHg (0.8 kPa) increase in end tidal CO2 (EtCO2), increased Ti and esophageal 
pressure in addition to small, but significant 1% change in SaO2 (Calero, et al. 2006). 
Interesting SpO2 features were observed as there was no difference between flow 
limitation and stable breathing. In practice this means that flow limitation, which was 
associated with PtcCO2 increase, could not be detected with SpO2 signal (Figure 3). 
As already mentioned, SpO2 changes may not occur with flow limitation, even when 
the effort was increased (Arora, et al. 2015). Peripheral chemoreceptor afferent 
discharge can be increased by simply increasing the PaCO2 in the carotid body 
(Kumar, Prabhakar. 2012), which could then ultimately lead to increased respiratory 
efforts even in the absence of PaO2 change. There was no difference in SpO2 
between wakefulness and stable breathing. This raises the question whether stable 
breathing sequences are recorded during wakefulness as there was no EEG to verify 
sleep. Sleep is associated with CO2 increase and we observed 0.41 kPa PtcCO2 
increase during stable breathing, which is similar to the differences that were 
previously reported for sleep (Aittokallio, J., et al. 2006, Aittokallio, J., et al. 2009, 
Holmedahl, et al. 2014) 
Variance of PtcCO2 was considerable within SDB subtypes, which was surprising 
because the physiological threshold for CO2 is quite narrow. When PtcCO2 during 
stable breathing was used as reference level, it was observed that the variances of 
SDB subtypes became smaller and the variance of PtcCO2 during wakefulness 
increased. This finding underlines the sensitivity of PtcCO2 measurement and 
supports the idea that recordings should be done in a very standardized manner, 
which includes also controlling the signal drift after overnight recording. 
6.3 Pregnancy, sleep-disordered breathing and PtcCO2 (Study 
III) 
Pregnant women were older, but since all of the subjects were premenopausal the 
age is not expected to play a major role in the results compared to the effects of 
pregnancy. Contrary to our expectations, we were unable to find difference in SDB 
between pregnant women and control subjects. In addition to AHI and related 
indexes, SDB was previously described by Connolly by means of a “flattening index” 
showing that inspiratory flow limitation increases with progressing pregnancy 
(Connolly, et al. 2001). We used similar flattening index, which was available in 
Somnologica. There could be several reasons for our negative finding. One 
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possibility is that selection bias occurred with control population, so that those 
women who had suspicion of SDB might have been more inclined to participate. 
Other explanation is that the pregnant women were exceptionally healthy in terms 
of upper airway. It is also possible that algorithms behind flattening indexes were 
different. 
We were also unable to find differences in PtcCO2 levels during flow limitation 
between pregnant and controls. Successful analysis required that PtcCO2 could be 
linked to flow limited breaths. PtcCO2 was advanced 30 seconds to achieve 
synchronization between flow and PtcCO2. Given that this might not be completely 
accurate, data was not included from a sleep stage if there was not enough data. It 
was estimated that 75 data points would account for 3 to 5 minutes of breathing, 
which could be a long enough period to determine PtcCO2 for flow limitation. 
Automated analysis would pick sporadic breaths also and it was speculated that 
limiting the data inclusion would exclude sporadic breaths, but if longer sequences 
were present, they would be included. Small sample size and/or signal drift might 
explain this negative result. If flow limitation and normal breathing are collected 
from different parts of the night PtcCO2 signal drift may amplify or dampen the 
difference in PtcCO2 values, which widens the variance of the sample.  
Unexpected finding was also that there was no difference between groups in 
wakefulness and sleep stage specific PtcCO2 values. This was an interesting finding 
since PaCO2 levels are clearly lower during pregnancy (Machida. 1981). Sleep related 
increase in PtcCO2 was observed in both groups, which does not support that 
PtcCO2 measurement would be insensitive. Inter-individual differences can be 
considerable as shown already in the second study and previously also by Fukui 
(Fukui, et al. 1993) but on a group level the difference should be clear. PtcCO2 is not 
the same as PaCO2 and therefore it could be that PtcCO2 measurement was affected 
by the increased metabolism in the peripheral tissue (Clark, et al. 1992), which would 
lead to increased CO2 production and consequently similar values. Sleep related 
PtcCO2 increase seemed to be smaller in pregnant subjects, which could be explained 
by respiratory stimulation by progesterone (Machida. 1981) or increased sensitivity 
to PaCO2 (Jensen, et al. 2005), but these differences were not statistically significant.  
Sleep disturbances are commonly reported during pregnancy (Mindell, et al. 2015) 
and this was clearly shown by our PSG results also. Almost all sleep related 
parameters deteriorated. It could be speculated that increased amount of 
wakefulness and larger proportion of lighter sleep hinder the PtcCO2 increase during 
sleep. This might explain the smaller variance in PtcCO2 that was observed during 
NREM sleep. 
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Frequent PtcCO2 peaks in pregnant women was the novel finding of this study. 
Association to flow-limitation was expected but “only” 62.7% were associated with 
inspiratory flow-limitation. This may be explained by the fact that one of the 
pregnant women had oscillating PtcCO2 not associated with flow limitation which 
was counted as peaks (n = 22) in order to describe the phenomenon (Figure 9B). 
Existence of the peaks is confusing because pregnancy is associated with enhanced 
response to hypercapnia (Jensen, et al. 2005). Explanation could be the increased 
risk for upper airway obstruction during pregnancy (Bourjeily, et al. 2014), which 
may be a result of multiple factors such as reduced lung volume (Owens, et al. 2010), 
increased blood volume (Sanghavi, Rutherford. 2014) or mucosal edema (Hegewald, 
Crapo. 2011). Fluctuating PtcCO2 which was present in two pregnant women may 
be the result of unstable respiratory control and increased loop gain as slight 
fluctuation of ventilation was present. Increased plant gain is supported by the fact 
that small changes in ventilation associate with increased (Ptc)CO2 response and on 
the other hand decreased controller gain is supported because large changes in 
PtcCO2 associate with small changes in ventilation effectively canceling each other 
out and resulting in only small fluctuation (Dempsey. 2005). It was shown by 
Wellman et al. that loop gain is low in healthy normal men and women and periodic 
breathing did not develop easily even when ventilation was increased experimentally 
with ventilator (Wellman, et al. 2003). This supports the idea that loop gain may be 
increased during pregnancy. Given that the studied population was healthy, the 
PtcCO2 changes are likely to be more pronounced in other populations such as in 
obese (narrow airway) or those with hypertension (increased sympathetic activity). 
6.4 Strengths and Limitations 
The studies presented in this book have many strengths as well as limitations. In the 
first two studies, diagnostic cardiorespiratory polygraphies were used. Therefore, the 
results represent symptomatic population. However, the patient selection was 
skewed because the studies were event driven towards more milder patients in terms 
of AHI, and therefore the results cannot be generalized to average clinical sleep 
apnea population. In addition, AHI was not determined according to AASM criteria 
so the reported indexes are likely to contain some errors. However, full spectrum of 
symptomatic SDB is not captured by AHI, and considering also flow limitation 
improves the accuracy (Hosselet, et al. 1998). Unfortunately, EEG was not recorded 
in these studies. Therefore, the important relation to sleep stages can only be 
 70 
speculated. It can be claimed that PtcCO2 plateau is a very subjective measure. This 
is true, but inter-individual variation of PtcCO2 is considerably large, while intra-
individual changes are usually quite small (Figure 7). During normal sleep, periods 
of horizontal PtcCO2 are often recorded and using these levels as reference is a 
feasible approach. Highest levels of stable PtcCO2 were used in the first study to 
determine the PtcCO2 plateau. Therefore, it is unlikely that these periods are derived 
from wakefulness since wakefulness is associated with lowest values (Figure 7). Small 
sample sizes in two retrospective studies limits statistical power, but in order to have 
good data from clinical population, which is not collected for the purpose, this 
tradeoff is inevitable. It may be criticized that a 2-minute duration for flow limitation 
was too long and limited the availability of scorable events, but with this approach 
the change in PtcCO2 is more reliable. PtcCO2 measurement can be criticized that it 
does not reflect the PaCO2 accurately as outlined in section 2.3.1. PtcCO2 measures 
the CO2 that diffuses through the skin (Stock. 1988) and it is likely that they produce 
different values even though correction factors can be calculated and the two 
measurements may correlate. Oscillating PtcCO2 adds noise to the signal, which was 
corrected by using the linear regression. Used values are therefore not the real 
PtcCO2 values but estimates in the first two studies. However, since the signal 
oscillates and the flow limitation episodes are linear it is assumed that significant 
error is not introduced. PtcCO2 signal is also known to drift overtime. This drift was 
not controlled and it is another factor that increases the variance of the measured 
PtcCO2 values. Despite the limitations listed here the sensitivity of PtcCO2 signal to 
respiratory phenomena was encouraging  
Strength of the pregnancy study was that both pregnant and control subjects were 
healthy and the phenomena that were seen were part of normal pregnancy. This is 
helpful when PtcCO2 measurements are performed in high-risk populations. Flow 
limitation was assessed with algorithm, which can be criticized for not being sensitive 
enough because we could not replicate the previous clear finding of increased flow 
limitation in the third trimester in a similar population (Connolly, et al. 2001). This 
approach however removes the unconscious variation that occurs when scoring is 
done manually. In addition, flow limitation presents differently between individuals 
in terms of flow shape (Aittokallio, T., et al. 2001) and to this day there is no uniform 
way to characterize these differences. Post-hoc finding of PtcCO2 peaks and 
oscillations are valuable markers that serve future studies. Criteria for characterizing 
the PtcCO2 peaks is biased since it was made after the data was seen, but bias was 
inevitable since this phenomenon has not been described before. PSGs were 
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performed, which allowed to see the effects of sleep stage on PtcCO2 as well as 
objectively verify the deterioration of sleep parameters during pregnancy.  
6.5 Clinical significance of the findings 
These studies show that PtcCO2 has a strong association to ventilatory changes 
caused by SDB. Partial upper airway obstruction and flow limitation may associate 
with increased PtcCO2, which may not be noticed if only SpO2 is used. Treatment 
of mild sleep apnea is controversial because the condition is not associated with 
increased mortality as recently reviewed and the diagnosis requires more sensitive 
tools for verification in comparison to more severe disease (McNicholas, et al. 2016). 
On the basis of our results it seems that PtcCO2 measurement is sensitive to flow 
limitation (both progressive and steady) in comparison to SpO2 measurement, which 
might be useful in the characterization of the mild sleep apnea. Presence of sleep 
apnea or hypopnea is dependent on multiple factors of which CO2 is one via control 
of breathing (Owens, et al. 2015). Overnight profile of PtcCO2 may help to 
understand why SDB has a certain set of events at certain times of the night, which 
might improve the diagnosis and also treatment.  
Increased amount of PtcCO2 peaks associated with SDB were observed during 
pregnancy compared to controls despite similar amounts of overnight flow limited 
breathing between groups. Whether these peaks are even more frequent in high-risk 
populations or have any predictive value in terms of preeclampsia or other pregnancy 
related complications remains to be studied. Ventilatory and PtcCO2 pattern 
indicative of increased loop gain was observed in two pregnant women. Central sleep 
apnea is virtually non-existent in the pregnant (Bourjeily, et al. 2015), but in the 
presence of obstructive SDB, high loop gain may sustain the respiratory system 
instability. Role of loop gain in SDB during pregnancy has not been explored. 
6.6 Future directions 
CO2 measurements are not performed in large scale during sleep studies like SpO2 
measurements. Only by showing that measuring CO2 gives useful information the 
interest will increase and more data would accumulate, which would then lead to 
development of more robust and affordable devices. 
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There are a number of important questions that need to be answered. Studying 
the determinants of the plateau level of PtcCO2 and the impact of different sleep 
stages would help to determine guidelines. Also, studies with controlled upper airway 
resistance and collapsibility probably could add on our understanding of the 
pathophysiological mechanisms. Determining autonomic nervous system responses 
and local effects of CO2 on vasculature (vasodilatation / constriction) and on 
cutaneous circulation during sleep remains an important unexplored field. If 
symptomatic and asymptomatic mild sleep apnea populations would differ in terms 
of PtcCO2 dynamics, the use of PtcCO2 could be extended from the detection of 
hypercapnia based on a fixed value to PtcCO2 changes that are physiologically 
significant without the need to wait until disease progresses and becomes detectable 
also with AHI and ODI3.  
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7 SUMMARY AND CONCLUSIONS 
The health burden of sleep apnea is massive, and any means that could improve the 
diagnostics and make the treatment more specific and therefore effective are 
welcomed. The use of CO2 measurements has been largely limited to research 
purposes mainly because of the lack of a good parameter that could be obtained with 
relative ease, such as oxyhemoglobin desaturation from pulse oximetry, with an 
acceptable cost. 
The present study characterized the transcutaneous CO2 during different types 
of SDB and during pregnancy. The aim was to find out whether it could give 
information that would be useful not just from a scientific standpoint but also 
clinically.  
The main conclusions from the studies I to III are: 
I. Progressively developing inspiratory flow-limitation is associated with a systematic 
PtcCO2 increase. This suggests that the measurement is sensitive to even small 
changes in ventilation. In addition, there seems to be a threshold for PaCO2 above 
which the respiratory effort increases considerably. The increase in effort is probably 
caused by relative hypercapnia, which should be corrected. Once this threshold is 
crossed, increased inspiratory efforts are initiated in order to restore the ventilation 
and return the PaCO2 to normal level. Below the threshold, the CO2 level can be 
thought as being hypocapnic and ventilation is not stimulated because CO2 should 
increase and increased respiratory efforts are not witnessed. PtcCO2 measurement 
may have utility in SDB diagnostics if symptoms in the milder OSA population are 
linked to PtcCO2 changes. 
II. Distinct SDB phenotypes associate with different levels of PtcCO2. During sleep, 
there is invariably a CO2 increase, so the events of SDB which associate with central 
ventilatory inhibition, namely the central and mixed apnea, are found between 
wakefulness and sleep in terms of PtcCO2 levels. While there seems to be a small 
trend that CO2 is lower during obstructive apnea and hypopnea than during steady 
breathing, the difference between these events could not be shown. Steady flow-
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limitation was associated with the highest PtcCO2, exceeding the levels observed 
during steady breathing and all other SDB types. However, there was no difference 
in SpO2 between these two events. These findings suggest that the apnea type is 
connected to the PtcCO2 level and that steady prolonged inspiratory flow-limitation 
predisposes to relative hypercapnia before SpO2 is affected. 
III. Pregnant women and control women had similar levels of PtcCO2 during 
different sleep stages although there was a trend towards a lower PtcCO2 in the 
pregnant ones. Pregnant women showed a smaller variance of PtcCO2 during 
NREM sleep, which could indicate more rigorous ventilatory control or hindered 
sleep related PtcCO2 increase due to lighter sleep. In addition, transient PtcCO2 
increases were observed more frequently in the pregnant women, and 63% of these 
“peaks” were associated with inspiratory flow-limitation. This finding suggests that 
if inspiratory flow-limitation occurs during pregnancy, the resulting CO2 increase 
could be more prominent. Remaining PtcCO2 peaks are most likely a result of 
unstable ventilatory control in the form of increased loop gain. These findings 
indicate that even though the ventilation is stimulated and PtcCO2 is kept within a 
(more) narrow range during pregnancy, if flow-limitation occurs, the consequence 
can be more severe compared to non-gravid women. Even without flow-limitation 
the CO2 control might be unstable, leading to fluctuating ventilation. 
In conclusion, transcutaneous carbon dioxide measurement is sensitive to ventilatory 
changes. SDB is heterogeneous, and the sum of various different factors as discussed 
above. The prevailing PtcCO2 level is affected by the sleep stage and SDB 
phenomena, and ventilatory output is modulated continuously with feedback loops. 
For these reasons, PtcCO2 measurement offers a simple way to observe what 
ventilatory control is trying to achieve once the effect of each type of disturbance on 
PtcCO2 is known. With SDB, there seems to be an offset of CO2 with every 
phenomenon. In central events both the apneic and hypopneic CO2 levels are too 
low, which leads to ventilatory inhibition. Obstruction, on the other hand, associates 
with a CO2 increase, so these events cycle around the target level or exceed it. During 
deep sleep and a lateral position, the obstruction is usually not as severe as in light 
sleep and may manifest as prolonged inspiratory flow-limitation with high CO2. 
Output of ventilation is critically determined by PaCO2. Therefore monitoring CO2 
and aiming to stabilize it could be the best way to manage the effects of SDB. 
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a b s t r a c  t
Upper  airway ﬂow-limitation  is often  but  not always  associated  with prolonged gradually increasing
respiratory  effort. We investigated the  changes  in transcutaneous  carbon dioxide  tension (tcCO2) during
episodes  of upper airway ﬂow  limitation during  sleep  with or  without  respiratory effort response.
Seventy-seven  episodes  of  progressive  ﬂow-limitation were  analyzed in  36 patients  with sleep-
disordered  breathing. TcCO2 and  arterial oxyhaemoglobin  saturation (SaO2) were  measured during steady
breathing  and during  episodes  of ﬂow-limitation with  and without  effort response.
After  lights-off  tcCO2 increased  and leveled-off at  plateau, when  breathing  stabilized. During ﬂow-
limitation  tcCO2 increased at  rate of  4.0  kPa/h. Flow-limitation  with increasing  respiratory effort
associated  with tcCO2 increase  above the  plateau (terminating  at 105.2%,  p <  0.001), whereas ﬂow-
limitation  without  effort response  associated  with tcCO2 increase  starting below  the plateau (95.8%,
p  < 0.001).
We  conclude  that  the  nocturnal tcCO2 plateau  indicates  the  level above which the increasing respiratory
effort  is  triggered as response  to  upper airway ﬂow-limitation.  We  propose  that ﬂow-limitation below
the  tcCO2 plateau is an event related to  stabilization  of  sleep and  breathing.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
Measurement of inspiratory ﬂow with  nasal prongs has become
a standard method to screen and  diagnose sleep-disordered breath-
ing (SDB) (Johnson et al., 2005). While the clinical signiﬁcance of
repetitive episodes of obstructive sleep apnea (OSA) is well estab-
lished, there is less agreement about how to analyze or interpret
the various non-apneic episodes with signiﬁcant inspiratory ﬂow
limitation (Aittokallio et al., 2001). Development of  clinically useful
scoring criteria for ﬂow limitation requires better understanding of
the underlying pathophysiological mechanisms.
There is evidence that increased inspiratory effort is an impor-
tant determinant of subjective sleepiness both in  obstructive sleep
apnea syndrome (OSAS) and upper airway resistance syndrome
(UARS) (Pelin et al., 2003).  Heavy snoring is  a surrogate for increased
∗ Corresponding author at: Ville Rimpilä c/o Unesta Research Centre, Biokatu 14,
Finn-Medi  6, 3rd ﬂoor, Room 3010, 33520 Tampere, Finland. Tel.: +358 405944358.
E-mail  address: ville.rimpila@uta.ﬁ (V. Rimpilä).
respiratory effort, which at least in women  seems to be  a better pre-
dictor of  symptoms of  SDB than the apnea–hypopnea index (AHI)
(Svensson et al., 2008). We  have previously shown that transcuta-
neous carbon dioxide (tcCO2) level increases during ﬂow limitation
(Rauhala et al., 2007),  which could explain the gradually increas-
ing respiratory effort. However, the clinical signiﬁcance of the
tcCO2 increase during ﬂow limitation is not  known and therefore
overnight tcCO2 measurement is  rarely included in  polygraphic
sleep studies.
While prolonged episodes of increased respiratory effort  are
always associated with ﬂow limitation, episodes of ﬂow limitation
may  also occur without increased effort (Ayappa et al.,  2000).  Since
carbon dioxide is a more potent modulator of respiratory drive
than oxygen (Dean and  Nattie, 2010), hypercapnia is more likely
to  drive breathing during sleep than hypoxia. During withdrawal
of  the wakefulness stimulus for  breathing after onset of sleep, the
tcCO2 increases and levels off with stabile sleep. We  hypothesized
that this stabile tcCO2 level is  critical for  respiratory drive mod-
ulation; respiratory events with tcCO2 below this reference are
associated with low respiratory drive whereas events with tcCO2
1569-9048/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
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above this reference level occur with high respiratory drive.  We
tested this hypothesis with progressively developing episodes of
ﬂow-limitation, which are likely to associate with changes in CO2.
Some of the results of this study have been previously reported in
the form of an abstract (Rimpilä et al.,  2010).
2.  Methods
This study is a cross-sectional retrospective database analy-
sis of cardiorespiratory sleep recordings from  patient population
with suspected SDB. All the patients had been  studied according
to the standard clinical practice, without any modiﬁcation for any
potential study. Therefore, approval of  the institutional ethics com-
mittee was not required; according to  the Finnish National Medical
Research Act (488/1999). The study consisted of  two  parts: ﬁrst,
the screening of the patient population for partial upper airway
obstruction and second, the  detailed analysis of inspiratory ﬂow
limitation episodes in the selected population.
2.1. Measurements
The cardiorespiratory recordings included overnight mea-
surement of arterial oxyhaemoglobin saturation (SaO2), tcCO2,
transcutaneous oxygen (tcO2), nasal ﬂow (prongs), anterior tibial
electromyography (EMG), body position, respiratory efforts from
thorax and abdomen with respiratory inductance plethysmogra-
phy (RIP) belts and snoring sound (Somnologica, Medcare Flaga
hf, Reykjavik, Iceland). The partial pressures of  CO2 and O2 were
measured transcutaneously with a dual  sensor, (TCM4, Radiome-
ter, Copenhagen, Denmark). The sensor was ﬁxed parasternally on
the chest and warmed up to  43.0 ◦C, at  which temperature the sen-
sor could be kept in the same position for the duration of  the night.
Demographic features of the  patients such as  age, gender or BMI
were collected from patient records.
2.2. Selection of recordings
Initially, 425 cardio-respiratory sleep recordings performed for
screening SDB at Tampere University Hospital were assessed for
signal integrity and presence of ﬂow limitation. Recordings were
discarded if, (1) contingent progressive inspiratory ﬂow limita-
tion patterns were not observed, or (2) the key signals (nasal ﬂow,
thoraco-abdominal belts) were unusable (missing or poor  quality
at the time of episodes). In  order to ensure the tcCO2 signal qual-
ity, a physiological range (approx. 1.33 kPa) of  tcCO2 throughout the
night within recording was preferred starting point. TcCO2 drift cor-
rections per se were not performed because information from  other
CO2 measurements such as  arterial blood gases was not available.
137 recordings were approved for  a more detailed analysis of the
respiratory episodes and periodic leg  movements (PLM). Finally,
36 recordings contained 77  episodes of  ﬂow limitation that ful-
ﬁlled our inclusion criteria for the study. Episodes of apnea were
scored according to the AASM criteria (Iber et  al., 2007).  Hypop-
nea was scored if the nasal ﬂow drop was ≥50% of  the baseline;
event lasted for at least 10  s and was associated with 3% desatura-
tion from pre-event baseline. An arousal criterion was not applied
as it cannot be determined accurately without EEG. AHI does not
Fig. 1.  Common characteristics of  plateau, non-high-drive and  high-drive episodes.
Nasal  prongs were used to measure the ﬂow. The  determination of the degree of
respiratory  drive was based on measurements of the respiratory effort with thoraco-
abdominal  belts and demonstration of absence or presence of heavy snoring on
the  microphone as supportive criterion. TcCO2 mean values during plateau, non-
high-drive  and high-drive were 5.75 kPa, 5.74 kPa and 5.92 kPa,  respectively, for
this  subject. For progressive (decreasing or increasing) patterns of  effort see  Figs. 3
and  4.
predict the presence or type of  ﬂow limitation and therefore it was
not used as a criterion for inclusion or  exclusion. Leg movements
(LM) were  scored according to the WASM criteria (Zucconi et al.,
2006) adapted for  non-EEG recordings.
2.3. Detailed scoring of the ﬂow limitation episodes
Detailed analysis of the ﬂow limitation episodes was performed
in 137 recordings pre-screened for the  presence of one or  more
episodes of inspiratory ﬂow limitation with minimum duration of
2 min per episode. Scoring of  the episodes was  performed blind to
simultaneous tcCO2 readings.
Nasal ﬂow signal from the  prongs was used to determine the
presence of ﬂow limitation. Breath-to-breath evolution of the nasal
ﬂow contour revealed progressively developing pattern of ﬂow lim-
itation. Respiratory effort was  visually determined from RIP belts.
The effort was determined to  be low when amplitude change across
the ﬂow limitation episode was  decreasing or steady and high
when amplitude change was increasing. Episodes with any uncer-
tainty of  interpretation were  not included. The selected episodes
of  ﬂow limitation were classiﬁed as either high-drive (HD)  or
non-high-drive (NonHD) episodes. HD  episodes were deﬁned to
have: (1) progressive inspiratory ﬂow limitation; (2) rounded or
ﬂow limited inspiratory contour at the beginning of the episode;
(3) sudden termination of the  episode; (4) increasing thoracic or
abdominal amplitude (crescendo pattern) developing during the
episode (waxing and waning pattern not allowed); (5) presence
of  snoring allowed as a supportive criterion. The NonHD episodes
were deﬁned as: (1) progressive inspiratory ﬂow limitation; (2)
rounded inspiratory contour at the beginning of  the episode; (3)
sudden termination of the episode; (4)  decreasing or steady tho-
racic  and abdominal respiratory amplitude (5) absence of snoring as
a supportive criterion. Table 1 summarizes the classiﬁcation. When
rounded ﬂow contour could not be  identiﬁed prior  to the episode,
the starting point was the ﬁrst  breath after which the ﬂow contour
started to  show a progressive pattern of  ﬂow limitation (Fig. 1).
2.4. Deﬁning the tcCO2 plateau
After identiﬁcation of ﬂow limitation episodes, the overnight
tcCO2 signal was uncovered and ﬁrst visually screened for  stabile
Table 1
Classiﬁcation of ﬂow limitation episodes and plateau.
Plateau Non-high-drive High-drive
Flow limitation None or stabile Progressive Progressive
Effort  Stabile Stabile or decreasing Increasing
Snoringa Absent or minor, stabile Absent Absent, present or crescendo
a Presence and quality of snoring was a supportive criterion only.
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levels as candidates for tcCO2 plateau. In  this study we deﬁned the
tcCO2 plateau as the highest level of tcCO2 that is reached dur-
ing regular unobstructed or obstructed breathing during the night.
Unobstructed breathing is  the optimum, but due to the popula-
tion used, a minor stabile inspiratory ﬂow limitation was allowed:
ﬂow limitation needed to be  stabile on  a breath-by-breath basis
in  terms of inspiratory ﬂow and respiratory efforts. Minor snoring
was also allowed. In case of several possible plateau candidates, the
plateau in the closest proximity to the episode(s) was chosen. The
validity of the chosen plateau was then conﬁrmed by stabile venti-
latory pattern and stabile respiratory effort throughout the plateau
as described (Table 1).
2.5. Data analysis
TcCO2 data collected for the duration of the selected episodes
was analyzed with software developed by one of  the authors (AV)
for this purpose (Aittokallio et al., 2008; Virkki et al., 2008).  The
tcCO2 signal was advanced by 30 s to  compensate for the long
response time and to reach synchronization with the respiratory
episodes. The tcCO2 signal that was available contained oscillation
(see raw tcCO2 signals in Figs. 2–4,  B panels), which is a technical
artifact related to software version of  TCM4 device. Therefore a
linear regression line was ﬁtted to the signal with  least squares
method and tcCO2 values in the  beginning and termination of  this
line were used in the analysis. SaO2 values were determined at the
start and at the termination of the ﬂow limitation episodes and
plateau.
2.6. Statistical analyses
Demographic variables between patient groups were assessed
with Kruskal–Wallis test. Episode durations between the NonHD
and HD episodes were compared with Mann–Whitney U-test.
TcCO2 slope of the  determined plateau and ﬂow limitation
episodes was  assessed with one-sample t-test. Differences between
NonHD and HD episode slopes were compared with independent
samples median test and Mann–Whitney test. Both absolute (kPa)
and relative values (percent of the plateau tcCO2,  when plateau was
set to 100%) of tcCO2 at  the start and at the end of the ﬂow limitation
episodes were  compared against plateau tcCO2 with pairwise t-test,
assuming that the episodes were independent. Differences in  abso-
lute and relative tcCO2 values between the  NonHD and HD episodes
were compared with a linear mixed model taking patient as random
effect which enables multiple episodes per patient. Inter-patient
variation of  tcCO2 between the  start and at  the end of  the episodes
was compared with independent samples t-test in  both  NonHD and
HD episodes.
SaO2 change (SaO2) during the ﬂow limitation episodes was
assessed with related samples Wilcoxon signed rank  test. Dis-
tribution of SaO2 between the episodes was assessed with
Mann–Whitney U test.  Linear mixed model was  used to compare
the SaO2 values between the NonHD and HD episodes. Nocturnal
mean SaO2 and plateau mean  SaO2 were compared with paired
samples t-test.
Spearman’s correlation was  used to test  the connection between
tcCO2 and SaO2 during the ﬂow limitation episodes. Posi-
tion, snoring, leg movements and periodic leg movements were
treated qualitatively and differences between episode types were
addressed with Chi-Square test with the assumption that episodes
are  independent. SPSS  (version 20, IBM, Armonk, NY, US) was used
for statistical analyses.
3.  Results
3.1. Patient characteristics
Seventy-seven episodes from 36 patients fulﬁlled the inclusion
criteria. The  demographic features of the patients are shown in
Fig. 2. Example of two consecutive non-high-drive (NonHD) episodes. Only the latter fulﬁlls the duration criteria (minimum of 2  min) of the study. (A) Overnight transcuta-
neous  CO2 proﬁle. The plateau level is marked with dashed line and the two  ﬂow limitation episodes are marked with the dashed box. Signal is  averaged and marked with
bold  line. See text for details. (B) Detailed view of  a low drive episode. Width of the panel is 10 min. The evolution of  the inspiratory ﬂow contour indicates worsening ﬂow
limitation  over time. Abdominal and thoracic excursions do not  respond despite increasing tcCO2. The  episode is  terminated with opening of the airway with movement
arousal.  Leg twitches are present throughout the night. Plateau level is marked with dashed line and  the episode selected for analyses is marked with vertical lines and solid
arrows.  Based on the tcCO2 trace, an alternative plateau could be proposed at  around 4:45, but this is  rejected because unstable abdominal respiratory signal, not shown
in  the ﬁgure. TcCO2 signal is advanced 30 s to show the correspondence between tcCO2 and respiratory episode. TcCO2 = partial pressure of transcutaneous carbon dioxide;
SaO2 = oxygen saturation from oximetry; Abd. = abdominal band; Tib. Ant. =  anterior tibial EMG activity.
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Fig. 3. Example of a high-drive (HD) episode. (A) Overnight transcutaneous CO2 proﬁle. The plateau level is  marked with dashed line and the  ﬂow limitation episode is  marked
with  the dashed box. Signal is averaged and marked with bold line. See text  for  details. (B) Detailed view of the high drive episode. Width of the panel is  10 min. Ventilatory
drive  responds to increasing tcCO2. After a period of time,  ﬂow limitation resolves without movement arousal. Plateau level  is marked with dashed line and the episode
selected  for analyses is marked with vertical lines and solid arrows. Alternative plateau candidates at around 22:00 and around 1:00 are rejected because of respiratory
pattern:  The ﬁrst episode contains irregular breathing and  movements, the second long episodes of hypopnea. TcCO2 signal is  advanced 30 s to show the correspondence
between  tcCO2 and respiratory episode. TcCO2 = partial pressure of transcutaneous carbon dioxide; SaO2 = oxygen saturation from oximetry; Abd. = abdominal band.
Table 2. The AHI ranged from 0 to 42/h of time in  bed, but the major-
ity of patients presented with mild SDB: 18 (50%) of  the patients
had an AHI less than 5/h.  Most of  the patients were overweight
(average BMI  27.7 kg/m2, range 20.5–41.4 kg/m2).  The median PLM
index was 5/h, (range  0–88/h). The number of episodes selected
from each subject ranged from  one to eight. Twenty-two episodes
were classiﬁed as NonHD type and 55 as HD type. The dura-
tion of NonHD episodes was  at median 177 s (interquartile range
Fig. 4. Example of an episode of ﬂow limitation with mixed drive response. (A) Overnight transcutaneous CO2 proﬁle. The plateau level is marked with dashed line and
the  ﬂow limitation episode is  marked with the dashed box.  Signal is averaged and marked with bold line. See  text for details. (B) Detailed view of the episode. Width of
the  panel is 12 min. Non-high-drive is followed by high-drive. Transition occurs when tcCO2 crosses the plateau level. Increasing respiratory drive is unable to resolve ﬂow
limitation  before movement arousal terminates the episode. Plateau level is marked with dashed line and the episode selected for analyses is marked with vertical lines and
solid  arrows. Alternative plateau level observed around 23:30 is rejected because of somewhat irregular breathing. Breathing during the morning period is highly regular.
TcCO2 signal is advanced 30 s to show the correspondence between tcCO2 and respiratory episode. TcCO2 = partial pressure of  transcutaneous carbon dioxide; SaO2 = oxygen
saturation  from oximetry; Abd. = abdominal band.
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Table  2
Demographic features of the study population, n = 36.
Mean SD Median Min–max
Females, n (%) 13 (36.1) – –
Age  48 10.79 48 26–74
BMI  (kg/m2) 27.7 4.52 26.8 20.5–41.4
AHI  (#/h) 10.1 11.90 4.9 0–42.3
AI  (#/h) 3.5 5.90 0.8  0–22.2
HI  (#/h) 6.7 8.36 3.4 0–40.7
SaO2 mean (%) 94.6 2.39 95.0 88.3–97.6
SaO2 min  (%) 82.6 6.43 84 67–91
TcCO2 set-point (kPa) 5.69 0.42 5.72 4.84–6.73
PLM index (#/h) 10.8 16.77 4.9 0–88
LM  index (#/h) 18.2 17.13 11.7 1.6–94
Deﬁnition of abbreviations: BMI, body mass index;  AHI, apnea–hypopnea index; AI,
apnea  index; HI, hypopnea index; SaO2,  arterial oxyhemoglobin saturation; tcCO2,
transcutaneous carbon dioxide; PLM,  periodic leg  movements; LM, leg movements.
131–221 s) and HD episodes 397 s (interquartile range 242–594 s,
p  < 0.001). Supine sleeping position was equally common during
NonHD and HD episodes. Seven patients had only NonHD episodes
(NonHD patients), twenty-ﬁve patients had only HD episodes (HD
patients), and four patients had both types of  ﬂow limitation
episodes (mixed patients). Comparison between the three patient
groups (NonHD, HD and mixed) with Kruskal–Wallis test did not
reveal any signiﬁcant differences in BMI, AHI, apnea-index (AI),
hypopnea-index (HI), mean SaO2,  min  SaO2,  tcCO2 plateau, PLM
index or LM index (Table 3).
3.2. TcCO2
The tcCO2 increased during both the NonHD and HD episodes
at  an average rate of 4.04 kPa/h. The slopes of increase were signif-
icantly different from zero (5.11 kPa/h during the NonHD episodes
and 3.61 kPa/h during the HD  episodes, p  < 0.001) but did not  dif-
fer from each other (p = 0.12). The tcCO2 increased also during the
plateau (p = 0.045), but with a lower slope (0.33 kPa/h, p < 0.001)
than that measured during either type of ﬂow limitation episodes.
NonHD episodes (Fig. 2.)  occurred at  a lower tcCO2 level com-
pared to HD episodes (episode start mean 95.8% vs 99.3% of plateau,
p = 0.071, episodes termination mean 100.1% vs. 105.2%, p = 0.055,
Fig. 5). NonHD episodes started with tcCO2 that was on aver-
age  0.24 kPa below the plateau (p < 0.001) and ended with tcCO2
equal to the plateau (−0.01 kPa; p = 0.808). HD episodes (Fig.  3.)
started with tcCO2 at around the plateau (−0.04 kPa; p = 0.076) but
ended with signiﬁcantly higher tcCO2 (0.30 kPa higher than plateau,
Fig. 5. Summary of ﬂow limitation episodes. (A) Panel shows a box-plot with the
median,  quartiles and range of  tcCO2 at  the start and  termination (connected with
solid  lines, start of the episode on the left  side) of all  analyzed episodes of progres-
sive  ﬂow-limitation and plateau. The dashed line indicates the plateau level set to
100%.  P-values connected with lines denote the differences between the different
episode  types at  the start and termination of episode. Vertical P-values denote the
difference  between plateau level and the particular episode phase. Non-high-drive
(n  = 22) episodes start below the tcCO2 plateau whereas high-drive (n  = 55) episodes
terminate  above  the plateau. Non-high-drive episodes terminate and high-drive
episodes start  at around the plateau. There is no consistent trend  of tcCO2 during
the  plateau episodes. (B) Panel shows a  box-plot presentation of the  corresponding
SaO2. The dashed line indicates the median SaO2 of 95% observed during the tcCO2
plateau. P-values connected with lines denote the differences between episodes at
the  start and termination of episodes. TcCO2 = partial pressure of transcutaneous
carbon  dioxide; SaO2 = oxygen saturation from oximetry.
Table  3
Characteristics of the two types of ﬂow limitation episodes.
Non-high-drive (n = 22) High-drive (n = 55) p
Episode duration (s) 177 (131–221) 397 (242–594) <0.001
TcCO2 (% of plateau)
Episode start 95.8a (0.036) 99.3 (0.029) 0.071
Episode  end 100.1 (0.029) 105.2a (0.044) 0.055
Slope  (kPa/h) 5.11 (4.88)  3.61 (3.28) 0.182
SaO2 (%)b
Episode start 96.50 (95.75–98) 95 (93–96) 0.212
Episode  end 94 (93–95.25) 93 (90.75–94) 0.03
SaO2 (end-start) −2.00 (−4.0  to −0.75) −2.00 (−3.25 to −0.75) 0.871
Supine  position, n (%) 10 (45.5) 26 (50)c 0.80
Snore,  n (%) 0 (0%)  28 (50.9%) <0.001
LM,  n (%) 3 (13.6%) 14 (25.5%) 0.37
PLM,  n (%) 1 (4.6%) 11 (20%) 0.10
Episode duration and SaO2 values are  presented as median and  quartiles. TcCO2 and qualitative data are  presented as mean and SD. SaO2, episode end-episode start; LM,
leg  movements; PLM, periodic leg movements.
a p < 0.001 compared to plateau.
b Not available during one high-drive episode.
c Not measured during 3 episodes.
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p < 0.001). Episodes with both  NonHD and HD  components were
treated as HD episodes (Fig. 4).
During NonHD episodes the standard deviation (SD) of  relative
tcCO2 was 0.0357 at the start and 0.0288 at the end (p < 0.001).
During HD episodes the opposite was found: SD  at  the start (0.0293)
was lower than at the end (0.0438, p  < 0.001).
3.3. SaO2
The arterial oxyhemoglobin saturation decreased (SaO2) simi-
larly during both NonHD and HD episodes with  median decrease of
2.0%-units during both type of episodes (p < 0.001), but distribution
of  SaO2 did not differ between episodes (p =  0.871). The median
SaO2 did not differ between the episodes at the  start (96.5 vs. 95.0%,
p = 0.212) but the HD episodes terminated at lower SaO2 compared
to the NonHD episodes (94.0 vs. 93.0%, p = 0.03, Fig. 5).
The SaO2 measured during the plateau correlated highly with
the mean nocturnal SaO2 (r = 0.939, p  < 0.001). A signiﬁcant cor-
relation was also observed between the tcCO2 increase and the
SaO2 decrease during the episodes (Spearman’s rho for NonHD:
r  = −0.382, p = 0.004 and HD: r = −0.460, p = 0.031). The tcCO2
increased during all but one  NonHD episode in a linear function
of  time, whereas SaO2 decrease was observed during 75.9% of HD
episodes and 77.3% of NonHD episodes.
4. Discussion
Our new data demonstrate that tcCO2 increases during all
episodes of progressive ﬂow limitation, irrespective of the degree of
respiratory effort. We  have previously shown that tcCO2 increases
during episodes of progressive ﬂow limitation with high respira-
tory drive (Rauhala et al., 2007). Our  new data  demonstrate that
tcCO2 also increases during episodes of progressive ﬂow limita-
tion in the absence of progressively increasing respiratory drive.
This ﬁnding contradicts the common thinking that the respiratory
drive during sleep increases as a linear function of increasing CO2.
The novel ﬁnding is that during ﬂow limitation the tcCO2 needs
to  exceed a certain set-point level until respiratory effort starts to
increase. This set-point corresponded to the visually determined
plateau tcCO2,  measured during episodes of stabile breathing dur-
ing sleep. The NonHD episodes started with signiﬁcantly lower
tcCO2 than the set-point but as the episodes evolved, the tcCO2
gradually increased, terminating at tcCO2 levels close to the set-
point. Analogically, the tcCO2 values at the beginning of  the HD
episodes did not differ from the set-point, but at the moment
of  termination were signiﬁcantly above the set-point. Our  results
conﬁrm the previous ﬁnding that episodes of inspiratory ﬂow limi-
tation may  occur with both low and high respiratory drive (Ayappa
et al., 2000). In the current study we  demonstrate that the level
of tcCO2 measured during stabile sleep is  the set-point, which the
control of breathing targets during ﬂow limitation.
Our new ﬁnding indicates that the respiratory effort during
ﬂow limitation do not increase as a  linear function of the tcCO2.
Instead, there is a set-point level of  tcCO2, measurable through
the  skin, below which respiratory drive during sleep does not
strongly respond to tcCO2 increase. Below this set-point, despite
progressive tcCO2 increase, ﬂow limitation is not associated with a
crescendo pattern of  increasing respiratory effort.  We suggest that
drive to both respiratory pump muscles and upper airway dilator
muscles during transitions between wakefulness and stabile sleep
remains low and produces the NonHD ﬂow limitation episode.
Low drive to respiratory pump muscles could result from  central
hypoventilation, aiming at  physiological tcCO2 increase up  to the
set-point. Low drive to upper airway dilator muscles predisposes
to ﬂow-limitation, which contributes to tcCO2 increase. Compared
to HD episodes, the  NonHD episodes were  shorter and the tcCO2
increased faster. Because clear marker of event termination was
required for event inclusion, a selection bias toward episodes with
fast tcCO2 increase terminating at arousal may  have occurred.
Therefore, we may  have missed those NonHD episodes, during
which more slowly rising tcCO2 could  stabilize at  set-point level
without disturbance. Whether acceleration of  the tcCO2 increase
by  ﬂow limitation during a NonHD episode has some role in  induc-
ing arousal (respiratory effort related arousal, RERA), remains to be
studied.
In contrast to NonHD episodes, progressive ﬂow limitation dur-
ing HD  episodes results in  vigorous response, producing prolonged
episodes of  constantly increasing respiratory effort (crescendo pat-
tern) and corresponding tcCO2 increase. Depending on the response
of  the upper airway dilator muscles, continuing ﬂow limitation with
tcCO2 above set-point either stabilizes the upper airway (sufﬁcient
response) or initiates a vicious circle of aggravating ﬂow limita-
tion with increasing respiratory effort (insufﬁcient response). The
HD  episodes may  continue for several minutes, since they only
occur when the arousal threshold is highest during slow-wave
sleep. In  literature, this pattern is referred to as  increased respi-
ratory resistance (IRR) pattern (Alihanka, 1987; Polo et al., 1991;
Anttalainen et al.,  2007), obstructive hypoventilation (Isono and
Remmers, 1994) or crescendo pattern (Stradling, 1995). Simulta-
neous measurements of esophageal pressure have conﬁrmed that
these events are associated with highly increased intrathoracic
pressure variation as a marker of increased respiratory drive (Polo
et  al., 1991;  Rauhala et al., 2007).
Reliable identiﬁcation of  the tcCO2 plateau was critical for the
study. The increase of CO2 is a well-known physiological event
while  falling asleep, which has been demonstrated by measuring
the arterial or end-tidal CO2 (Henke et  al., 1990).  However, to  our
knowledge, the leveling-off of tcCO2 during stabile sleep has  not
been reported before. The plateau seems more evident on tcCO2
signal than when using other methods of  CO2 monitoring. This is in
line with the idea that the plateau is not  determined by ventilation
alone but  by the product of  ventilation and perfusion, controlled
by the autonomic nervous system. The tcCO2 plateau was unan-
imously identiﬁable in most recordings, when the  detection was
based on  high, constant tcCO2 level combined with stabile unob-
structed respiratory pattern. However, some degree of stabile ﬂow
limitation or snoring was  allowed, since ﬂow limitation was  com-
mon  in  this population. In some patients this may have led to  minor
over-estimation of  the plateau-level. In  case signal drift was sus-
pected, the plateau level was  determined as close as possible to the
ﬂow-limited episodes. Awareness of potential artifacts and rejec-
tion of technically insufﬁcient recordings are essential for  obtaining
reliable tcCO2 readings.
The tcCO2 method was developed for  non-invasive monitoring
of the arterial CO2. Decent performance has been demonstrated in
situations where the  autonomic state of  the patient remained stable
(e.g. mechanical ventilation during anesthesia (Xue et al., 2010)).
The accuracy of tcCO2 measurements to estimate arterial CO2 has
been questioned because the method is  sensitive for vasoconstric-
tion (Healey et al.,  1987; Clark et al., 1992).  It  is  possible that slow
wave sleep as a hemodynamically stabile  vasodilatory state could
also  stabilize the tcCO2 readings. Despite marked recent advance in
the tcCO2 technology regarding calibration and long-term stability
(overnight) of the signal, the reliability of the readings are chal-
lenged by  problems such as  drift, air leakage and changes in  body
position. In our data, body position did  not explain the observed
tcCO2 differences between NonHD and HD episodes. The consis-
tency  of  the connection between the respiratory effort driven by the
chemoreceptors and the tcCO2 levels measured across the periph-
eral skin is striking. During wakefulness or during arousals from
sleep, surges of sympathetic outﬂow to the carotid body (Fidone
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and Gonzalez, 1986) and to the skin (Morris, 1997) may parallel.
We  have previously modeled potential modulation of the carotid
body sensitivity by changes in  carotid body perfusion under control
of sympathetic outﬂow (Virkki et al., 2007).  The rapid drops seen at
Figs. 2–4 A-panels are most likely arousals. Arousals drop the tcCO2
rapidly toward the levels measured during wakefulness since both
the respiratory and circulatory demands are changed from those of
sleep to those of wakefulness. In conclusion, the value of the tcCO2
signal as a measure of the product of ventilation and  peripheral per-
fusion should be understood and taken advantage of  as a measure
of the peripheral acid-base balance.
The validity of the inductance belts used in our study in assessing
respiratory drive can be questioned. Esophageal pressure mea-
surement would have been the optimal metrics for measuring
respiratory drive and pneumotachography for exact measuring of
airﬂow and ﬂow contour. Taken  into account the large patient
population that was needed for primary screening of episodes,
this approach was not feasible. The thoraco-abdominal belts are
a decent surrogate in most occasions for measuring the respira-
tory efforts (Masa et al., 2003). It is possible, although unlikely,
that narrowing of the upper airway may  limit the  movement of
the ribcage or diaphragm in  a way that increasing respiratory
drive would result in decreasing thoraco-abdominal amplitude.
This would have caused mislabeling of  an HD episode as a nonHD
one. On the other hand, we are  not aware of any mechanism that
would cause mislabeling of nonHD episodes as HD  ones. Failure to
distinguish between the types of episodes would have resulted in
weakening of our results. The consistent results are in line with
sufﬁciently successful episode labeling. Any improvement in  drive
measurement should only enhance our ﬁndings.
Only cardiorespiratory polygraphic recordings were available
for analysis. One could argue that without polygraphic recording of
sleep, it would not be possible to differentiate between wakefulness
and sleep, or, more importantly, between REM and NREM sleep.
There are a number of arguments that make us convinced that the
episodes we chose for analyses were all during NREM sleep. First,
we started with episodes of clear, long lasting episodes of regular
breathing with constant or gradually aggravating ﬂow limitation.
It is highly unlikely that these  episodes of ﬂow limitation would
have occurred while awake. Second, there are a number of clues to
suspect REM from respiratory parameters. Episodes of ﬂow limi-
tations were not included when bursts of  phasic events typical for
REM sleep manifested either as irregular breathing efforts, variable
heart rate or twitches in the anterior tibial EMG  were  present. The
muscle atonia of REM affects more the intercostal muscles than the
diaphragm, resulting in decreased respiratory movement ampli-
tude that is only seen in the thoracic belt signal. For the purpose
of the study we could afford rejecting any episode of ﬂow limita-
tion that did not fulﬁll all the  strict inclusion criteria. Therefore, it
is unlikely that any of the chosen respiratory episodes would have
occurred during REM sleep. Episodes of ﬂow limitation rejected
because of possible REM were  short and represented NonHD type
episodes, even when the tcCO2 levels increased above the estab-
lished tcCO2 plateau level. This  is in line with the fact that the
control of breathing during REM differs from NREM sleep and sug-
gests that the tcCO2 plateau chosen according to  our criteria to
represent the set-point of respiratory drive is valid only for NREM
sleep.
Our study was a retrospective analysis of consecutive cardio-
respiratory recordings collected as part of clinical diagnostic
procedures. To reveal the existence of  a new phenomenon with
methodology that was available, we carefully selected patients with
sleep recordings of high technical quality, who fulﬁlled our strict
inclusion criteria for ﬂow-limitation. The high number of excluded
patients does not mean that these phenomena as  such are rare in
patients with SDB. In technically successful recordings, the tcCO2
plateau level can be determined in almost all  cases. Flow-limitation
episodes are particularly common in patients, in whom SDB ranges
from non-apneic snoring to mild  to moderate sleep apnea. The
most common reason for exclusion was  the minimum duration
of  the ﬂow-limitation episodes of 2 min. This resulted in exclu-
sion  of many patients, whose inspiratory ﬂow limitation episodes
with low respiratory drive were shorter than required. We  did
not want to  compromise with  these criteria, since we wanted a
clear trend in the relatively slow responding tcCO2 signal. This
was only a methodological limitation, without any suspicion that
shorter episodes as such  would behave differently. We also care-
fully rejected episodes with potential waxing and waning pattern
of  the respiratory drive in the background. Many HD episodes were
not included because the initial crescendo pattern did not termi-
nate but shifted to stabile HD breathing with stabile ﬂow-limitation
or heavy snoring, indicating that inspiratory duty cycle and effort
are in balance (Schneider et al.,  2009).  By careful episode selection,
we  aimed at uncovering mechanisms that could be generalized to
much larger groups of  patients.
Identiﬁcation of the tcCO2 plateau and the set-point for respi-
ratory drive during sleep as part  of polygraphic sleep recording or
cardiorespiratory recording has signiﬁcant clinical value and has
become a routine practice at our sleep center. The major advan-
tage is that it may help to differentiate between respiratory events
that are either of central or obstructive origin. Respiratory episodes
during sleep, including episodes of apnea or hypopnea, may result
either from unstable sleep with repetitive arousals constantly shif-
ting the respiratory set-point (Wellman et  al., 2011) or from unsta-
ble  upper airway. This results in  a mixture of central and obstructive
events. The conventional differentiation between episodes of cen-
tral  and obstructive apnea has  recently been extended to also
include central and obstructive hypopnea (Berry et al., 2012;
Mooney et al., 2012). Based on our results, this concept could
perhaps be  applied also to ﬂow limitation, the NonHD events repre-
senting ﬂow limitation from central origin  and the HD  events ﬂow
limitation driven by upper airway obstruction (Rimpilä et al., 2010).
Therefore, differentiation between episodes of low and  high drive
may have clinical implications; since also central and obstructive
sleep apnea are treated differently. An analysis of the respiratory
events in  relation to  the tcCO2 plateau may  be of interest when
patients are symptomatic with low AHI (Anttalainen et al., 2007).
In conclusion, the tcCO2 plateau phenomenon, expressing the
level of peripheral CO2 during which airway stability is balanced
with minimal respiratory drive during sleep, may help to assess the
clinical importance or  understand the clinical manifestation of  the
symptoms and cardiovascular co-morbidities of the patient. Our
novel ﬁnding in  patient population with suspected SDB suggests
that there is a target CO2 level during sleep, which is  dependent on
both ventilation and  perfusion, and which determines the degree
of respiratory drive and the autonomic nervous system state. Opti-
mizing the CO2 level at this set-point level should be  the target of
all  therapies aiming at  improving SDB.
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a  b  s  t  r a c  t
Respiratory  drive  is tightly  controlled  by the carbon  dioxide levels. We  tested the  hypothesis  that
sequences  of sleep  apnoea  (obstructive,  central or  mixed), hypopnoea  and  ﬂow limitation  are  character-
ized  by  different  levels of transcutaneous CO2 (PtcCO2).  Polygraphic recordings  (n =  555)  from patients
with  suspected sleep-disordered breathing (SDB) were  retrospectively screened to  ﬁnd sequences (5 min
or  10  events) of  both SDB  and steady  breathing. Eighty-eight SDB sequences from  44  patients  were
included  and PtcCO2 and SpO2 values were  collected. PtcCO2 values during  sequences were normalized
by  setting wakefulness level  as 100%.  In terms of  PtcCO2, apnoea  sequences with central component
(central  (n = 7) and  mixed  (n = 3) apnoea)  did not  differ from  wakefulness (102.0% vs  100%, p =  0.122)
whereas  obstructive apnoea  (105.8%,  p  < 0.001) and  hypopnoea did (105.4%,  p  < 0.001). PtcCO2 during
ﬂow  limitation  was higher than  that during  any other sequence, including  steady breathing  (112.2%  vs
108.4%,  p =  0.022).  Continuous PtcCO2 monitoring during sleep  adds to the  understanding of different
SDB  phenotypes.
© 2015 Elsevier  B.V. All rights reserved.
1. Introduction
Recording the arterial oxyhaemoglobin saturation (SaO2) during
sleep is a standard method to monitor the effect of  sleep-disordered
breathing (SDB) on arterial oxygen content. Monitoring the car-
bon dioxide during sleep is technically more demanding and its
interpretation more complex. Therefore, the carbon dioxide is  less
frequently monitored during standard polysomnography (PSG) and
its physiology less understood. Since carbon dioxide has important
physiological roles including controlling pH and local perfusion
through nitric oxide production (Lavi  et al., 2003), better under-
standing of carbon dioxide physiology during sleep is  needed.
∗ Corresponding author at: Unesta Research Center, Näsilinnankatu 48 D,  4th ﬂoor,
33520  Tampere, Finland.
E-mail address: rimpila.ville.p@student.uta.ﬁ (V. Rimpilä).
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Carbon dioxide is usually measured to detect hypoventilation
during sleep (Pautrat et  al.,  2015). Gold standard is the arterial
partial pressure of  carbon dioxide (PaCO2), but repetitive samples
are  difﬁcult to obtain during sleep. Therefore, surrogate measures
are  used. End-tidal carbon dioxide (PetCO2)  provides breath-to-
breath measurement, but low  tidal volumes or mouth breathing can
distort the results. Transcutaneous carbon dioxide (PtcCO2), which
reﬂects both ventilation and perfusion at the periphery (Stock,
1988; Clark et al., 1992), is not  directly affected by mouth breathing
or mask ventilation, but slow response time affects the timing in
the analysis of individual respiratory events (Janssens et al.,  1998;
Kesten  et al., 1991).  Comparison between these different methods is
difﬁcult since they  measure carbon dioxide at different sites and dif-
ferent phases of  CO2 production, diffusion, buffering or transport.
Therefore, one CO2 signal should not only be used as an estimate of
another, since each signal has  value in  its own right. The PtcCO2 sig-
nal is closest to the CO2/pH environment at the tissue level,  which
in many clinical situations would be  more useful than PaCO2, if
understood and interpreted accordingly.
We previously introduced the concept of PtcCO2 plateau,
deﬁned as steady level of PtcCO2 associated with steady breathing
http://dx.doi.org/10.1016/j.resp.2015.10.002
1569-9048/© 2015 Elsevier B.V. All rights reserved.
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during sleep (Rimpilä et al.,  2014).  This plateau was shown to
differentiate two phenotypes of upper airway ﬂow limitation.
The aim of the present study was to assess: (1) whether PtcCO2
measurement is sensitive enough to detect differences between
SDB types and (2) if so, how  the PtcCO2 levels associated with
different phenotypes of SDB relate to the PtcCO2 levels measured
during wakefulness and the  plateau PtcCO2 during sleep. We
hypothesized that each breathing type has a distinct PtcCO2 level.
2.  Methods
2.1. Ethical approval and patients
Initially, 555 cardio-respiratory sleep recordings with PtcCO2
measurement performed between June 2005 and May  2007 in  Tam-
pere University Hospital, Tampere, Finland, were used for the study.
All patients had previously been studied according to the standard
clinical practice, without any  modiﬁcation for research purposes.
Approval of the institutional ethics committee was therefore not
required according to Finnish legislation.
2.2. Measurements
The cardiorespiratory recordings included overnight measure-
ment of arterial oxyhaemoglobin saturation from pulse oximetry
(SpO2), nasal ﬂow (prongs), anterior tibial electromyography
(EMG), body position, respiratory efforts (uncalibrated thoracic and
abdominal respiratory inductance plethysmography) and snoring
(piezoelectric sensor) (Somnologica, Medcare Flaga hf, Reykjavik,
Iceland). The partial pressures of CO2 and O2 were measured
transcutaneously with a dual sensor, (TCM4, Radiometer, Copen-
hagen, Denmark). Device was calibrated with ﬁxed gas composition
(CO2:7.5%, O2:20.9%, N2:71.6%) before sleep studies. The sensor was
attached to upper chest next to sternum and warmed up to 43.0 ◦C,
at which temperature the sensor was kept in the same location for
the duration of the night. Online recording of the  digital output
of the TCM4 device with custom written software (TCM4ebm by
Jussi Virkkala) ensured full synchronization and integration of the
PtcCO2 signal with Somnologica. Background information such as
age, gender and BMI  were collected from patient records. Arterial
blood gas values were not available.
2.3. Design
This study is a database analysis of cardiorespiratory sleep
recordings from patient population with suspected SDB. The study
consisted of two phases. First, screening of the patient population
for  SDB sequences and normal breathing, and second the analy-
sis of the effect of different types of SDB sequences on PtcCO2 and
SpO2 levels. A recording was included to the study if all of the  fol-
lowing sequences were identiﬁed: (1) a sequence of undisturbed
normal breathing during evening wakefulness, (2) a sequence
of steady breathing with minimal ﬂow-limitation during sleep,
and (3) one or more sequence(s) of cyclic SDB  (central, mixed
and obstructive apnoea or hypopnea). After inclusion, the PtcCO2
traces were uncovered and recordings with insufﬁcient PtcCO2
quality: detached sensor or air  leak within sensor, extremely low
(below 3.0 kPa) or high (above 7.0 kPa) levels, suspicion of exces-
sive overnight signal drift (more than 1.0 kPa difference between
evening and morning wakefulness) or  incomplete signal (morn-
ing/evening values missing), were excluded.
2.4. Sequence selection
Unﬁltered nasal pressure signal, nasal ﬂow signal with square
root transformation and signal from snoring sensor were used to
score the breathing. Wakefulness sequence with normal breath-
ing was identiﬁed in the beginning of  the recording, before
lights-off mark. Sequences of steady breathing with minimal ﬂow-
limitation were characterized by breathing with stable amplitude
and frequency and selected from period between wakefulness
in  the evening and clear awakening in  the morning. Minimal
ﬂow-limitation (the inspiratory ﬂow contour is not completely
round) without snoring, and absence of major body movements
were required to ensure that the sequence occurred during sleep.
Episodes with waxing and waning patterns were not accepted.
When more than one  sequence of steady breathing was identiﬁed,
the one with greatest stability was selected.
Inspiratory ﬂow-limitation sequence with or without snoring
was also included in  the analysis when present. Identiﬁcation of
ﬂow-limitation was  based on typical inspiratory peaks and ﬂat-
tening of the inspiratory ﬂow (Aittokallio et al., 2001), associated
with signs of  increased respiratory effort on  the thoraco-abdominal
belts.
Sequences of  cyclic SDB events, repeating with similar pattern,
were scored  by using the following criteria: (1) the sequence length
should be  ﬁve minutes or more, or contain ten or more similar indi-
vidual events; (2) the consecutive events within the sequence had
to  resemble each other in terms of their length and respiratory pat-
tern. At least 50% of the respiratory events had to have the same
classiﬁcation (central, mixed, obstructive or hypopnea). Sequences
were classiﬁed according to their most frequent event type. The
respiratory events were scored apnoea, if they had a 90%  reduction
in inspiratory amplitude for  a minimum duration of  ten seconds.
Episodes of hypopnoea were required to  have 30% reduction in
inspiratory amplitude for a minimum duration of  ten seconds with
no desaturation criteria. However, desaturation of  3%  or more was
noted when present. For the purpose of the study, one represen-
tative sequence of each type from  each patient was included to
the analysis. In the case of several candidate sequences the one
with greatest stability and highest proportion of events with same
classiﬁcation was  selected.
2.5.  Data analysis
There is  marked inter-individual variation in the  PtcCO2 read-
ings (Fukui et al., 1993). Therefore, instead of comparing the
absolute levels of  the PtcCO2 during various types of  SDB, we
analyzed the differences between sequences using either absolute
(PtcCO2, kPa) or relative (%) scales by ﬁxing the PtcCO2 levels
observed during wakefulness as zero kPa  or 100%. Additionally,
the relative PtcCO2 levels (%) during sequences were  also com-
pared when the PtcCO2 during steady breathing with minimal
ﬂow-limitation was  set to 100%.
Pre-event SpO2 levels (SpO2 start) and desaturations related
to  individual respiratory events in sequences with cyclic nature
were determined and average values were used in  the analysis. For
stable sequences (wakefulness, steady breathing and ﬂow limita-
tion) median values were  used. Once the ﬁnal study population was
conﬁrmed the apnoea–hypopnoea-indices (AHI) were determined
according to the latest consensus statement with the exception of
arousal criterion for hypopnoea, which could not be  used (Berry
et al., 2012). Leg movements and PLM were scored according to
the WASM criteria (Zucconi et al.,  2006)  with the exception that
leg movements occurring within ten seconds on both sides of
apnoea termination were considered to have an association and
were excluded from the PLM index.
2.6. Statistical methods
The effect of gender on PtcCO2 values was  tested with
Mann–Whitney U test and the effect of age with univariate ANOVA.
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Fig. 1. Selection of the ﬁnal study population, which included 44/555 (7.9%) of ini-
tial  patient population. SDB = sleep-disordered breathing, PtcCO2 = transcutaneous
carbon  dioxide.
Differences in PtcCO2 and SpO2 values between sequences were
assessed using independent samples Kruskal–Wallis test with Bon-
ferroni correction. The effect of using  different ﬁxation points for
PtcCO2 (wakefulness 100% vs steady breathing 100%) was assessed
with Levene’s test for equality of variances. p-value of less  than
0.05 was considered signiﬁcant. Statistics were  analyzed using  SPSS
software (IBM Corp. Released 2010. IBM SPSS  Statistics for Win-
dows, Version 19.0. Armonk, NY: IBM  Corp.)
3. Results
3.1. Characteristics of the study population
Tracings from 44 patients (34 men  and 10 women) fulﬁlled the
inclusion criteria of the study and were further analyzed (Fig. 1.).
Main characteristics of the population are shown in Table 1. AHI
Table 1
Patient characteristics.
Mean/median SD/IQR
Sex, M:F(n) 34:10
Age  (years) 52.8 11.0
BMI  (kg/m2) 30.5 5.9
AHI  (#/hour) 21.8 13.2
Apnoea  index 8.4 8.4
Central  apnoea index 1.7 2.9
Obstructive  apnoea index 5.5 6.2
Mixed  apnoea index 1.2 2.9
Hypopnoea  index 13.4 10.0
PLM  (#/hour) 10.9 28.7
Recording  length, (min) 443.4 75.9
PtcCO2, wakefulness, (kPa) 5.18 0.45
PtcCO2, steady breathing, (kPa) 5.47 0.61
PtcCO2 (steady breathing-wake), (kPa) 0.41 0.44
Overnight  SaO2 mean, (%) 93.8 2.0
Overnight  SaO2 min, (%) 82.4 6.4
Indices calculated as #/analyzed hours. AHI,  apnoea-hypopnoea index; PLM,
periodic  leg movements; PtcCO2,  transcutaneous carbon dioxide; SaO2,  arterial oxy-
haemoglobin saturation. Median and interquartile ranges (IQR) presented in italics.
range of  this study population was  3.6–53  1/h. Mean increase in
PtcCO2 from wakefulness to  sleep was 0.41 kPa (3.04 mmHg). Nei-
ther gender nor age had an effect on PtcCO2 values.
3.2. Characteristics of SDB sequences
Eighty-eight SDB  sequences were detected. Most of  these were
hypopnoea sequences (n = 32)  or ﬂow limitation (n  = 32). Only three
sequences of mixed apnoea were detected and they  were pooled
together with central apnoea (n = 7) sequences, with  central com-
ponent  of breathing as a common feature. Table 2 shows the  SDB
sequence characteristics. Most  notable differences can be seen  in
absolute and relative values of PtcCO2 and position distributions:
two thirds of the cyclic SDB sequences occurred in  supine position
(66.7–92.9%), whereas one third of  the steady breathing with min-
imal ﬂow-limitation and ﬂow limitation sequences occurred while
supine (31.0% and 32.3%, respectively).
Total of 608 respiratory events were  included from central,
mixed, obstructive and hypopnoea sequences. 534  events (87.8%)
were associated with  arterial oxyhaemoglobin desaturation (3% or
more). The analyzed SDB sequences were very homogenous; only
41 events (6.7%) in  18 sequences did not  match with their sequence
classiﬁcation. Figs. 2 and 3 show examples of overnight tracings.
3.3. Transcutaneous carbon dioxide in  SDB sequences
Eight patients showed average PtcCO2 values  higher than
6.00 kPa  (45 mmHg), highest being 6.54 kPa (49.1 mmHg) during
ﬂow-limitation. In  three patients the morning PtcCO2 was higher
than 6.0  kPa, highest being 6.47 kPa (48.5 mmHg). The other two
were 6.02 kPa.
Pairwise comparisons of  the absolute and relative changes
in  PtcCO2 levels during SDB sequences, wakefulness, and steady
breathing during minimal ﬂow limitation are shown in Table 3
and Fig. 4.  In the  absence of  SDB, the PtcCO2 was  higher during
sleep (steady breathing with minimal ﬂow limitation) compared to
wakefulness. The PtcCO2 levels during respiratory sequences with
central component (central or mixed apnoea) did  not differ from
those measured during wakefulness, but  they were lower than the
PtcCO2 levels during stable breathing with minimal ﬂow limita-
tion. The  PtcCO2 levels during the other SDB events (obstructive
apnoea, hypopnoea and ﬂow-limitation) were higher than those
during wakefulness. The highest levels of PtcCO2 were observed
during ﬂow limitation, the difference being signiﬁcant when com-
pared to steady breathing during minimal ﬂow limitation and all
other forms  of SDB, Supplementary Fig.  A.1 and A.2  for individual
PtcCO2 values.
When steady breathing was used as a baseline for relative
PtcCO2 instead of  wakefulness, the variances of  PtcCO2 within
SDB sequences became signiﬁcantly smaller, except for obstructive
apnoea which had the smallest variance (Fig. 5).
Supplementry material related to this article found, in the  online
version, at http://dx.doi.org/10.1016/j.resp.2015.10.002.
3.4. Arterial oxyhaemoglobin saturation during SDB sequences
The SpO2 results are shown in Table 2 and Fig. 4. The lev-
els of SpO2 at the beginning of desaturation events during cyclic
SDB did not differ from each other (p = 0.066), but the SpO2
nadirs during hypopnoea (91.6%) sequences were more shallow
than those during central (89.9%, p  =  0.035) or obstructive apnoea
sequences (88.8%, p = 0.05). The median SpO2 during wakefulness
(95.0%) was similar to steady breathing with minimal ﬂow limita-
tion (94.0%, p  = 0.078) but higher than that during ﬂow-limitation
(94.0%, p  = 0.006).
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Table  2
Characteristics of the SDB sequences (n = 88).
Cyclic breathing
Sequence (n) Wakefulness Central +  Mixed apnoea (10)  Obstructive apnoea (14) Hypopnoea (32) Steady breathing Flow-limitation (32)
PtcCO2 (kPa) 5.18, (0.45) 5.11, (1.00) 5.31, (0.37) 5.50, (0.75) 5.47, (0.61) 5.64, (0.66)
PtcCO2, wake (kPa) 0 0.10, (0.43) 0.29, (0.25) 0.27, (0.47) 0.41 (0.43) 0.60, (0.32)
PtcCO2 (%), (%-units) 100  (0) 102.0 (8.5) 105.8 (5.5) 105.4 (9.4) 108.4 (8.6) 112.2 (6.8)
SaO2, event start (%) – 96.4 (1.4) 96.6 (1.9) 95.9 (1.8) – –
SaO2, event desaturation (%) –  89.9 (5.6) 88.8 (7.0) 91.6 (3.6) – –
SaO2 (%) 95.0  (2.0) – – –  94.0 (3.0) 94.0 (3.0)
Sequence  length (min) 0:04:41 0:07:48 0:08:46 0:07:00 0:05:56 0:07:06
Supine  (%) 69.8  70.0 92.9 74.2 31.0 32.3
Values presented as medians with interquartile range  in the parentheses. Sequence lengths are shown as mean values. Pairwise comparisons of PtcCO2 values are shown in
Table 3. PtcCO2, transcutaneous carbon dioxide; SaO2,  arterial oxyhaemoglobin saturation.
Fig. 2. An example of hypopnoea sequence within an overnight PtcCO2 and SpO2 proﬁle with expanded views of all  included sequences. Lower panel shows the dynamics
of  PtcCO2 and SpO2 using the time scale below. Upper panels show part of the (SDB) sequence from the corresponding part of PtcCO2 signal (rectangles and numbers). Scale
bar  indicates 30 s. Sequences associate with different PtcCO2 levels, the steady breathing (4) being situated between hypopnoea (3) and ﬂow-limitation (2)  sequences.
Table  3
Pairwise comparison of absolute and %-units changes of tcCO2 between wakefulness, cyclic SDB sequences, steady breathing and ﬂow limitation.
Pair (n) PtcCO2,  (kPa) p  PtcCO2,  %-units p
Wakefulness (44) Central apnoea (10) 0,10 0.116 1,987 0.122
Obstructive  apnoea (14) 0,29 <0.001* 5,822 <0.001*
Hypopnoea (32) 0,27 <0.001* 5,363 <0.001*
Steady breathing (44)  0,41 <0.001* 8,439 <0.001*
Flow limitation (32)  0,60 <0.001* 12,207 <0.001*
Central apnoea (10) Obstructive apnoea (14) 0,19 0.181 3,835 0.168
Hypopnoea  (32) 0,16 0.086 3,376 0.086
Steady  breathing (44)  0,30 0.016  6,452 0.015
Flow  limitation (32)  0,50 <0.001* 10,220 <0.001*
Obstructive
apnoea
(14)
Hypopnoea (32) -0,02 0.831 −0,459 0.876
Steady  breathing (44)  0,12 0.341 2,617 0.365
Flow  limitation (32)  0,31 0.012  6,385 0.011
Hypopnoea  (32) Steady breathing (44)  0,14 0.336 3,076 0.326
Flow  limitation (32)  0,33 <0.001* 6,844 0.002*
Steady breathing (44) Flow limitation (32)  0,20 0.026 3,768 0.022
Signiﬁcant pairwise differences are marked with bold (p < 0.05).  * = Signiﬁcant difference between sequences after Bonferroni correction (p  < 0.0033)airwise comparisons
marked  with bold indicate p < 0.05.
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Fig. 3. An example of obstructive apnoea within overnight PtcCO2 and SpO2 proﬁle with expanded views. Lower panel shows the dynamics of PtcCO2 and SpO2 using  the time
scale  below. Upper panels show part  of the (SDB) sequence from the corresponding part  of PtcCO2 signal (rectangles and numbers). Scale bar of 30 s is  shown. An obstructive
sleep  apnoea sequence (4) is associated with low PtcCO2 compared to steady breathing (2) or ﬂow limitation (3). Each sequence type is associated with speciﬁc PtcCO2 level.
4. Discussion
Measuring PtcCO2 during sleep is of potential interest, but there
are no common guidelines for interpretation. The purpose of  the
study was to evaluate if  the PtcCO2 measurement is sensitive
enough to detect differences between different SDB types and to
see what those differences are. Sleep is associated with a  physio-
logical CO2 increase but the  interaction between this increase and
SDB is not fully elucidated. The main ﬁndings of this study are as
follows: (1) the different types of SDB  are associated with different
relative levels of PtcCO2,  (2)  PtcCO2 levels during central or mixed
apnoea are close to those observed during wakefulness, whereas
during obstructive apnoea and hypopnoea they are higher than
during wakefulness and (3)  the highest PtcCO2 levels are observed
during ﬂow-limitation. There  are two major implications of our
results. First, it is possible that cyclic SDB inhibits the physiological
CO2 increase which should occur during sleep. Second, ﬂow limita-
tion (non-cyclic SDB) seems to cause CO2 increase that exceeds the
physiological sleep-related CO2 level and may  therefore predispose
true hypercapnic conditions.
Our ﬁnding that the different types of SDB are associated with
different levels of PtcCO2 is  in  line with previous studies. The type
of apnoea tends to change overnight from obstructive to central
events (Meer et al., 1992).  In patients with chronic heart failure
(CHF), the overnight change of apnoea type from obstructive to
central sleep apnoea has been associated with  PtcCO2 decrease
(Tkacova et al., 2001). We  also found that the PtcCO2 levels dur-
ing cyclic SDB sequences are often below steady breathing levels.
This predicts that successful treatment of SDB  with cyclic breath-
ing results in an increase, not  decrease in PtcCO2. This is supported
by other studies. A decrease in the frequency of the apnoeic and
hypopnoeic episodes as a result of using CPAP for  one month was
associated with increased PtcCO2 during stage 2 sleep (Naughton
et al., 1994).  Similar observations have been reported in studies
with  adaptive servoventilation (ASV) (Teschler et  al., 2001). The
interaction between sleep apnoea type and PtcCO2 is bidirectional:
an  increase in inspired CO2 stabilizes breathing and may  completely
abolish the episodes of  central apnoea (Xie et al., 1997) and reduce
the occurrence of  obstructive apnoea (Hudgel et al.,  1988).
Flow-limitation and “simple” snoring without hypoxemia is
often considered as  a benign type of SDB, not warranting treatment.
However, our study shows that ﬂow limitation is  associated with
the  highest levels of  PtcCO2. The increase in CO2 is probably a  result
of hypoventilation as the tidal  volume is  reduced by  ﬂow-limitation
(Schneider et al., 2009). Patients with symptomatic ﬂow limitation
respond well to CPAP  therapy and adhere to treatment similar to
patients with obstructive sleep apnoea (Anttalainen et al., 2007). In
addition to controlling SDB, early treatment of ﬂow limitation may
be warranted, since fully developed hypercapnic respiratory fail-
ure may  be  a therapeutic challenge. Opposite to obstructive sleep
apnoea,  the therapeutic response of  hypercapnic respiratory failure
to CPAP  therapy is  decrease of  CO2 (Piper and Sullivan, 1994). When
the level of PtcCO2 observed during steady breathing is  exceeded,
the respiratory effort  increases (Rimpilä et al., 2014). This effect can
be  seen when progressively developing ﬂow-limitation is used as
a model. Based on these phenomena we propose that during sleep
the  PtcCO2 increases from the levels observed during wakefulness
to  the levels characteristic for  stable sleep and breathing, unless
prevented by cyclic SDB or ﬂow-limitation.
For the purpose of  the study, we included the conventional
apnoea classes into the analysis as sequences rather than individ-
ual events. This was done because of two reasons. First, the type of
SDB and  the autonomic background state  during SDB may vary as
a result  of arousals and sleep stage changes. Choosing a sequence
of  repetitive events of the same  type of  SDB ensures that the auto-
nomic state during the sequence would remain as stable as possible.
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Fig. 4. PtcCO2 and SpO2 during SDB sequences, wakefulness and  steady breathing. Panel A shows absolute differences in PtcCO2 in comparison to wakefulness (PtcCO2, kPa
on  left, mmHg on right). The ﬂow limitation differs from all other  sequences and the PtcCO2 during the central apnoea sequences (*pooled with mixed apnoea) is lower than
that  during obstructive apnoea or hypopnoea sequences. The PtcCO2 levels  during steady breathing are  situated between cyclic and non-cyclic SDB. Panel B shows relative
differences  in PtcCO2 in comparison to wakefulness (100%). Panel C shows arterial oxyhaemoglobin saturation (SpO2) during the sequences. For cyclic SDB,  the starting level
of  desaturation is shown with medium dark grey and the nadir of desaturation level is  shown with dark grey. The box plot shows the median, interquartile range and the
minimum  and maximum values. Signiﬁcantly different pairs are  shown with lines. The pairs are the same for panel A and B, the exact p-values for PtcCO2 are  shown in bold
in  Table 3 and in the text for SpO2. Circles denote outliers.
Second, by analyzing longer sequences it was possible to circum-
vent issues arising from the slow response time related to PtcCO2
technology (Janssens et al., 1998).  On  the other hand, by doing
this,  large number of patients had to be  screened in order to ﬁnd
individuals showing sequences of both SDB and normal breathing
fulﬁlling our strict inclusion criteria. Only 7.9% out of the originally
screened population were ﬁnally analyzed, explaining also why  a
retrospective approach was chosen. The ﬁnal sample size is a trade-
off between having few recordings with uncompromised inclusion
criteria or more recordings with more confounding noise.
When steady breathing with minimal ﬂow-limitation was
used as a reference point for  PtcCO2,  the variance of PtcCO2
within SDB sequences became smaller (Fig. 5). This implies
that stable PtcCO2 during steady breathing is less affected
by external factors than during wakefulness. Such factors
include: previous physical activity or emotions, excitement
about the sleep study procedure, circadian rhythm, or use  of
stimulants. The lower variances add  to our conﬁdence that
the used deﬁnition of steady breathing with minimal ﬂow
limitation provided a decent estimation of  the PtcCO2 level dur-
ing optimal sleep and breathing. We have previously described the
concept of the PtcCO2 plateau, which links stable breathing with
minimal ﬂow limitation with stable PtcCO2 level (Rimpilä et al.,
2014).
This study has inherent limitations that should be  considered.
EEG was  not available so the determination of wakefulness and
sleep is  limited. We have previously shown that PtcCO2 increases
on average 0.4 kPa between wakefulness and SWS sleep (Aittokallio
et al., 2009). The current study did not include EEG, but the differ-
ence in PtcCO2 between wakefulness and steady breathing with
minimal ﬂow limitation was the  same (0.41 kPa), suggesting that
these sequences represented steady sleep. Sleep stage effects on
apnea severity have been demonstrated (Ratnavadivel et al.,  2009)
but their relations to CO2 were not reported. Prospective studies are
needed to conﬁrm the  links between SDB phenotype, sleep stage
and CO2.
Nasal ﬂow was used to measure air ﬂow. Oronasal ﬂow would
have been optimal to  detect oral breathing in order to  discriminate
episodes of  apnoea and  hypopnoea unequivocally. Misclassiﬁcation
is  an issue only for  episodes of  true hypopnoea, which may have
been considered as obstructive or mixed apnoea, when oral breath-
ing was not  detected. However, this is unlikely to have affected
our  results: the distribution of  PtcCO2 values during obstructive
apnoea is narrow compared to the other forms of SDB (Fig. 4). Mix-
ing episodes of hypopnoea with obstructive apnoea would have
widened the  PtcCO2 distribution. Long periods of oral breathing
which are characterized by poor  nasal ﬂow signal were not used
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Fig. 5. Difference in PtcCO2 distribution across sequences when different baselines are used. Notice that the y-axis on  the right is moved upwards so that wakefulness
and  steady breathing medians are  at  the same  level to allow comparison between panels. Sequence variances are smaller when steady breathing with minimal ﬂow
limitation  is used as baseline, except for obstructive apnoea. PtcCO2 = transcutaneous carbon dioxide, W = wakefulness, C = central and mixed apnoea, O  = obstructive apnoea,
H  = hypopnoea, S = steady breathing with minimal ﬂow limitation, F = ﬂow limitation. Circles denote outliers.
for PtcCO2 analyses. For AHI, missing oronasal ﬂow could have led
to modest underestimation of AHI.
Another major limitation arises from the PtcCO2 technology.
Recalibrations of PtcCO2 and drift corrections are usually not per-
formed after sleep study, which prevents the assessment of the
exact signal drift during the  night and hypoventilation may  not
be  detected. The highest mean PtcCO2 observed during ﬂow-
limitation was  6.54 kPa (49.1  mmHg), which does not fulﬁll the
recent AASM guidelines (Berry et al., 2012) for diagnosing hypoven-
tilation. Therefore, sleep-related hypoventilation is  unlikely to play
a  role in this dataset. Although signiﬁcant differences between the
PtcCO2 levels were found between various types of  SDB, there was
still large within-type variation in PtcCO2 suggesting that other fac-
tors such as arousals and the  O2–CO2-interaction are also involved
in  determination of the SDB phenotype. Despite these technolog-
ical limitations, demonstration of signiﬁcant PtcCO2 differences
between SDB phenotypes suggests that the signal quality was  suf-
ﬁcient for the purpose of this study.
For good quality overnight recordings, with current PtcCO2
monitoring techniques, there are two important issues to  be  con-
sidered: ﬁrst, the manufacturers instruct to change the  place of
the probe every four hours. This may  be a relevant instruction for
infants or children, but in adults this may  not be  needed, when using
probe temperature of 43.0 ◦C (Janssens et al., 2001).  Reddening of
the skin is common but signiﬁcant burn injuries of the skin under
the probe sites are rare and if occur, heal without complications.
Common practice in adults is to keep  the probe site unchanged for
the duration of the sleep study (up to 8 h). This allows an  undis-
turbed signal proﬁle overnight.
Also, at 43.0 ◦C the PtcCO2 correlates reasonably with PaCO2,
but the absolute values may  have large limits of agreement, so
the use of PtcCO2 as a direct surrogate of PaCO2 is  not  recom-
mended (Nishiyama et al.,  2006). Therefore, even though PaCO2
values would have been useful  for sensor calibration, deviations
between PtcCO2 and PaCO2 could not  have been ruled out during
an overnight recording. In  the  present study, the PtcCO2 was not
used as a surrogate of PaCO2.
Patients with obstructive sleep apnoea but without long
sequences of steady breathing with minimal ﬂow limitation were
excluded from the  present study. This does not mean that these
sequences do not exist. In clinical setting, when the respiratory
and the PtcCO2 signals are  simultaneously visible, it is possible
to ﬁnd shorter periods during which steady breathing associates
with steady PtcCO2 levels (plateau). In  patients with severe OSA,
the plateau may only become visible when on CPAP. Therefore, we
believe that our ﬁndings are applicable also to patients with  more
severe SDB  when PtcCO2 plateau may not be identiﬁed.
The control of periodic breathing during sleep has been mod-
elled using  a loop  gain concept (Khoo et al., 1982; Younes et al.,
2001). The loop gain is  the ratio expressing, how strong the physi-
ological response triggered by  the control loop is compared to the
initial disturbance. A high loop gain (>1) ampliﬁes the response and
predisposes the system to oscillation. In the context of SDB, high
loop gain results in  periodic breathing whereas low  loop gain stabi-
lizes the  respiratory oscillation. In our study the respiratory control
during upper airway obstruction was unstable (suggesting loop
gain >1)  when PtcCO2 was between the wakefulness and steady
breathing levels. When PtcCO2 increases above the levels observed
during steady breathing, the airway obstruction is  associated with
ﬂow-limitation, without oscillation of  the respiratory command
(loop gain <1). Further studies are needed to test whether the rela-
tive value  of PtcCO2 could be  used as a surrogate for  the loop gain.
In  clinical setting, PtcCO2 is increasingly measured during sleep
studies when assessing gas  exchange during SDB. PtcCO2 is  also
often measured as  part of research protocols, but the results are
rarely reported. In  contrast to  arterial oxyhaemoglobin saturation,
there are no common guidelines for analyzing and interpreting the
PtcCO2 phenomena during sleep. Conventionally the PtcCO2 sig-
nal has been considered as a noninvasive estimate of the arterial
PaCO2,  and  correction algorithms are used in order to reach a bet-
ter agreement between PtcCO2 and PaCO2. While PaCO2 measures
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the efﬁcacy of the respiratory system in  removing CO2, PtcCO2 is
additionally affected by cutaneous vasoconstriction (Clark et al.,
1992), determined by the output  of the sympathetic nervous sys-
tem. Therefore, PtcCO2 may be  a poor estimate of  ventilation, but
a useful parameter to assess the CO2 environment and pH control
of the periphery. Our demonstration of the existence of the PtcCO2
plateau during stable breathing and deviations from  this level to
both directions during different forms of  SDB may  add new interest
to measure PtcCO2 during sleep. In particular, the PtcCO2 increase
observed during ﬂow-limitation may imply that the clinical impor-
tance of this respiratory abnormality has been underestimated.
5.  Conclusion
In conclusion, the different forms of  SDB associate with differ-
ent levels of PtcCO2. The highest levels of  PtcCO2 occur during ﬂow
limitation. During obstructive apnoea or  hypopnoea the PtcCO2 is
higher than during wakefulness but lower than during ﬂow limita-
tion. The PtcCO2 levels during central or mixed apnoea are similar to
wakefulness. Our ﬁndings support the potential of  PtcCO2 monitor-
ing in understanding the pathophysiology of different phenotypes
of SDB. Treatment of SDB should focus on stabilizing breathing by
suppressing the oscillation related to ventilatory overshoots and
letting the sleep-related CO2 increase to occur, but it should also
remove the obstruction during ﬂow limitation in  order to ensure
adequate minute ventilation to prevent hypercapnia. Future stud-
ies  with prospective design in  different patient groups, such as
those with severe OSA (high AHI) as well  as symptomatic patients
with ﬂow limitation (low AHI), are needed in  order to better under-
stand sleep-disordered breathing and its  health consequences.
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Objective: Sleep during pregnancy involves a physiological challenge to provide sufﬁcient gas exchange
to the fetus. Enhanced ventilatory responses to hypercapnia and hypoxia may protect from deﬁcient gas
exchange, but sleep-disordered breathing (SDB) may predispose to adverse events. The aim of this study
was to analyze sleep and breathing in healthy pregnant women compared to non-pregnant controls,
with a focus on CO2 changes and upper-airway ﬂow limitation.
Methods: Healthy women in the third trimester and healthy non-pregnant women with normal body
mass index (BMI) were recruited for polysomnography. Conventional analysis of sleep and breathing was
performed. Transcutaneous carbon dioxide (TcCO2) was determined for each sleep stage. Flow-limitation
was analyzed using the ﬂattening index and TcCO2 values were recorded for every inspiration.
Results: Eighteen pregnant women and 12 controls were studied. Pregnancy was associated with shorter
sleep duration and more superﬁcial sleep. Apneaehypopnea index, arterial oxyhemoglobin desaturation,
ﬂow-limitation, snoring or periodic leg movements were similar in the two groups. Mean SaO2 and
minimum SaO2 were lower and average heart rate was higher in the pregnant group. TcCO2 levels did not
differ between groups but variance of TcCO2 was smaller in pregnant women during non-rapid eye
movement (NREM). TcCO2 proﬁles showed transient TcCO2 peaks, which seem speciﬁc to pregnancy.
Conclusions: Healthy pregnancy does not predispose to SDB. Enhanced ventilatory control manifests as
narrowing threshold of TcCO2 between wakefulness and sleep. Pregnant women have a tendency for
rapid CO2 increases during sleep which might have harmful consequences if not properly compensated.
© 2017 Elsevier B.V. All rights reserved.
1. Introduction
Pregnancy is a challenge for the cardiorespiratory system,
particularly during sleep when the body needs to rest without
compromising fetal oxygen supply and carbon dioxide removal. In
normal pregnancy, breathing during sleep is well preserved [1].
Plasma concentrations of progesterone are elevated during preg-
nancy and contribute to the increased ventilatory responses to
hypoxia [2] and hypercapnia [3]. Factors compromising breathing
during pregnancy are the growing uterus that elevates the
diaphragm, resulting in decreased functional residual capacity of
the lung. The decreased tracheal traction in turn predisposes to
upper-airway narrowing, and hormonal changes increase the
upper-airway edema. Obesity during pregnancy is an additional
factor predisposing to obstructive sleep apnea (OSA) or snoring [4].
Breathing abnormalities are purported to be common during
pregnancy, with partial upper-airway obstruction rather than OSA
usually observed [5]. Sleep-disordered breathing (SDB) in pregnant
women is associated with intrauterine growth retardation [6,7].
In sleep studies, CO2 is rarely measured, and little is known
about CO2 control during SDB, but we have previously shown the
effect of progressively developing ﬂow-limitation as well as steady
ﬂow-limitation on transcutaneous CO2 (TcCO2) increase [8e10].
CO2 has been suggested to play a role in hypertension in pre-
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eclampsia [11]. Central chemoreceptor sensitivity to CO2 is also
increased during pregnancy [3], which could destabilize the
ventilation when operated near threshold values.
The purpose of this study was to evaluate the differences in SDB
and TcCO2 parameters during normal pregnancy compared to non-
gravid controls. It was hypothesized that pregnant women may
have more ﬂow-limitation and snoring compared to non-pregnant
women (1). In addition, ﬂow-limitation in pregnant women may
cause greater TcCO2 increase (2), and consequently, TcCO2 values
during sleep should differ between pregnant and non-pregnant
women (3).
2. Methods
2.1. Participants
We recruited 18 pregnant women from maternity clinics in
Tampere and its nearby regions and from the antenatal outpatient
clinic and antenatal ward of Tampere University Hospital. Inclusion
criteria were 18e45 years of age, singleton pregnancy without fetal
demise, and gestational age 33 ± 1 weeks. Women with pre-
eclampsia or other complications warranting constant monitoring
and/or induction of labor were excluded.
Twelve non-pregnant women with body mass index similar to
that of pregnant women in the beginning of pregnancy were cho-
sen as controls. These women were recruited from Tampere Uni-
versity of Applied Sciences, Medical School of University of
Tampere, and Tampere University Hospital, Department of Ob-
stetrics and Gynecology, using recruitment posters. The study was
approved by the local Ethics Committee (Identiﬁcation Number
R12102), and all women received oral and written information on
the trial and signed a consent form before attending.
2.2. Obstetrical examination
The patients were ﬁrst seen by an obstetrician (R.J.) at the
antenatal outpatient clinic or ward. From the maternity card the
following baseline information (standard recordings of the ﬁrst
maternity clinic visit in early pregnancy) was obtained: initial
weight, height, body mass index (BMI), initial blood pressure, and
the results of the oral glucose tolerance test if performed. Fetal
ultrasound was performed using Voluson ultrasound equipment
(Voluson S6 ultrasound, GE Healthcare, CT, USA) to record a fetal
weight estimate, amniotic ﬂuid index (AFI), fetal movements, and
to assess the ﬂow of the umbilical artery (uA). After a minimum of
15 min rest in a supine position in the examination room, blood
pressure was measured from the right arm using a validated
oscillometric technique (Omron automated manometer, M4-I
Intellisense, Omron Corporation, Japan) with medium cuff-size.
Weight was measured on a regular weighing scale. Urine dip stick
test was analyzed for protein and glucose (Combur3 Test, Roche
Diagnostics, Germany).
2.3. Sleep recordings
An overnight polysomnography was performed at Unesta
Research Centre within a week after the obstetrical examination in
the pregnant group. Controls visited the sleep laboratory once and
all the information needed was then gathered. Recording montage
contained electroencephalogram (EEG)with eight channels (A1, A2,
O1, O2, F3, F4, C3, C4), electrooculogram (EOG), submental elec-
tromyography (EMG), anterior tibial EMG, nasal ﬂow (prongs/can-
nula), body position, and inductance plethysmography (RIP) belts,
which reﬂect the respiratory effort of the abdomen and thorax
(Somnologica, Medcare Flaga hf, Reykjavik, Iceland). The sleep
investigations included also nocturnal measurement of trans-
cutaneous partial pressure of carbon dioxide (TcCO2) and trans-
cutaneous partial pressure of oxygen (TcO2). A parasternally ﬁxed
dual sensor (TcCO2 and TcO2) warmed up to 43.0 C was used
(TCM4, Radiometer, Copenhagen, Denmark).
2.4. Data analysis
Sleep was scored according to AASM (American Academy of
Sleep Medicine) criteria [12], and former stages S3eS4 were used
in the breath-by-breath analysis. Proprietary scoring function of
Somnologica was used to score ﬂow limitation and snoring
(default ﬂattening index of 0.13 was used) and reported as per-
centage of total sleep time. Episodes of apnea were scored ac-
cording to AASM rules [13], hypopnea was scored when a 30%
reduction of ﬂow was observed for a minimum of 10 s and apnea-
hypopnea index (AHI) was calculated. Oxyhemoglobin desatura-
tions of 3% (ODI3) or more were tabulated. TcCO2 values were
sampled with the frequency of 1 Hz and the data values during
each sleep stage were pooled to calculate the statistics, including
the median and quartiles for each sleep stage. This means that
each epoch produced 30 data points to the corresponding sleep
stage data pool. TcCO2 values were also determined separately
during inspirations with and without ﬂow-limitation in each
sleep stage. For this respiratory analysis, the TcCO2 data was
advanced 30 s in order to correct the physiological delay between
breathing and the CO2 reading on the skin. In addition, to avoid
the disproportionately marked effect of individuals with low
levels of ﬂow-limited breathing on overall data, the TcCO2 data
was excluded from this analysis if less than 75 data points were
available in a given sleep stage. One to two data points were
available from each inspiration. Accordingly, short episodes (less
than 3e5 min, depending on respiratory rate) of ﬂow-limitation
were not included. Poor quality TcCO2 data (missing, unphysio-
logical behavior and drift more than 1 kPa between evening and
morning wakefulness for sleep stage analysis) as well as data
during calibrations were omitted. TcCO2 drift corrections were
not done. Technical drift occurs both upwards and downwards,
which results in a reduced effect of signal drift on a group level,
but at the same time increases the variance of the sample which
affects statistical analysis.
2.4.1. Peak analysis
The overnight proﬁle revealed TcCO2 ﬂuctuations, which have
not been reported or identiﬁed earlier in any other patient popu-
lation or healthy controls. Based on initial visual observation, a set
of rules to identify and numerically characterize these events were
established. A TcCO2 peak was scored when a sudden TcCO2 in-
crease followed by decrease to baseline was observed. Since no
guidelines exist for scoring this type of event, TcCO2 increase of
more than 0.1 kPa was chosen as a loose criterion to score a TcCO2
peak. For exclusion of clear episodes of apnea and hypopnea,
minimum event duration was set to 1 min and 30 s. Peaks during
rapid eye movement (REM) sleep were excluded due to normal
ventilatory instability and ﬂuctuating TcCO2 that is commonly seen.
Sleep state was required for the peak to be scored and peak events
containing two or more consecutive epochs of wakefulness were
excluded. Association to arousal or respiratory arousal was also
scored. Respiratory arousal was scoredwhen inspiratory ﬂow shape
improved simultaneously with arousal. The start of the peak was
marked when TcCO2 slope started to increase. The end of the event
was marked when TcCO2 returned to starting value or slope
returned near zero (applied when the peak ended at higher TcCO2).
Signal drift was considered insigniﬁcant during these shorter
events.
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2.5. Statistics
The data were analyzed using SPSS (IBM SPSS Statistics for
Windows, Version 24.0. Armonk, NY: IBM Corp.). The differences
between pregnant and controls were analyzed with independent
samples ManneWhitney U-test. Non-parametric tests were used
due to small sample size and skewed distributions. Results are
expressed as medians with interquartile range (IQR) except for age
and BMI where full range is shown. Pearson's chi-square test was
used to test the prevalence of peaks between groups. Non-
parametric Levene's test was used to compare the variance of
TcCO2 between groups in different sleep stages. A p-value <0.05
was considered statistically signiﬁcant.
3. Results
3.1. Obstetrical characteristics
Study enrollment ran from 1 January 2013 to 31 December 2015.
Findings on general physical and obstetrical examination were
normal. All subjects were normotensive without proteinuria. All
fetuses presented with normal bioproﬁles in ultrasound examina-
tion. The outcomes of the pregnancies were analyzed (possible
complications during pregnancy, time and mode of delivery,
birthweight, Apgar scores at 1 and 5 min, umbilical artery pH and
base excess). Fourteen patients delivered vaginally and four via
caesarean section. Gestation at birth ranged from 37 þ 3 to 42 þ 0
weeks. Obstetrical characteristics are presented in Table 1.
3.2. Sleep and demographics
The control population was younger than the pregnant popu-
lation (26, range: 24e31, vs 30, range: 26e36, p < 0.001). There was
no difference in BMI at the beginning of pregnancy compared to
controls (22.0, range 19.0e29.4, vs 21.7, range: 18.8e25.4,
p ¼ 0.245). Sleep quality of the pregnant women was worse
compared to controls. Pregnant women had more light sleep (N1)
and less deep sleep (N3) and REM sleep. Also, total sleep time (TST)
was shorter and wake after sleep onset (WASO) was longer in
pregnant women. A clear difference between the groups was seen
on oxyhemoglobin parameters (SaO2), which were lower in preg-
nant women. Considerable increase in average heart rate was
observed in pregnant women also. Common SDB parameters AHI
and ODI3 showed no differences. Additional measures that were
used (FL-index (%) and snore time (%)) did not show statistical
difference. Two pregnant subjects and one control subject were
identiﬁed as signiﬁcant snorers with episodes of prolonged ﬂow
limitation. Detailed values are presented in Table 2.
3.3. TcCO2
In terms of TcCO2 levels (absolute or relative) there were no
differences in TcCO2 between the pregnant and control groups in
any of the sleep stages (Table 3). In general, the pregnant women
had a wider range for TcCO2 when absolute values were used.
However, we discovered that in pregnant women the variance of
TcCO2 across sleep stages became smaller for non-rapid eye
movement when TcCO2 during wakefulness was used as the
reference value (Table 3, Fig. 1). Sleep stage and TcCO2 analysis was
possible only for 15 pregnant and eight non-pregnant women due
to TcCO2 signal drift and poor data in three pregnant women and
four controls. Inspiratory ﬂow-limitation did not cause greater
Table 1
Obstetrical characteristics of 18 healthy pregnant women participating in the sleep study.
Subject Age P US RR BMI Del Mode Sex BW Apgar uApH
1 36 2 34 þ 6 130/75 25.7 40 þ 3 V Boy 3740 9/9 7.28
2 29 1 32 þ 1 108/69 27.3 39 þ 4 V Boy 3605 9/10 7.26
3 29 0 31 þ 4 112/72 21.0 42 þ 0 V Girl 3300 9/9 7.28
4 36 2 33 þ 2 118/82 NA 39 þ 1 CS Boy 3470 9/9 7.37
5 31 0 33 þ 2 102/67 21.6 40 þ 6 CS Girl 3740 9/9 7.34
6 36 0 33 þ 0 122/71 25.8 40 þ 2 V Boy 3650 8/9 7.21
7 36 2 32 þ 6 124/79 27.7 39 þ 0 V Boy 3120 9/9 7.19
8 29 0 32 þ 6 121/72 29.4 40 þ 1 CS Girl 3080 9/8 7.34
9 29 0 32 þ 3 99/51 25.0 41 þ 3 V Girl 3260 7/8 7.17
10 29 3 32 þ 4 104/58 19.2 39 þ 0 V Girl 3195 9/10 7.24
11 31 1 32 þ 4 120/76 33.0 38 þ 3 V Boy 3800 9/9 7.17
12 30 1 31 þ 4 112/84 22.0 39 þ 3 V Boy 3920 8/9 7.30
13 29 0 34 þ 0 108/72 28.0 41 þ 1 CS Girl 4480 8/8 7.36
14 30 0 31 þ 2 118/74 21.6 39 þ 6 V Boy 3255 7/9 7.13
15 35 0 32 þ 4 112/70 19.2 37 þ 3 V Girl 2385 8/8 7.17
16 34 0 31 þ 5 113/77 19.0 41 þ 1 V Girl 3340 8/9 7.28
17 30 0 33 þ 4 110/80 23.0 39 þ 4 V Girl 3250 6/9 7.20
18 26 0 34 þ 0 124/74 22.0 42 þ 0 V Girl 4190 9/9 7.20
Apgar, Apgar score 1 min/5 min; BMI, body mass index at the beginning of pregnancy; BW, birth weight (g); CS, ceasarean section; Del, gestation at delivery (weeks þ days);
Mode, mode of delivery; NA, not available; P, parity; RR, blood pressure at ultrasound visit; US, ultrasound scan; V, vaginal; uApH, umbilical artery pH at birth.
Table 2
Polysomnography data.
Pregnant Controls p
Median (Q1eQ3) Median (Q1eQ3)
TST (min) 361.0 (330.5e418.9) 415.5 (391.5e429.4) 0.007
Sleep onset (min) 17.5 (11.5e27.6) 21.5 (15.1e27.0) 0.518
WASO (min) 110.5 (58.5e151.1) 39.7 (21.8e77.0) 0.003
Sleep efﬁciency (%) 76.7 (68.3e88.6) 91 (85.0e95.0) 0.002
N1 sleep (min) 30.3 (25.5e45.3) 21.0 (16.3e30.8) 0.004
N2 sleep (min) 141.8 (96.0e168.0) 140.5 (109.9e174.0) 0.884
N3 sleep (min) 118.5 (97.5e143.6) 156.5 (133.3e190.8) 0.009
REM sleep (min) 53.0 (40.3e69.5) 91.5 (73.5e99.6) 0.001
AHI (#/h) 1.55 (0.73e3.25) 0.75 (0.23e1.45) 0.124
ODI3 (%) 0.4 (0e2.1) 0.2 (0e0.38) 0.200
SaO2 mean (%) 95.9 (95.2e96.3) 97.5 (96.1e97.9) <0.001
SaO2 min (%) 93.0 (91.5e94.0) 94.5 (93.3e95.8) 0.008
FL-index (%) 11.3 (6.1e23.6) 10.10 (6.3e18.4) 0.573
Snore time (%) 0 (0e0.33) 0 (0e0.08) 0.914
PLM (#/h) 2.4 (0e5.2) 0.5 (0e1.4) 0.296
Average HR (bpm) 71.7 (64.3e79.0) 59.6 (55.7e66.9) 0.002
Data presented with medians and interquartile range. AHI, apneaehypopnea index;
FL-index, percentage of ﬂow-limited breaths during sleep; HR, average heart rate;
N1, N2, N3, non-rapid eye movement (NREM) sleep; ODI3, oxyhemoglobin desa-
turation for 3% or more; PLM, periodic leg movements; REM sleep, rapid-eye
movement sleep; TST, total sleep time; WASO, wake after sleep onset. Signiﬁcant
p-values are marked with bold.
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TcCO2 increase in pregnant women compared to controls in any of
the sleep stages (data not shown).
3.3.1. TcCO2 peaks
A further look into TcCO2 overnight proﬁles of the pregnant
group showed a number of distinctive peaks (Figs. 2, 3), which are
not commonly seen in overnight proﬁles of non-pregnant subjects.
Eleven of 18 pregnant women had these peaks, whereas four of 12
non-pregnant women had similar TcCO2 peaks (p ¼ 0.136). Alto-
gether, only ﬁve peaks were observed in the control population
versus 78 peaks in the pregnant population (0.42 peaks/person in
controls vs 4.33 peaks/person in pregnant, p¼ 0.028) rendering the
peaks approximately 10-times more frequent in the pregnant
population. Mean amplitude of the peak was 0.20 kPa with dura-
tion of 241 s (range 92e430 s). Mean slopes were 0.11 kPa/min
upwards and 0.09 kPa/min downwards. When present, the number
of peaks per person ranged from 2 to 22 in pregnant women. Fifty-
two TcCO2 peaks (62.7%) were associated with clear inspiratory
ﬂow-limitation (Fig. 2). Respiratory arousal was associated with 14
peaks and arousal with 37 peaks. Amplitude criterion of hypopnea
was reached in 24 peaks and apnea in one peak. Oxyhemoglobin
desaturation of 3e4% was associated with eight events.
4. Discussion
We studied sleep and breathing parameters in 18 healthy
women during pregnancy weeks 31e34, and in 12 healthy non-
gravid controls. Pregnant women slept less and stayed less time
in slow wave sleep and REM sleep. No difference was observed
between groups in terms of ﬂow-limitation or snoring, AHI or pe-
riodic leg movements. However, pregnant women had lower
average and minimum SaO2 levels and increased heart rate. Un-
expectedly, the TcCO2 levels showed no difference between groups
during different sleep stages, only the variance of NREM TcCO2 was
smaller in the pregnant group. These ﬁndings suggest that the
TcCO2, which represents the peripheral pCO2 at the tissue level,
remains unchanged and is carefully controlled during pregnancy.
The most intriguing ﬁnding of our study was that more than half of
the pregnant women presented with transient TcCO2 increases in a
pattern that to our knowledge has not been previously described in
any other control or patient population. Post-hoc analysis showed
that most of these TcCO2 increases were associated with transient
episodes of inspiratory ﬂow-limitation, although in some pregnant
women ﬂow limitationwas absent. The transient TcCO2 increases in
pregnant women are in contrast with otherwise strictly controlled
TcCO2 and may reveal episodes when the maintenance of homeo-
stasis is challenged.
Our study corroborates previous ﬁndings that sleep quality is
diminished during pregnancy [14]. Total sleep time was shorter
with 40-min reductions in N3 and REM sleep and increase in N1
sleep.We showed that breathing is only minimally disturbed in late
pregnancy, a ﬁnding that has been reported several times before. A
recent study performed by Sarberg et al. [15] had a similar, albeit
larger, healthy study population with comparable results of very
low levels of AHI, ODI and nadir SaO2 from the respiratory re-
cordings. We observed lower levels of snoring than have been
previously reported, but this difference may result from method-
ological differences.
The average SaO2 during sleep was lower in pregnant women
compared to the controls. This is in line with earlier ﬁndings
showing progressively decreasing PaO2 levels [16] from second to
third trimester of pregnancy seen in the supine position. The fact
that PaO2 does not decrease during pregnancy in the sitting posi-
tion [16] suggests that also the lower SaO2 in our study during sleep
is associated with body position and the progressive impact of
Table 3
Absolute and relative transcutaneous CO2 data for sleep stages.
Pregnant (N ¼ 15) Controls (N ¼ 8) p p (variance)
Median (Q1eQ3) Median (Q1eQ3)
TcCO2, absolute (kPa)
Wake 6.19 (5.41e6.65) 6.16 (5.96e6.51) 0.776
N1 sleep 6.28 (5.35e6.75) 6.49 (6.04e6.74) 0.428
N2 sleep 6.28 (5.43e6.75) 6.57 (5.97e6.89) 0.392
N3 sleep 6.32 (5.92e6.65) 6.52 (5.97e7.08) 0.506
REM sleep 6.41 (5.28e6.95) 6.39 (5.72e6.78) 0.825
NREM sleep 6.29 (5.48e6.67) 6.56 (5.98e7.01) 0.357
DTcCO2 (kPa)
Wake (reference) 0 0 e
N1 sleep 0.08 (0.03 to 0.18) 0.20 (0.03e0.61) 0.115 0.323
N2 sleep 0.12 (0.05e0.29) 0.24 (0.04 to 0.65) 0.506 0.213
N3 sleep 0.15 (0.08e0.38) 0.21 (0.04e0.53) 0.825 0.075
REM sleep 0.15 (0.08e0.43) 0.16 (0.15 to 0.49) 0.925 0.067
NREM sleep 0.11 (0.07e0.22) 0.24 (0.03e0.62) 0.506 0.038
Data presentedwithmedians and interquartile range. N1, N2, N3, non-rapid eyemovement (NREM) sleep; REM, rapid eyemovement; TcCO2, transcutaneous carbon dioxide. p
(variance) denotes Levene's test. Signiﬁcant p-values are marked with bold.
Fig. 1. Relative transcutaneous carbon dioxide (TcCO2) in pregnant women and con-
trols during different sleep stages. Wakefulness was assigned as 0 kPa and sleep stages
are relative to that. TcCO2 levels did not differ between groups, but the variance
(Levene's test) was different for pooled non-rapid eye movement. Boxplots show
median values with interquartile range and minemax. Circle denotes outlier.
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elevating diaphragm on functional residual capacity (FRC) and
oxygenation [17]. The cardiac output increases during pregnancy
[18] but also becomes sensitive to body position suggesting
compression of the inferior vena cava by the uterus [19]. Decreased
venous return to the heart could contribute to the observed
increasing heart rate in the third trimester since stroke volume
decreases from the second trimester [18].
The role of CO2 in SDB during pregnancy has been speculated
[11,20], as well as in pre-eclampsia [11]. CO2 measurements are not
routinely measured during adult sleep studies [21], mainly due to
lack of simple, robust and noninvasive methods of CO2 monitoring.
The reference measurement is partial pressure of the arterial CO2
(PaCO2), which is a reliable measure of ventilation but requires
blood samples and is not suitable for sleep studies. End-tidal CO2
(EtCO2) is noninvasive and allows for continuous monitoring of the
mixed venous CO2 provided that the tidal volumes are sufﬁcient to
produce readable end-tidal CO2-plateau: this may be a challenge in
subjects with mouth breathing, SDB, nocturnal hypoventilation or
usage of a continuous positive airway pressure (CPAP) mask, which
is often the case in subjects in whom this type of measurement is
indicated [13].
TcCO2 measurement is probably best adapted for sleep re-
cordings. It reﬂects both ventilation and peripheral blood perfusion
[22,23]. The main issues with TcCO2 are slow response time and
potential signal drift during prolonged recording [24,25]. The
overnight TcCO2 proﬁles can display either technical drift or phys-
iological trends. The technical drifts can be related to changes in the
contact between the sensor and the skin after changes in body
position but may also occur within the sensor. The physiological
trends arise from changes in control of breathing and circulation at
the system level or changes in metabolism and blood perfusion
locally. The TcCO2 signal is a combination of ventilation at system
level and perfusion at local level, which are both under the control
of the sympathetic nervous system. The sympathetic tone from
Fig. 2. Three examples of overnight transcutaneous carbon dioxide (TcCO2) proﬁle with hypnogram. For drift assessment, we expect that the wakefulness TcCO2 should be the same
in the evening and in the morning. Also, the plateau levels during slow-wave sleep should repeat at about the same levels. (a) A pregnant woman with TcCO2 peaks (arrows)
associated with short episodes of ﬂow-limitation. Overnight ﬂow-limitation index was 4.3%. Downward trend of the signal is considered physiological, related to respiratory stimuli
from circadian process and/or sleep fragmentation. (b) A pregnant womanwith TcCO2 peaks (arrows) without ﬂow-limitation episodes. Overnight ﬂow-limitation index was 4.7%. A
minor upwards drift is probable, since the wakefulness levels are higher in the morning. The lower ﬂuctuating TcCO2 level during the early part of the recording seems to hinder
TcCO2 increase to the so-called plateau level during slow-wave sleep, so drift may seem more accentuated than what it really is. (c) A control woman without any TcCO2 peaks.
Overnight ﬂow-limitation index was 3.1%. Decreasing trend of the plateau levels and evening/morning wakefulness levels suggest a technical drift.
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hypothalamic origin displays a circadian rhythm with high tone
during wakefulness and a nadir tone around 03:00e04:00 h. Dur-
ing the morning hours this sympathetic tone starts to increase and
is potentially reﬂected as a decreasing trend in TcCO2, as superﬁcial
skin perfusion starts to increase. A physiological trend may also
occur, if the proportion of slow-wave sleep (SWS) decreases and the
proportion of sleep stages N1eN2, REM or wake increase as they
often do during the latter part of the night. This is the likely
explanation for the decreasing trend in Fig. 2(a), since the wake-
fulness levels are the same before sleep onset and after sleep.
Frequent arousals from sleep decrease the TcCO2 (hyperventilation)
whereas periods of upper-airway ﬂow-limitation increase it
(hypoventilation). Long or repeated periods of ﬂow-limitation may
also cause a physiological TcCO2 increase over time. In the pop-
ulations of the current study, prolonged ﬂow-limitation was rare
and its contribution toTcCO2 trends was unlikely. We conclude that,
at present, it is not possible to distinguish between technical and
physiological trends. Therefore, we preferred only to exclude cases
with extreme trend/drifts but include signals with limited drift.
We are not aware of previous reports of TcCO2 during sleep in
pregnancy. Therefore, we can only compare our results with studies
using other methods, including also measurement while awake. It
is well established that the minute ventilation increases and PaCO2
decreases during pregnancy [26]. This effect is considered as an
exaggeration of ventilation to ensure sufﬁcient gas exchange to the
fetus and is at least partly driven by increasing levels of proges-
terone during pregnancy [3]. Against our expectations, we failed to
show decreased TcCO2 levels in pregnant women. There are several
possible explanations for this observation. First, the sensitivity or
accuracy of the TcCO2 method is not sufﬁcient to demonstrate
difference. This interpretation is not supported by the observed
lower variance in our larger study group (15 pregnant women vs
eight controls), which may reﬂect increased chemoreceptor sensi-
tivity [3]. The PaCO2 increases during sleep [27] but decreases
during pregnancy while awake [26]. When using TcCO2, we see
sleep-related increase but not pregnancy-related decrease while
awake (Table 3), which should be of about similar magnitude. This
suggests that the effects of sleep and pregnancy on the TcCO2 are
mediated through different mechanisms. One possible explanation
for similar TcCO2 values could be that the TcCO2 measures the
combination of the increased metabolic rate with increased CO2
production and decreased PaCO2, resulting in no change. However,
the lower partial pressure of CO2 in the arteries and higher heart
rate during pregnancy could represent adaptive measures to
maintain constant pCO2 at the tissue level.
Discovering the TcCO2 peaks in the healthy pregnant women
(but not in controls) is new and seems contradictory in relation to
the mechanisms mentioned above. One would assume that
changes in TcCO2 should be minimal. Yet, visually detectable tran-
sient TcCO2 increases are common pregnancy-speciﬁc ﬁndings. The
transient TcCO2 increases with upper-airway ﬂow limitation can be
explained as obstructive events. Partial upper-airway collapse de-
creases minute ventilation, which results in transient CO2 increase
followed by corrective response. We have previously shown that
upper-airway ﬂow limitation during sleep is associated with
increasing TcCO2 [8,9]. There are several reasons for upper-airway
narrowing during pregnancy, including upper-airway edema and
decreased tracheal traction due to pregnancy-induced elevation of
the diaphragm. On the other hand, tight respiratory control during
pregnancy ensures that the minor upper-airway obstructive event
is promptly corrected and does not develop into an episode of OSA.
Examples of transient TcCO2 increases with ﬂow limitation are
presented in Fig. 2(a) and Fig. 3. These episodes may play a role in
pre-eclampsia [11].
In contrast to TcCO2 peaks associated with ﬂow-limitation, in
some individuals the phenomenon is more likely to be associated
with unstable respiratory control. A different type of TcCO2 pattern
is seen in Fig. 2(b). This ﬂuctuation was counted as peaks, but since
ﬂow-limitation is not observed it can be speculated that ventilatory
plant gain is increased (small changes in ventilation cause
augmented CO2/O2 response). Slight ﬂuctuation of ventilation is
observed during these peaks in SWS which indicates an overall
increase in loop gain, as ventilation during SWS is usually very
stable. Respiratory stimulation during pregnancy probably
Fig. 3. A pregnant woman with two transcutaneous CO2 peaks associated with ﬂow-limitation episodes. (a) Hypnogram. (b) The overnight TcCO2. (c) A detailed 18-min time
window, from the darkened area shown in (a) and (b). Traces: SaO2 (%), arterial oxyhemoglobin saturation; TcO2 (kPa), transcutaneous partial pressure of oxygen; TcCO2 (kPa),
transcutaneous partial pressure of carbon dioxide; Flow (ml/s), ﬂow at nasal prongs.
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prohibits the development of (central) apneic behavior because
reaching the apneic threshold would require further increase in
ventilation [27]. In fact a recent study showed that central sleep
apnea is almost non-existent during late pregnancy [20]. This could
also explain why the observed large ﬂuctuations in TcCO2 are
accompanied by very little waxing and waning behavior. In our
previous studies we have used the concept of TcCO2 plateau to
describe optimal TcCO2 during sleep and normal breathing [9]. If
this level is exceeded, respiratory efforts increase. Fig. 2(a) repre-
sents this idea well during the ﬁrst sleep cycle; ﬂow-limitation
causes upward deviation of the TcCO2 from the target level, but
compensatory mechanisms quickly restore the optimal level. On
the other hand, if a disturbance such as an arousal decreases CO2
from the target level, the ventilation is repressed in order to restore
that optimal level. An extreme case is the momentary repression to
zero when apneic threshold is reached. The pregnant woman in
Fig. 2(b) presumably ﬂuctuates around the plateau level since there
is neither ﬂow-limitation nor hypopneic breathing present. Our
results show the dynamic behavior of CO2 during sleep in preg-
nancy, which could beneﬁt the understanding of SDB during this
vulnerable state. It remains to be investigated whether the CO2
events observed here are prolonged or exaggerated in risk pop-
ulations and how they may contribute to pathophysiological
processes.
The strength of this study is the use of overnight TcCO2 mea-
surement and a healthy population. Changes that are seen in TcCO2
proﬁle should be considered as normal ﬁndings, which is useful
when TcCO2 is measured in high-risk populations or in pre-
eclamptic patients. In addition, a full polysomnographic recording
allowed detailed determination of sleep. Determination of PaCO2
during sleep would have been informative, but being invasive and
uncomfortable procedure it would have disturbed sleep unduly.
EtCO2 measurement would have also been useful, but was not
available for this study. The number of subjects in this exploratory
study is quite small and thus decreases the statistical power.
However, recruitment of women for an overnight sleep recording in
late pregnancy is challenging, particularly when no previous
measurement standards exist for all the events. Hence, a novel
method for scoring TcCO2 peaks was developed and used in this
study.
Our approach for respiratory analysis has limitations, which
should be considered when evaluating the data. First, the use of
automated scoring function for breathing may not be optimal, but
subject-to-subject variation is minimal and systematic error is
similar between subjects. Second, the TcCO2 signal is known to drift
and this will have an effect if normal breathing and ﬂow-limited
breathing occur at different times during the night. In order to
counter this effect, datawith large differences between the evening
and morning were discarded. Also, large ﬂuctuations in TcCO2
signal without any discernible change in ventilation were consid-
ered erroneous. Some individuals had virtually no ﬂow-limitation
and in order to avoid overrepresentation in the data, data from
sleep stages with small amounts of ﬂow-limited breathing were
excluded.
For the analysis of sleep stage TcCO2 the data was pooled from
the whole night to give a sleep-stage-speciﬁc TcCO2 value. In the
case of signal drift, this approach is problematic since it introduces
bias. Signal drift downwards will give values that are too low and
upward drift will give TcCO2 values that are too high. Technical drift
however, occurs in both directions and when the data is analyzed
on a group level the effect of drift is diminished to some extent.
Unfortunately the variance is increased at the same time, which
makes it more difﬁcult to see statistical differences between
groups. This may explain why we failed to see differences between
sleep stages. Despite of these limitations we see that our data gives
a detailed view of overnight CO2 dynamics that should be further
studied.
Our results open new perspectives to cardiorespiratory moni-
toring during sleep and pregnancy. In healthy individuals, even
subtle changes in ventilation may lead to notable changes in TcCO2.
Our subjects were healthy and had a relatively low level of SDB, but
in individuals with complicated pregnancies, upper-airway ﬂow-
limitation could result in marked (Tc)CO2 changes affecting heart
and endothelial function. CO2 increase related to ﬂow-limitation
may contribute to overnight increase in blood pressure [11] that
is reversible with treatment. Identiﬁcation of clinically signiﬁcant
TcCO2 patterns could in the future guide to treatment decisions in
symptomatic patients with low AHI. Flow limitation can be effec-
tively controlled with CPAP (continuous positive airway pressure), a
mode of therapy which helps to stabilize CO2 levels and sleep.
5. Conclusions
In conclusion, during normal pregnancy SDB is very mild and
comparable to non-pregnant controls. In contrast to the earlier
ﬁndings of decreased PaCO2 during pregnancy, the absolute levels
of TcCO2 showed no difference between the groups. However, the
variance of TcCO2 is smaller in the pregnant group when relative
values are used. We suggest that the decreased PaCO2 during
pregnancy is an adaptive measure to maintain constant pCO2 at the
tissue level. Transient changes are seen in overnight TcCO2 proﬁle,
which reﬂect altered respiratory control. Further studies with a
larger population are evidently needed in the ﬁeld of sleep disor-
ders during pregnancy and different pregnancy complications.
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